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ABSTRACT
Background: Polycystic Ovary Syndrome (PCOS) is a common endocrine
disorder in women of reproductive age, associated with complications of metabolic,
reproductive, and psychological health. Adolescence is an optimal time for early
identification of PCOS in order to mitigate long-term health risks. Pediatric primary care
providers (pedPCPs) are the first-line for early identification and coordination of longterm comprehensive management. Limited information exists to describe how PCOS is
addressed in primary care and if adolescent-specific guidelines are applied.
Objectives: Describe practice behaviors of pedPCPs in the diagnosis and
management of PCOS, and identify barriers and facilitators to inform future interventions
to optimize comprehensive care for adolescents with PCOS.
Methods: A mixed-methods sequential explanatory design included survey
research and semi-structured interviews. A barrier assessment framework, combined with
behavior change models, underpin the conceptual framework that guided survey
development. Snowball sampling recruited physicians, physician assistants and nurse
practitioners in primary care in Virginia, Maryland and Washington D.C. through
professional associations and academic institutions. Descriptive statistical analysis of
survey data was conducted utilizing SPSS. Respondents from the survey research who
volunteered for follow up participated in 1:1 semi-structured interviews, which were

vii
audio recorded, transcribed verbatim and coded. Nvivo 12 was used to code using
thematic analysis.
Results: Fifty-two completed survey responses were analyzed for practice
behaviors and attitudes/beliefs. Qualitative data from 20 interviews offered rich
descriptions of pedPCPs’ experience in addressing PCOS. Integration of the quantitative
and qualitative results demonstrated that level of engagement to address PCOS varied
among pedPCPs. Differences in provider confidence, collaboration with colleagues
and/or specialists, practice structure and policies, and pedPCPs’ perception of patient
factors explain some variations observed across practices.
Conclusion: PedPCPs play an important role in the identification and
management of PCOS in adolescence. Research results provide a model to map
intervention components that will overcome barriers and enhance facilitators to address
PCOS in primary care. Interventions should include case based learning and a platform
for pedPCPs to collaborate with experts. Improving the capacity of pedPCPs to diagnose
and manage PCOS is key to optimize care for adolescents and reduce risks of immediate
and long-term complications of PCOS.

Keywords: Polycystic Ovary Syndrome, Adolescents, Diagnosis, Treatment,
Management, Primary Care, Pediatric, Family Medicine

viii

TABLE OF CONTENTS
ACKNOWLEDGMENTS ................................................................................................. iv
ABSTRACT....................................................................................................................... vi
LIST OF TABLES ............................................................................................................ xii
LIST OF FIGURES ......................................................................................................... xiv
CHAPTER 1: INTRODUCTION ....................................................................................... 1
Overview ................................................................................................................. 1
Statement of the Problem ........................................................................................ 6
Purpose and Research Questions ............................................................................ 6
Statement of Potential Impact ................................................................................. 7
Translational Nature of the Study ........................................................................... 8
Conceptual Framework ........................................................................................... 9
Summary of Methodology .................................................................................... 11
Limitations & Delimitations ................................................................................. 11
Definition of Key Terms ....................................................................................... 13
CHAPTER 2: LITERATURE REVIEW .......................................................................... 14
Introduction ........................................................................................................... 14
Polycystic Ovary Syndrome (PCOS) in Adolescents ........................................... 15
Pathophysiology........................................................................................ 16
Clinical Presentation ................................................................................. 18
Diagnosis of PCOS in Adolescents........................................................... 19
Management/Treatment of PCOS in Adolescents .................................... 28

ix
Unique Considerations in the Adolescent Patient with PCOS.................. 34
Practice Behaviors ................................................................................................ 39
Current Trends in Practice Behaviors ....................................................... 40
Barriers to Diagnosis and Management of PCOS in Adolescents ............ 45
Conceptual Framework ......................................................................................... 47
CHAPTER 3: METHODOLOGY .................................................................................... 50
Research Methodology ......................................................................................... 50
Research Design ................................................................................................... 52
Study Population and Setting: Inclusion/Exclusion Criteria .................... 54
Quantitative Study ................................................................................................ 54
Survey Development................................................................................. 55
Sampling and Recruitment........................................................................ 60
Study Procedure ........................................................................................ 64
Data Analytic Plan .................................................................................... 64
Qualitative Study .................................................................................................. 69
Qualitative Research Activities................................................................. 69
Sampling and Recruitment........................................................................ 70
Procedure .................................................................................................. 72
Data Analysis ............................................................................................ 73
Accuracy ............................................................................................................... 75
Protection of Human Subjects .............................................................................. 78
Quantitative Research ............................................................................... 78
Qualitative Research ................................................................................. 79

x
CHAPTER 4: RESULTS .................................................................................................. 82
Quantitative Results .............................................................................................. 82
Demographics ........................................................................................... 82
Behavior: Identification of PCOS ............................................................. 89
Behavior: Diagnosis of PCOS in Adolescents .......................................... 90
Behavior: Management of PCOS in Adolescents ..................................... 95
Referral to Specialty Care ....................................................................... 101
Knowledge Seeking Behaviors ............................................................... 101
Aim 1 Key Points .................................................................................... 102
Provider Knowledge ............................................................................... 104
Practice Characteristics ........................................................................... 106
Provider Attitudes and Beliefs ................................................................ 112
Aim 2 Key Points .................................................................................... 120
Qualitative Results .............................................................................................. 122
Participant Characteristics ...................................................................... 122
Participant Behaviors and Attitudes/Beliefs ........................................... 124
Interview Data ......................................................................................... 126
Thematic Analysis .................................................................................. 126
Theme #1 ................................................................................................ 127
Theme #2 ................................................................................................ 132
Theme #3 ................................................................................................ 140
Qualitative Summary .............................................................................. 146
Mixed Methods Results ...................................................................................... 147

xi
CHAPTER 5: DISCUSSION.......................................................................................... 154
Introduction ......................................................................................................... 154
Major Findings of the Dissertation ..................................................................... 155
Behavior, Knowledge, and the Role of the PedPCP ............................... 156
Behavior and Attitude/Beliefs................................................................. 161
Behavior and External Factors: Practice Characteristics ........................ 163
Behaviors and External Factors: Patient Factors .................................... 168
Study Limitations ................................................................................................ 169
Recommendations/Directions for Translational Research ................................. 172
ECHO Model .......................................................................................... 174
Development and Implementation of PCOS Toolkit .............................. 176
Conclusion .......................................................................................................... 179
REFERENCES ............................................................................................................... 181
APPENDICES ................................................................................................................ 196
Appendix A. Survey Instrument ......................................................................... 196
Appendix B. Qualitative Interview Guide .......................................................... 205
Appendix C. Qualitative Categories and Codes ................................................. 206
Appendix D. Qualitative Codebook.................................................................... 207

xii

LIST OF TABLES
Table 1. Diagnostic Criteria for Polycystic Ovary Syndrome in Adolescents .................22
Table 2. Diagnostic Testing for Adolescents with Suspected PCOS ................................26
Table 3. Recommendations and Medication Options for the Management of PCOS in
Adolescents ........................................................................................................................29
Table 4. Variables for Provider and Practice Characteristics and Provider Behaviors .58
Table 5. Provider Attitude and Beliefs Scale ...................................................................59
Table 6. Provider Behavior ..............................................................................................66
Table 7. Provider Demographics and Characteristics ....................................................84
Table 8. Practice Characteristics Across Practice Settings ............................................88
Table 9. Estimate Number of Patients with PCOS Annually ...........................................91
Table 10. Key Behaviors to Diagnose PCOS ...................................................................93
Table 11. Distribution of Practice Scores ........................................................................94
Table 12. Distribution of Screening Practice Scores .......................................................99
Table 13. Frequency Table Practice Behaviors .............................................................100
Table 14. Continuing Education Activities ....................................................................102
Table 15. Knowledge of Diagnostic Criteria .................................................................104
Table 16. Analysis of Variance for Diagnostic Practice Score and Practice
Characteristics .................................................................................................................108
Table 17. ANOVA Post Hoc Tests ..................................................................................109

xiii
Table 18. Psychometric Properties for Attitude and Beliefs Scale and Subscale
(n=52) 114
Table 19. Attitude and Belief Scale Analysis (n=52) .....................................................115
Table 20. Variable for Mean Comparisons of Attitude and Belief Scale and
Subscales ..........................................................................................................................117
Table 21. Comparison of Attitudes/Beliefs Scale/Subscale Scores with Diagnostic
Behaviors .........................................................................................................................118
Table 22. Comparison of Attitudes/Beliefs Scale/Subscale Scores With Treatment
Behaviors .........................................................................................................................119
Table 23. Comparison of Attitudes/Beliefs Scale/Subscale Scores With Screening
Behaviors .........................................................................................................................120
Table 24. Provider Demographics and Provider Characteristics of Interview
Participants (n=20) .........................................................................................................123
Table 25. Interview Participant Knowledge and Behaviors ..........................................125
Table 26. Interview Participants Attitude and Beliefs ...................................................126
Table 27. Barriers and Facilitators to Management .....................................................137
Table 28. Ways to Address .............................................................................................145
Table 29. Mixed Methods Results ..................................................................................148

xiv

LIST OF FIGURES
Figure 1 Development of Adolescent-Specific PCOS Diagnostic Criteria ......................20
Figure 2 Conceptual Framework .....................................................................................49
Figure 3 Study Design ......................................................................................................53
Figure 4 Study Schema .....................................................................................................75
Figure 5 Maxwell’s Alignment .........................................................................................78
Figure 6 Practice Location and Region ...........................................................................85
Figure 7 Encounters When Providers Inquire About Menses ..........................................90
Figure 8 Diagnostic Tests Selected ..................................................................................92
Figure 9 Diagnostic Practice Scores ...............................................................................94
Figure 10 Provider Identified Treatment Goal ................................................................96
Figure 11 Provider Treatment Selection ..........................................................................97
Figure 12 Screening for Complications of PCOS ............................................................98
Figure 13 Screening Practice Scores ...............................................................................99
Figure 14 Knowledge of Diagnostic Criteria.................................................................105
Figure 15 Categories and Overarching Themes ............................................................127
Figure 16 Divergent Experiences in the Management of PCOS ....................................133
Figure 17 Barriers and Facilitators to Address PCOS Among Adolescents in a Primary
Care Setting .....................................................................................................................155
Figure 18 Intervention Mapping ....................................................................................173

CHAPTER 1: INTRODUCTION

Overview
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that is
characterized by ovulatory dysfunction and hyperandrogenism (Ibanez et al., 2017;
Witchel et al., 2020). PCOS is considered one of the most common endocrine disorders
in women, the leading cause of infertility in the U.S., and a major risk factor for
metabolic syndrome and type 2 diabetes (T2DM) (Dokras et al., 2014; Witchel et al.,
2019). Symptoms of PCOS often begin in adolescence, but it is commonly not diagnosed
until adulthood when women present with complications such as infertility (Gibson-Helm
et al., 2017). The prevalence of PCOS in adolescents is unclear due to variations in
populations studied and diagnostic guidelines, but estimated prevalence in women of
reproductive age in the U.S. is 8-13% and 6% in adolescent girls (Witchel et al., 2020).
Many experts agree that there is a missed opportunity when PCOS is not diagnosed until
adulthood as this condition is associated with several complications of reproductive,
metabolic, and mental health (Dokras et al., 2014). Early identification is critical to
prompt early intervention and reduce risk from both immediate and chronic
complications of PCOS (Gibson-Helm et al., 2017). Pediatric primary care providers
(PedPCP) within the United States (e.g., MDs, PA-Cs, ARNP) are on the first-line for
early identification and diagnosis of PCOS, and for coordination of comprehensive

management. However, no empirical research to date has evaluated pedPCP practice
behaviors and the role of the primary care provider in the identification, diagnosis and
management of PCOS in adolescents.
PCOS is associated with complications of both reproductive and metabolic health,
including infertility, endometrial hyperplasia, endometrial cancer (Rosenfield, 2015; Yii
et al., 2009), metabolic syndrome, T2DM, sleep disorders, insulin resistance (IR), and
cardiovascular disease (Dokras et al., 2018; Kamboj & Bonny, 2017). Additionally,
research demonstrates psychological implications and a negative impact on quality of life
in both adolescent and adult populations (Dokras et al., 2018; Rofey et al., 2009; Snyder,
2005; Trent et al., 2003; Trent et al., 2005; Yii et al., 2009). Symptoms of PCOS usually
manifest during adolescence and include hirsutism, severe acne, and/or irregular menses
(Dokras et al., 2017; Powers et al., 2015). Research has shown that the symptoms of
PCOS and concern for long-term complications of PCOS, such as infertility, can have an
immediate and significant negative impact on adolescents at a vital time for social,
emotional and physical development (Snyder, 2005; Trent et al., 2003; Trent et al., 2005).
Women (ages 18-35 years) with PCOS have also reported dissatisfaction in their
care due to a delay in diagnosis of PCOS (most women reported over 2 years and visits to
multiple clinicians prior to a diagnosis), and lack of information provided to them at the
time of diagnosis (Gibson-Helm et al., 2017). Research also demonstrates an association
between length of time before receiving a diagnosis of PCOS and higher anxiety and
depression (Gibson-Helm, et al., 2011).
Adolescence may be a critical period for the initial identification of PCOS.
Dokras and Witchel (2014) describe a missed opportunity for optimal care when PCOS is
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not diagnosed during adolescence. They argue that health care is often not a priority for
emerging adults and as a result, care for PCOS is suboptimal or absent early in young
adulthood, resulting in both short-term (i.e., presenting symptoms are not addressed) and
long-term (i.e., diagnosis is delayed) gaps in care. This results in not only a lack of early
and effective treatment, but also a missed opportunity to screen for other comorbid
conditions and appropriately transition adolescents into adult care as a young adult
(Dokras & Witchel, 2014). The end-result is women not seeking care until they
experience complications of PCOS, such as infertility or PCOS-related comorbidities,
such as T2DM (Dokras & Witchel, 2014).
The complexity of PCOS requires comprehensive and multidisciplinary treatment
with a long-term management approach. This is best facilitated by the primary care
provider for three reasons: First, often specialists will not accept self-referrals and require
a referral from a pedPCP. Second, many third-party payers require an initial assessment
by a pedPCP to justify a referral to a specialty provider. Third, there may be limited
access to specialty providers due to provider shortages in certain geographical regions.
Primary care providers are in an optimal position for early identification and diagnosis to
ensure optimal management. Treatment and management of PCOS includes not only
addressing the presenting clinical manifestations of PCOS, but also screening for
comorbid conditions associated with PCOS. Similar to other chronic conditions and
complex disorders, pedPCPs play a crucial role in initial identification of PCOS, carrying
out secondary disease prevention, and referring to specialty care when appropriate.
The complexity of PCOS may be overwhelming for some pedPCPs, and the
diagnosis of PCOS in the adolescent population is challenging due to difficultly
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distinguishing between manifestations of PCOS and normal physiologic changes of
puberty. Providers must be aware of adolescent-specific guidance for the diagnosis and
management of PCOS and evidence in the literature that addresses the unique
considerations of PCOS in adolescence. Adolescent-specific guidance for the diagnosis
and management of PCOS have been discussed in the literature for nearly a decade, but
have not been widely disseminated outside of the specialty literature (Vassalou et al.,
2019). The most up to date guidance, which is promoted by the Pediatric Endocrine
Society (PES), is from the International Consortium of Paediatric Endocrinology (ICPE)
2017 Consensus Statement. The aim of the 2017 consensus statement was to improve
worldwide care of adolescent girls with PCOS (Ibanez et al., 2017). The international
consensus statement addresses the unique considerations to diagnose PCOS during
adolescence, provide symptom-focused treatment recommendations, and guidelines to
screen for metabolic disorders associated with PCOS (Ibanez et al., 2017).
Peer-reviewed literature on PCOS in adolescence is mainly distributed in medical
specialty journals (e.g., The Journal of Clinical Endocrinology and Metabolism,
Hormone Research in Paediatrics), resulting in limited knowledge dissemination to
PedPCPs who are unlikely to routinely subscribe to these journals given the niche target
audience inconsistent with their general practice. Thus, PedPCPs likely have little to no
exposure to adolescent specific guidelines supported by the PES. This limits
identification and management of PCOS to the lens of a specialist. Evidence of
dissemination of PES PCOS guidelines to pedPCPs, or investigation of knowledge gaps
in the diagnosis and management of PCOS amongst pedPCPs, is scarce. Literature that
examines differences in the diagnosis and management of PCOS across the specialty
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providers (e.g., gynecologist, endocrinologist), demonstrates that limited awareness and
familiarity with practice guidelines is a key barrier to appropriate diagnosis and treatment
(Dokras et al., 2017). The literature remains silent regarding primary care providers;
therefore, it can only be hypothesized that lack of awareness and familiarity with
adolescent specific PCOS guidelines is also a major barrier to appropriate diagnosis and
management of PCOS among pedPCPs.
A 2012 executive summary of a National Institutes of Health (NIH) workshop on
PCOS calls for greater engagement of primary care providers in the development and
implementation of PCOS guidelines. There is little evidence of efforts aimed at engaging
pedPCPs, or even understanding current trends in practice behaviors to address PCOS.
An example from the Australia National Health and Medical Research Council
(NHMRC) Centre for Research Excellence in PCOS (CRE PCOS) (2017) highlights
efforts focused on the dissemination and implementation of updated PCOS guidelines to
include comprehensive needs assessment research with primary care health professionals.
There is no evidence of current efforts in the Unites States.
Frameworks that explain factors that influence provider practice behaviors suggest
knowledge is only one barrier to the implementation of guidelines in practice (Cabana et
al., 1999; Cochrane et al., 2007). Awareness of clinical practice guidelines has limited
effect on provider behaviors as adherence to guidelines is influenced by multiple factors
that will vary in different settings (Cabana et al., 1999). The overarching hypothesis of this
study is that practice behaviors among pedPCPs in the identification, diagnosis and
management of PCOS are influenced by multiple factors to include knowledge, practice
characteristics such as geographical region, and provider attitude and beliefs.
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The ultimate goal of this research is to support pedPCPs as a key player in the
diagnosis and management of adolescents with PCOS. This research aimed to identify
current practice behaviors, and explain, through a mixed-methods research design, the
factors that influence pedPCPs behaviors to diagnose and manage PCOS. This study is
the first to generate knowledge specific to the behaviors of and barriers for pedPCPs in
addressing PCOS. Knowledge gained from this study will inform future interventions for
the dissemination and implementation of clinical guidelines into practice among
pedPCPs.
Statement of the Problem
The literature examining knowledge gaps in diagnosis and treatment of PCOS has
mostly focused on specialty providers and lacks insight into the knowledge, behaviors,
attitudes, and beliefs of pedPCPs. No empirical research has systematically evaluated
pedPCP practice behaviors and the role of the primary care provider in the identification,
diagnosis and management of PCOS in adolescents. Primary care providers are not only
the first line for early identification but they are also well positioned to coordinate the
management of this complex condition that often requires a long-term multidisciplinary
approach. There is lack of understanding of current practices and the potential barriers
that must be addressed in order to influence practice behaviors and develop strategies to
support a comprehensive approach to optimal management of PCOS among pedPCPs.
Purpose and Research Questions
The goal of this dissertation is to describe practice behaviors of pediatric PCPs in
the diagnosis and management of PCOS, and identify barriers and facilitators to inform
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interventions to change practice behaviors. Specific aims and accompanying research
questions include:
Aim 1. Identify current practice behaviors among pediatric primary care providers
in the identification, diagnosis and management of PCOS in adolescents. RQ1: What are
the practice behaviors of pediatric primary care providers in the identification, diagnosis
and management of PCOS in adolescents?
Aim 2. Evaluate the factors (provider knowledge, practice characteristics and
provider attitudes and beliefs) that influence practice behaviors to address PCOS in a
pediatric primary care setting. RQ 2: What factors, both modifiable and non-modifiable,
influence practice behaviors of pediatric providers to address PCOS in a primary care
setting?
Aim 3. Understand barriers and facilitators to the identification, diagnosis and
management of PCOS in adolescents in a primary care setting in order to inform future
interventions to influence practice behaviors. RQ 3: How do pediatric primary care
providers experience barriers and facilitators in the identification, diagnosis and
management of PCOS among adolescents, and how can they be addressed in order to
optimize care?
Statement of Potential Impact
This research will inform the future development of interventions for the
dissemination and implementation of adolescent PCOS diagnostic and treatment
guidelines into practice. The opportunity exists for primary care providers to diagnose
and effectively manage PCOS at younger ages and mitigate the risk of long term
complications and poor health outcomes. The long-term goal is to provide clinical
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support tools to guide pedPCPs in the delivery of evidence based patient-centered care
for adolescents with PCOS. This research will provide a foundation for future work and
makes a significant contribution to expanding what is known in the primary care
literature, which has limited focus on PCOS in the primary care setting.
Translational Nature of the Study
The Biomedical Research Translation Continuum (Drolet & Lorenzi, 2011)
highlights the pathway from basic science to clinical practice, noting “chasms” between
areas of action where knowledge from research is applied. Translation chasm #3 relates to
the implementation and adoption of current practice guidelines, driven by evidence, into
practice (Drolet & Lorenzi, 2011). This research is applicable to this translational chasm as
it aims to understand barriers and facilitators in order to facilitate implementation and
adoption of guidelines for management of PCOS in adolescents. It is important to highlight
the paucity of research that identifies current primary care behaviors and potential barriers
in practice. Straus and colleagues (2013) state that barriers and facilitators must be
understood prior to the implementation of strategies to drive knowledge into practice
(Straus et al., 2013). Knowledge generated from this research will direct next steps and the
appropriate tools needed for either dissemination and/or support implementation of
adolescence PCOS guidelines into practical clinical settings. Findings from this research
will clarify if next steps will require efforts focused on dissemination of knowledge prior to
implementation, or translation of knowledge with efforts specifically aimed at
implementation.
Similarly, the NIH Translational Science Spectrum highlights various stages of
research from basic discovery to public health outcomes research. The NIH Translational
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Science Spectrum is not linear, but rather it recognizes that each phase builds upon and
informs the others. There are still areas of growing knowledge related to underlying
pathophysiology and optimal diagnostic tools for adolescent PCOS, but moving current
evidence toward implementation is timely. Knowledge generated from this study will not
create an end-point, but rather contribute to ongoing research efforts in PCOS and potentially
inform future research in other areas to include public health and clinical research.
Finally, translational research is recognized as research that “fosters
multidirectional and multidisciplinary integration of basic research, patient-oriented
research, and population-based research with the long-term aim of improving” (p. 470)
public health (Rubio et al., 2010). This research focuses on provider practice to affect
change that will improve patient health and long term population-health. Furthermore, it
investigates provider behavior across a variety of practice settings and locales to identify
potential health disparities at an early stage in the life-span continuum that would also
have an impact on population health outcomes.
Conceptual Framework
The conceptual framework driving this study is a combination of a barrier
assessment framework for behavior change (Cabana et al., 1999; Cochrane et al., 2007) and
the Health Belief Model (Glanz, Rimer, & Viswanath, 2015). The barrier assessment
framework is supported in the literature as a methodology to explore “Barriers to Physician
Adherence to Practice Guidelines in Relation to Behavior Change” (Cabana et al., 1999;
Cochrane et al., 2007). The Theory of Planned Behavior (TPB) underpins this framework.
TPB states that intentions to carry out a certain behavior are influenced by attitudes,
subjective norms, and perceived control of one’s behavior and the ability to make a
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difference (Grol, 2013). The framework for Barriers to Physician Adherence to Practice
Guidelines in Relation to Behavior Change further offer that external barriers will also
influence attitudes and behavior (Cabana et al., 1999; Cochrane et al., 2007).
The Health Belief Model (HBM), traditionally used to predict whether or not a
patient will take action to participate in a certain health behavior, will be applied to
further explore provider perceptions and beliefs that reflect likelihood for behavior
change (Glanz et al., 2015). In this setting the behavior is the diagnosis and management
of adolescents with PCOS in a primary care setting.
The combine TPB and HBM framework aligned with the research goal to
describe current practice behaviors and identify barriers to determine target areas for
future intervention. Constructs of the HBM explore perceptions and state that a person
will take action if they feel a negative health consequence can be avoided, can expect
positive results from taking action and that they can successfully participate in that action
(Glanz et al., 2015). To identify target areas for future intervention, current behaviors
versus intended behaviors must be investigated in order to determine the need for change
and provide the foundation to understand barriers and facilitators for change. Constructs
in the TPB explore behavior intention by focusing on attitudes, perceived social norms,
and perceived behavior control (Glanz et al., 2015).
HBM was utilized to frame questions in this study around perception of the
prevalence of PCOS within a provider’s patient population, perception of the
severity/significance of PCOS, perception of the benefit to patient health outcomes if
PCOS is addressed in primary care setting, and perceived barriers to adopting current
guidance on the diagnosis and management of PCOS in their own practice. TPB, within
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the barrier assessment model, explored provider attitude about PCOS, norms in how other
colleagues approach PCOS, and their perception of control that they have over their
practice behaviors. Combining constructs within these two models enabled this research
to generate information not only about current practice, but what pedPCPs perceive are
barriers to participating in these behaviors. These two models set the framework for
building the quantitative survey and also guided the development of the qualitative
interview questions.
Summary of Methodology
The study’s mixed methods design used an explanatory sequential approach. The
quantitative arm utilized a survey that was distributed to primary care providers across the
District of Columbia, Maryland and Virginia who treat female patients age 12-17 years.
The quantitative inquiry collected data regarding provider and practice characteristics,
provider behaviors, and knowledge, attitudes and beliefs about PCOS. Development of the
survey instrument (Appendix A) was informed by previous surveys regarding provider
knowledge about PCOS and the conceptual framework for this study.
Providers who participate in the quantitative arm were invited to participate in
semi-structured interviews that built upon the quantitative results and further explored
barriers and facilitators to practice behaviors related to the identification, diagnosis and
treatment of PCOS in adolescents. Twenty 1:1 interviews with providers were completed.
Limitations & Delimitations
This study collected survey data from diverse clinical practice settings across the
state of Maryland, Virginia and the District of Columbia. An unexpected finding in this
research is the variety of practice settings that providers identified as primary care.
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Several pedPCPs who participated in this study were not from traditional pediatric or
family medicine practice settings. Non-traditional practice settings include urgent care
practices, and community or public health clinics. Some of the barriers and facilitators
identified may be unique to these non-traditional practice settings.
The explanatory design allowed the dissertation research to gather more specific
information to explain the survey results, clarify some of the differences in provider
behaviors observed from the survey responses, and highlighted similarities and
differences in barriers and facilitators to practice. It is unclear though if this variety of
practice settings is an accurate representation of where adolescents seek medical care.
Modern medical practice has resulted in patients seeking primary care within nontraditional settings, such as urgent care clinics, but trends in adolescent health-seeking
behaviors is unknown.
In addition, clinical practice providers are extremely busy and often over
burdened by patient care. Their responses to surveys and interviews may be influenced by
feelings pressured for time. Providers may also find this inquiry itself burdensome in
reflecting on what they need to change or improve in their practice. With many
competing priorities in patient care, time constraints of providers may create a bias.
Parameters for this study are providers in the States of Virginia and Maryland,
and the District of Columbia versus a national sampling. This is done to improve
participant responses by engaging a smaller, regional population in which the researcher
may have a greater ability to engage providers and achieve a higher response rate
(Portney and Watkins, 2015). A well-designed study with a high response rate sets the
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foundation for this study to be replicated in a different location with a different
population of pedPCPs.
Definition of Key Terms
Amenorrhea. The abnormal absence of menstruation.
Anovulation. The absence of ovulation resulting in either frequent menstrual
bleeding patterns of < 21 days, or infrequent bleeding at intervals > 35 days
Endometrial cancer. A malignancy of the uterus.
Endometrial hyperplasia. An abnormal thickening of the lining of the uterus.
Hirsutism. An unwanted male-pattern hair growth in females; excessive amounts
of dark, coarse hair on body areas where men typically grow hair.
Hyperandrogenism. An excess production of androgens, resulting in increases
androgen levels in circulation.
Infertility. The inability to conceive after twelve months of regular sexual
intercourse without protection.
Metabolic syndrome. A combination of conditions to include hypertension, high
blood sugar, high cholesterol levels and/or excess fat around the waist.
Oligomenorrhea. Menstrual cycles lasting longer than 45 days.
Secondary amenorrhea. The absence of cycles for more than three months.
Type 2 diabetes (T2DM). Also known as diabetes mellitus type 2.
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CHAPTER 2: LITERATURE REVIEW
Introduction
The literature review is summarized in three sections. First a brief overview of the
current knowledge about PCOS as an endocrine disorder; adolescent-specific practice
guidelines for the diagnosis and management of PCOS, and unique considerations in the
adolescent patient with PCOS. The second section discusses what is known about
provider practice behaviors in addressing PCOS and potential barriers for pedPCPs
addressing PCOS among adolescents. The final section provides an overview of the
theoretical framework for this research inquiry.
The literature search was initiated in PubMed with the search terms: Polycystic
Ovary AND Adolescents* with limitations of literature in English published from
January 2013 to present. Parameters of five years was established as it has been within
the last five years that the Endocrine Society updated their practice guidelines (Legro et
al., 2013) and that an international consortium update has been published related to the
diagnosis and treatment of adolescents with PCOS (Ibanez et al., 2017). Abstracts were
reviewed and articles that were most relevant to this research were selected. This search
included: general reviews of pathophysiology, etiology, clinical presentation, and
complications of PCOS specific to adolescents; articles that discuss guidelines for
diagnosing PCOS in adolescents; research or reviews of treatment/management of PCOS
among adolescents; targeted discussions of specific clinical features or complications of
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PCOS in adolescents that are well documented such as obesity, mental health
complications and considerations of quality of life. Articles that discussed new research
related to biochemical markers of PCOS among adolescents or new discoveries related to
pathogenesis of various complications of POCS that are early in the translational
spectrum of research were not included.
The search was then expanded to SCOPUS and CINAHL with the same criteria
applied. Most articles were found to be duplicates from the PubMed search, indicating
saturation in the literature search. Additional articles were selected from the reference list
of the initially selected articles that were noted to be significant in contributing to the
growing body of knowledge around PCOS in adolescents. This included some articles
that were outside the time limited parameters of five years.
Finally, a search of updated practice guidelines and/or practice bulletins from
professional associations most relevant to primary care practice to include: The American
Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP),
and the American College of Obstetricians and Gynecologists (ACOG, 2018). AAP
offers a review that summarizes the consensus of international pediatric subspecialty
societies on diagnostic criteria for adolescents with PCOS (Rosenfield, 2015). AAFP
offers a review article on diagnostic and management guidelines as part of a continuing
medical education activity (Williams et al., 2016).
Polycystic Ovary Syndrome (PCOS) in Adolescents
PCOS was first described by Doctors Stein and Leventhal in 1935. Their
evaluation of seven women who had excess body weight, amenorrhea, and infertility
revealed a common finding of multiple ovarian cysts (Christensen et al., 2013). The
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condition was initially understood as a primary ovarian disorder, and later named
polycystic ovary syndrome (Christensen et al., 2013). However, research over the last
several decades has demonstrated that PCOS is a complex endocrine disorder, involving
several endocrine signaling pathways, and is not solely defined by ovarian dysfunction
(Ibanez et al., 2017). Attention has been directed away from relying on polycystic ovarian
morphology (PCOM) as a main diagnostic feature, and many believe the current name of
this condition to be a misnomer (Teede et al., 2014). This is especially true in the
adolescent population where increased ovarian volume and polycystic morphology is a
normal finding in puberty (Witchel et al., 2020).
Pathophysiology
The pathophysiology of PCOS is complex and the exact etiology of PCOS is
unknown. Several publications on PCOS have emerged over the last two decades, with an
increase of annual publications on PCOS more than doubling from 2008 to 2016 (Ibanez
et al., 2017). These publications address multiple aspects of PCOS but almost all address,
to some degree, the complexity of the pathophysiology of PCOS. Ibanez and colleagues
(2017) offer a review of the literature on the pathophysiology of PCOS by an international
collaboration of pediatric endocrine and other societies, providing an up to date look at a
global understanding of the pathophysiology of PCOS and how this relates to adolescents.
Androgen excess is a hallmark of the PCOS, present in approximately 60-80% of
patients with PCOS. Hyperandrogenism, usually marked by high levels of testosterone, is
a major player in disrupting the balance of the key hormones of the menstrual cycle,
leading to menstrual irregularities (Ibanez et al., 2017). There is not one specific
mechanism known to be the origin of this imbalance, but rather there are several
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pathophysiologic components that may be involved (Ibanez et al., 2017). These
components include primary ovarian dysfunction, insulin resistance, alteration in
signaling from neuroendocrine hormones, genetics, epigenetics, and alterations in
sympathetic nerve activity. PCOS is the result of aberrant signaling among these various
pathophysiologic components, but not all components are involved in all cases of PCOS
(Ibanez et al., 2017). Discussed below are two of the pathophysiologic components for
which there is the most information in the literature and are most relevant and relatable to
the presentation and management of PCOS in primary care practice: primary ovarian
dysfunction and insulin resistance/hyperinsulinemia.
Primary Ovarian Dysfunction
Patients with PCOS have arrest of follicular maturation within the ovaries, leading
to anovulation. This is a result of a disturbance in the balance of follicle stimulating
hormone (FSH), luteinizing hormone (LH) and anti-Mullerian hormone (AMH); key
hormones within the hypothalamic pituitary ovarian (HPO) axis that regulate the
menstrual cycle. (Ibanez et al., 2017; Nicandri & Hoeger, 2012; Rothenberg et al., 2018).
Patients with PCOS have an abnormal ratio of LH to FSH, and higher than normal levels
of LH drive theca cells to produce androgens (Rothenberg et al., 2018). High levels of
LH prevent sufficient production of FSH and conversion of androgens to estradiol within
the granulosa cells of the ovary (Ibanez et al., 2017; Rothenberg et al., 2018). High levels
of AMH are also thought to contribute to excess androgen production by disrupting FSHstimulatory effect on granulosa cells (Nicandri & Hoeger, 2012; Rothenberg et al., 2018).
These high levels lead to failure to select a dominant follicle in the ovary and ultimately
anovulation, which manifests as menstrual irregularities (either oligomenorrhea or
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anovulatory bleeding). Androgen excess, from the excess production of ovarian androgen
from the theca cells, leads to higher circulating levels of testosterone in the body and
results in clinical findings of cutaneous hyperandrogenism (hirsutism or moderate-severe
acne) (Witchel et al., 2016).
Insulin Resistance/Hyperinsulinemia
Insulin resistance (IR) and hyperinsulinemia are common findings in PCOS
(Ibanez et al., 2017). IR does not seem to be dependent upon increases in adipose tissue
as it a finding in both lean patients with PCOS and PCOS patients with excess body
weight or obesity. IR drives the pancreas to produce more insulin, and increased insulin is
thought to contribute to hyperandrogenism through multiple mechanisms. First, high
insulin levels may play a role in increasing production of adrenal androgens (Fitzgerald et
al., 2018). It is noted in PCOS that increased activity within the adrenal gland contributes
to androgen excess, measure by elevated levels of hormones secreted by the zona
reticularis: dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and
androstenedione (Ibanez et al., 2017; Nicandri & Hoeger, 2012; Rothenberg et al., 2018).
Second, high levels of insulin have been found to decrease production of sex-hormone
binding globulin (SHBG) in the liver, thus decreasing the circulation of SHBG to bind
free testosterone (Ibanez et al., 2017; Nicandri & Hoeger, 2012; Rothenberg et al., 2018).
Clinical Presentation
The most common presenting signs and symptoms of PCOS in adolescents are
associated with ovarian dysfunction and hyperandrogenism (Ibanez et al., 2017). Ovarian
dysfunction manifests as irregular menses, and hyperandrogenism as hirsutism and/or
moderate-to-severe acne (also referred to as cutaneous hyperandrogenism) (DiVall &
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Merjaneh, 2019). Irregular menses and cutaneous hyperandrogenism can also be normal
findings during puberty, creating obscurity in differentiating between normal and
abnormal findings that require further evaluation.
Diagnosis of PCOS in Adolescents
Diagnosis of PCOS in the adolescent population is challenging due to difficultly
distinguishing between manifestations of PCOS and normal physiologic changes of
puberty; therefore, providers must be aware of adolescent-specific guidelines. In 2015,
the first consensus statement for the diagnosis of PCOS in adolescents was developed by
an international panel of pediatric and endocrine experts (Rosenfield, 2015). This
consensus statement was reaffirmed in 2017, resulting in the International Consortium of
Paediatric Endocrinology (ICPE) 2017 Consensus Statement (Ibanez et al., 2017). The
ICPE 2017 Consensus Statement is supported by the Pediatric Endocrine Society (2017)
(posted to the PES Clinical Resources webpage), and aligns with diagnostic criteria for
adolescents in the 2018 International Evidence-Based Guidelines for the Assessment and
Management of PCOS across the Lifespan (Pena et al., 2020). Additionally, the PES has
published on its website, Primary Care provider guidelines for the Adolescent Female
with Suspected PCOS, that aligns with the ICPE 2017 consensus statement.
The appropriate diagnostic criteria for PCOS, especially among adolescents, has
been debated for several decades. The more commonly known diagnostic criteria (NIH,
Rotterdam, and Androgen Excess and PCOS Society criteria), published between 1990
and 2009, did not account for physiologic differences in the adolescent population
(Vassalou et al., 2019; Christensen et al., 2013). The first official diagnostic criteria to
address the adolescent population, known as the Amsterdam Consensus, was published in
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2012 (Vassalou et al., 2019). Since then, experts have sought to clarify specific criteria
regarding when menstrual cycles are considered irregular, the appropriate evaluation for
hyperandrogenism, and whether or not polycystic ovarian morphology (PCOM) should
be consider for diagnostic criteria in an adolescent (Vassalou et al., 2019). Figure 1
Development of Adolescent-Specific PCOS Diagnostic Criteria, provides a timeline from
the development of adolescent-specific diagnostic guidelines since the Amsterdam
Consensus, identifies the expert organizations involved in the development of guidelines,
and briefly identifies the evolution of the diagnostic criteria (Vassalou et al., 2019).
Figure 1
Development of Adolescent-Specific PCOS Diagnostic Criteria

ESHRE/ASRM Amsterdam
Consensus:
IR, CH/BH & PCOM

(CH defined by moderate to severe
hirsutism, should be evaluated
biochemically)

2012

Endocrine Society
Diagnostic criteria:
CH or BH in the
presence of IR

(CH defined by moderate
to severe hirsutism)

Pediatric Endocrine
Society
(first international
consensus statement):
IR≥ 2yrs &
CH or BH

(CH defined by moderate to
severe hirsutism)

2013

International PCOS Network
2018 International EvidenceBased Guidelines for the
Assessment and Management
of PCOS across the Lifespan
Diagnostic criteria:
IR≥ 2yrs
CH or BH

(added severe acne to CH definition)

2017
2015

NIH Evidence-based
Methodology Workshop
Discussion that use of
imaging to establish PCOM
is inappropriate,
but no new
recommendations

AACE/ACE,
AES and PCOS Society
Diagnostic criteria:
IR≥ 2yrs & CH or BH

(CH defined by moderate to severe
hirsutism)

2018
ICPE Consensus
Statement :
IR≥ 2yrs
CH or BH

(CH defined by moderate
to severe hirsutism)

ESHRE=European Society of Human Reproduction and Embryology; ASRM=American Society of Reproductive Medicine; NIH=National Institute of Health; AACE=American Association of Clinical
Endocrinologists; ACE=American College of Endocrinology; ICPE= International Consortium of Paediatric Endocrinology; IR=irregular menses; CH=clinical hyperandrogenism; BH=biochemical
hyperandrogenism.
Figure adapted from Vassalou H, Sotiraki M, Michala L. (2019) Figure 2: Diagnosis of PCOS over time.

Adolescent-specific guidelines, based on the ICPE 2017 Consensus Statement,
provide the following criteria for diagnosing PCOS in adolescents: irregular menses in
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adolescents who are at least two-years post-menarche, the presence of persistent clinical
or biochemical hyperandrogenism, and exclusion of other causes of these findings (E.g.
thyroid disease and non-classic congenital adrenal hyperplasia) (Ibanez et al., 2017). In
addition, the consensus statement acknowledges that insulin resistance and obesity are
common characteristic among adolescents with PCOS, but that adequate evidence is not
available for these to be considered diagnostic criteria (Ibanez et al., 2017). Table 1
Diagnostic Criteria for Polycystic Ovary Syndrome in Adolescents, summarizes
diagnostic guidance from the ICPE 2017 Consensus Statement (Ibanez et al., 2017).
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Table 1
Diagnostic Criteria for Polycystic Ovary Syndrome in Adolescents
Required Criteria

Irregular
menses/ovulatory
dysfunction

Hyperandrogenism:
clinical or
biochemical

Rule out other
disorders of
hyperandrogenism

Definition & Method for Evaluation

Comprehensive history and physical/menses
tracking.
Irregular menses defined as:
• From 1-3 years post-menarche: <21 or >45
days
• From 3 years post-menarche:<21 days or >35
days, or < 8 cycles per year
• Menstrual cycle >90 days for any one cycle > 1
year post-menarche
• Primary amenorrhea by age 15 years or age 13
years with absence of menses and no secondary
sexual characteristics such as breast
development
Clinical hyperandrogenism
• Progressive hirsutism
• Complete physical exam, use of validated
visual scale to evaluate hirsutism
• Moderate to severe acne, follow up with
evaluation for biochemical hyperandrogenism
Biochemical hyperandrogenism
Use of high-quality assays for total and free
testosterone
Laboratory evaluation for pregnancy, thyroid
disorders, non-classic congenital adrenal
hyperplasia, Cushing syndrome, androgen
secreting tumor, etc.

Important
Considerations

Generally irregular
menses must be 2
years post-menarche

Moderate to severe
acne alone is not
adequate to
diagnosis clinical
hyperandrogenism,
must utilize follow
up testing
Ultrasound is not
recommended to
evaluate ovarian
morphology*

* Ultrasound should not be utilized to evaluate for PCOS in patients < 8 years post menarche.
Ultrasound should be reserved for evaluation of other conditions as needed, such as evaluation for
structural abnormalities in primary amenorrhea (Ibanez et al., 2017; Pena et al., 2020)
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Irregular Menses
Irregular menses can be normal in the early post-menarchal years as the
hypothalamus- pituitary-ovarian (HPO) axis matures. It can take up to five-years postmenarche for maturation of the HPO axis, but most adolescents will have regular
ovulatory cycles within 1-2 years post menarche (Ibanez et al., 2017). Based on this
evidence, the guidelines define parameters of when irregular menses may be considered
abnormal, which is presented in Table 1 Diagnostic Criteria for Polycystic Ovary
Syndrome in Adolescents. It may be challenging for adolescents to accurately track their
menstrual cycle; therefore, more general guidance suggests irregular menses that persist
two-years post-menarche be considered for evaluation of PCOS (Ibanez et al., 2017; Pena
et al., 2020).
Primary amenorrhea may also be a sign of ovulatory dysfunction in PCOS if the
adolescent otherwise has normal pubertal development. The guidelines define primary
amenorrhea as lack of menses by 15 years of age or greater than 3 years post-thelarche
(Ibanez et al., 2017).
Hyperandrogenism
Findings of irregular menses must occur along with evidence of excess androgens
(Ibanez et al., 2017; Pena et al., 2020). Excess androgens can present as clinical and/or
biochemical hyperandrogenism. While clinical hyperandrogenism, along with menstrual
irregularities, is suggestive of PCOS, confirmation of biochemical hyperandrogenism is
recommended prior to making a diagnosis of PCOS (Ibanez et al., 2017; Pena et al.,
2020).
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Clinical Hyperandrogenism. is defined as moderate to severe hirsutism (Ibanez
et al., 2017). Hirsutism is the presence of dark coarse hair growth in a male-like pattern
(upper lip, chin, sideburns, neck, periumbilical, chest, upper back, around nipple area)
(Ibanez et al., 2017; Pena et al., 2020). Dark hair growth on arms and lower legs is not
hirsutism and may represent ethnogenetic variation. Physical exam and use of a validated
numerical scale, such as the modified Ferriman-Gallway scale, to assess hirsutism is
recommended.(Pena et al., 2020) Measurement scales should be utilized with caution
however as normative cut offs for adolescents have not been established (Pena et al.,
2020).
Moderate or severe inflammatory acne, resistant to topical treatment, is suggestive
of clinical hyperandrogenism, but requires follow testing for biochemical
hyperandrogenism (Ibanez et al., 2017). While mild comedonal acne is considered a
normal finding of puberty, severe inflammatory acne is uncommon and is present in less
than 5% of adolescents during early post-menarchal years (Pena et al., 2020).
Biochemical Hyperandrogenism. Measurement of total testosterone or
calculated free testosterone with a high-quality assay (liquid-chromatography
spectrometry and extraction/chromatography immunoassays) is recommended to
document biochemical hyperandrogenism (Ibanez et al., 2017; Pena et al., 2020). Other
laboratory tests to evaluate hyperandrogenism include androstenedione,
dehydroepiandrosterone sulfate (DHEAS) and 17-hydroxyprogesterone (Ibanez et al.,
2017). These three tests are not used to diagnose PCOS, but rather to excluded other
causes of hyperandrogenism such as non-classic congenital adrenal hyperplasia, adrenal
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tumors, and other androgen secreting tumors (Pena et al., 2020).
Exclusion of Other Causes
PCOS is a diagnosis of exclusion. Other conditions that can result in irregular
menses or excess androgens must be excluded prior to a diagnosis of PCOS; these
include pregnancy, thyroid dysfunction, non-classic congenital adrenal hyperplasia, and
androgen-secreting adrenal or ovarian tumors (Ibanez et al., 2017). Cushing syndrome
and/or hypothalamic pituitary insufficiency may also be considered depending on clinical
presentation (Ibanez et al., 2017). Diagnostic laboratory tests suggested for the initial
evaluation for PCOS, to include tests that will help to rule out other endocrine disorder,
are summarized in Table 2 Diagnostic Testing for Adolescents with Suspected PCOS
(Ibanez et al., 2017; Pena et al., 2020; Witchel et al., 2020).
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Table 2
Diagnostic Testing for Adolescents with Suspected PCOS
Laboratory Test

Indication

Beta-hCG pregnancy test

Rule out pregnancy

TSH

Rule out thyroid dysfunction

17-OH progesterone

Part of testing to rule out non-classic congenital adrenal
hyperplasia

Total testosterone, free
testosterone

To document hyperandrogenism, elevated in PCOS. Required for
diagnosis of PCOS

FSH, LH, estradiol

Reserve for patients with amenorrhea to rule out premature
ovarian failure (high FSH, low estradiol). LH:FSH ratio of 2:1 or
greater common in PCOS but is not absolute (LH and FSH levels
vary in cycle) and is not diagnostic

Prolactin

Rule out hyperprolactinemia in patient with amenorrhea

Dehydroepiandrosterone
sulfate (DHEAS)

Part of testing to rule out non-classic congenital adrenal
hyperplasia and androgen secreting tumor

Androstenedione

Produced in both the ovaries and adrenal glands, part of testing to
rule out androgen secreting tumor

Two labs that are not recommended for initial evaluation, but are often discussed
in the literature regarding PCOS in adult women are sex-hormone binding globulin
(SHBG) and anti-Müllerian hormone (AMH) (Ibanez et al., 2017). SHBG is suppressed
by elevated androgen concentrations, which contributes to higher free testosterone
concentrations. SHBG levels provide additional information if free testosterone levels are
elevated, but they are not diagnostic of PCOS (Ibanez et al., 2017). Elevation of AMH is
reported in the literature as a common finding in women with PCOS, but research has
demonstrated a weaker association among adolescents with PCOS (Ibanez et al., 2017).
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Excess body weight and obesity are common findings of PCOS in both
adolescents and adult women. However, excess body weight is not present in all patients
with PCOS and is not a criterion for diagnosis (Witchel et al, 2020). The relationship of
obesity with PCOS is complex and not completely understood. Pre-clinical models
investigating the pathophysiology of PCOS have suggested a bidirectional relationship
between obesity and PCOS (Ibanez et al., 2017). Obesity exacerbates the metabolic
complications of PCOS, but has not been proven to be a distinct feature or cause of
PCOS (Witchel et al., 2020). From the opposite direction, PCOS has been associated with
inefficient energy oxidation and metabolic inflexibility, which are markers of reduced
metabolism, resulting in an increased risk of obesity (Rimmer et al., 2019).
Ultrasound for Polycystic Ovarian Morphology (PCOM)
Current adolescent-specific diagnostic criteria do not require the presence of
PCOM to diagnose PCOS (Ibanez et al., 2017). PCOM can be a normal finding in
adolescent girls with a prevalence of up to 54% (Witchel et al., 2015). Increased
gonadotropin stimulation during adolescence results in increased ovarian volume and
follicular maturation resulting in the appearance of polycystic morphology that is normal
in an adolescent (Witchel et al., 2019). Guidelines state that pelvic ultrasound should not
be used for the diagnosis of PCOS. Evaluation of ovarian morphology is not
recommended prior to 8 years post menarche (Pena et al., 2020). Additionally,
transvaginal ultrasound in adolescent girls is an invasive test that can cause significant
discomfort and is not recommended in non-sexually active adolescents (Ibanez et al.,
2017). A transabdominal approach may not be reliable especially in adolescents with
excess weight or obesity (Ibanez et al., 2017).
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Management/Treatment of PCOS in Adolescents
There are three main principles that guide the treatment and management of
PCOS in adolescents. First, lifestyle modifications should be considered for first-line of
treatment for all adolescent patients with either PCOS or determined to be at risk for
PCOS prior to confirmation of diagnosis (Ibanez et al., 2017). Second, additional
treatments should be individualized to optimize symptom relief (Witchel et al., 2019).
Third, screening for short and long-term complications of PCOS should be part of the
management plan (Witchel et al. 2019; Witchel et al., 2020).
Each patient and their clinical presentation is unique. Interventions should be
patient-centered and address the patient’s main concern. Additionally, adequate age and
culturally appropriate patient education and counseling about PCOS is vital. Discussions
about PCOS may need to be repeated over time as the adolescent ages and should include
recommendations for life-long management and screening for co-morbid conditions
associated with PCOS (Witchel et al., 2019).
Treatment
The ICPE 2017 consensus statement recommends treatment based upon the
clinical presentation that is unique to the individual patient. Table 3 Recommendations
and Medication Options for the Management of PCOS in Adolescents, outlines symptomspecific treatment recommendations as per the international consensus statement (Ibanez
et al., 2017).
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Table 3
Recommendations and Medication Options for the Management of PCOS in Adolescents
Treatment or
Medication
•
•
Lifestyle modifications

•
•
•
•

•
Metformin (850
mg/day up to 1g twice
a day)

•

Indication/Recommendation/
Potential Impact (level of evidence)
Lifestyle modifications based on combination of calorierestricted diet, exercise and behavior treatment (Level A)
First-line therapy in girls with excess weight or obesity
(Level C)
Decrease androgen levels (Level A)
Normalize menstrual cycles (Level A)
Improve markers of cardiometabolic health (Level B)
Increasing physical activity effective to reduce development
of metabolic syndrome in normal weight girls (Level C)
Beneficial in adolescents with PCOS and excess weight or
obesity based on short term data (Level A)
Improves hyperinsulinemia, ovulation and testosterone
levels in adolescents with PCOS who do not have obesity
(Level B)

Combined oral
contraceptive pills
(COCP)

•

Normalizes menstrual cycles, but there is no high quality
RCT to recommend a specific formulation over another
(Level B)

Cosmetic procedures
such as photoepilation
or
Topical eflornithine
(13.9% twice a day)

•

Photoepilation is first-line for long-term removal of
unwanted hair growth (Level B)
Topical eflornithine adjuvant to photoepilation in girls with
laser resistant facial hirsutism age 16 years or older (Level
A)

Anti-Androgens:
Spironolactone (50-200
mg/day), or
Flutamide (62.5
mg/day to 250 mg/day)

•

•

•
•
•

Features of hyperandrogenism that do not resolve after 6
months of COCP or cosmetic procedures*
Reduce androgen excess features more than metformin in
monotherapy (Level B)
Spirinolactone is most commonly used and recommended
due to lack of data on flutamide use in adolescents (Level C)
Anti-androgens should only be used when contraceptive
measures are guaranteed, because of risk of impairment of
external genital development in male fetuses.
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Based on recommendations from the ICPE 2017 Consensus Statement (Ibanez et al., 2017) and
2018 International Evidence Based Guidelines (Pena et al., 2020)
*Only referenced in Pena et al. 2020

Screening for Complications
PCOS is associated with complications of metabolic, reproductive, and
psychological health. Short and long-term management of PCOS includes screening for
these co-morbid conditions (Witchel et al. 2019; Witchel et al., 2020).
Metabolic Health. In terms of metabolic health, complications of PCOS include
excess body weight, obesity, hyperinsulinemia, insulin resistance (IR), impaired glucose
tolerance (IGT), dyslipidemia, hypertension, metabolic syndrome, nonalcoholic fatty
liver disease (NAFLD), gestational diabetes, T2DM, cardiovascular disease (CVD) and
obstructive sleep apnea (OSA) (Ibanez et al., 2017; Witchel et al., 2020). Adolescent girls
diagnosed with PCOS have a higher prevalence of IR, IGT, metabolic syndrome, and
T2DM when compared to adolescents without PCOS (Divall & Merjaneh, 2019; Witchel
et al., 2019). It is important to highlight that complications of IR and hyperinsulinemia
are also present in lean girls with PCOS (Ibanez et al., 2017; Witchel et al., 2020).
Glycemic status should be evaluated in all women at the time of diagnosis and screened
regularly (Witchel et al., 2020).
Increased risk for CVD in patients with PCOS is theoretical, though, studies have
identified increased arterial stiffness in adolescent girls with obesity and a diagnosis of
PCOS (Witchel et al., 2020). To date, there is limited data that demonstrate increased
cardiovascular events in patients with PCOS, however, some patients with PCOS have
early onset and higher incidence of features of metabolic syndrome, placing them at
greater risk for the development of CVD (Witchel et al., 2019).
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The impact of OSA on health outcomes in adolescents with PCOS has not been
determined; however, current literature has reported OSA in adolescent girls with PCOS
(Nandalike et al., 2012). The association with OSA is also not clear, and mostly related to
the other long-term sequelae associated with PCOS such as obesity (Witchel et al., 2020).
Risks of the aforementioned metabolic complications related to PCOS persist
throughout the lifespan. The implication is for primary care provider to be aware of
potential long-term sequela and recognize PCOS as a chronic condition that will require
screening for complications during adolescence and guidance for life-long management.
Guidelines do not make specific recommendations for frequency of screening of comorbid conditions associated with PCOS (Divall & Merjaneh, 2019).
Reproductive Health. Patients with PCOS have an increased risk of infertility,
endometrial hyperplasia, and endometrial cancer (Witchel, 2020). Though adolescents
may not desire pregnancy during adolescence, research has demonstrated that adolescent
patients diagnosed with PCOS are concerned about future fertility (Trent et al. 2003).
Endometrial hyperplasia and endometrial cancer may also not be a concern during
adolescence as the risk of these conditions is a result of long-term exposure to unopposed
estrogen due to anovulatory cycles. Educating adolescents with PCOS on long-term risks
to reproductive health and addressing any concerns they may have around future fertility
is an important consideration. However, providers need to be mindful of delivering
patient education that is culturally and age appropriate, as well as ensure they are offering
a balanced view about long-term risks. Several studies have noted frustration among
adult women with PCOS that providers were too focused on fertility (Weiss & Bulmer,
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2011), and that adolescents’ concerns about fertility had a negative impact on quality of
life (Trent et al, 2003; Hahn et al., 2005).
Psychological Health and Well-being. Current research also suggests that PCOS
is also associated with mental health disorders and/or can have a negative impact on
quality of life in adolescents (Dokras et al., 2018; Kaczmarek et al., 2016). Psychological
co-morbidities include depression, anxiety, eating disorders, negative body image, and
psychosexual dysfunction (Witchel et al., 2020). PedPCPs should be aware of the
increased risk of anxiety and depression in adolescents with PCOS and screen for
symptoms of anxiety and depression as part of routine care (Pena et al., 2020; Witchel et
al., 2020). A recent study investigating coping and depression in adolescents with PCOS,
revealed two aspects of PCOS that contributed to psychological distress: (1) not knowing
what is going on with their bodies; (2) not feeling in control of their symptoms (Hopkins
et al., 2019) Furthermore, there is a higher prevalence of clinical and subclinical eating
disorders in adolescents with PCOS, which calls for a thoughtful patient-centered
approached to addressing lifestyle modifications (Kamboj & Bonny, 2017).
While a majority of the literature related to psychological implications and health
related quality of life (HRQoL) is focused on adult women, literature over the past five
years demonstrates this association in adolescents with PCOS (Brutocao et al., 2018).
Brutocao and colleagues (2018) reviewed 57 studies of females with PCOS, one study
specific to adolescents and three with a mixed population of adult and pediatric patients,
and found that females with PCOS had a higher likelihood of having a psychiatric
diagnosis, including depression (odds ratio (OR), 2.79; 95% CI, 2.23-3.50), anxiety (OR,
2.75; 95% CI 2.10-3.60), bipolar disorder (OR, 1.78; 95% CI, 1.43-2.23) and obsessive
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compulsive disorder (OCD) (OR, 1.37; 95%CI 1.22-1.55). The authors noted a lack of
significant difference in the odds ratio between studies that included and did not include
adolescents. There was not an association of PCOS with increased diagnosis of social
phobia or panic disorder (Brutocao et al., 2018).
It has been hypothesized that risk of psychological conditions and impact on
quality of life is related to the undesirable physical features of obesity and/or
hyperandrogenism that is commonly present in adolescents with PCOS (Kaczmarek et
al., 2016). The literature varies on this position. Some studies suggest that body mass
index in overweight girls with PCOS contributes to reduced quality of life, and higher
risk for depression and anxiety (Jones et al., 2011; Moran et al., 2010; Trent et al., 2005).
Other research suggests that fertility concerns have a negative impact on quality of life
(Trent et al., 2003; Weiss & Bulmer, 2011). In contrast, other studies suggest that
elevated findings of psychological conditions in adolescent and women with PCOS are
independent of clinical features of increased body weight, hyperandrogenism or fertility
concerns (Dokras et al., 2018; Upadhya & Trent, 2007; Zachurzok et al., 2018). Another
study of quality of life in adolescents with menstrual irregularities demonstrated that
menstrual problems have a significant impact on quality of life (Nur Azurah et al., 2013),
but the study examined menstrual problems in general and was not specific to a diagnosis
of PCOS.
Considerations related to mental health, quality of life, and screening for
comorbid conditions such as metabolic syndrome and T2DM are important aspects of
managing PCOS in adolescents and fall within the scope of primary care practice. In
addition, pedPCPs have a salient role in facilitating care between specialists, who they
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may refer to for certain aspects of PCOS treatment. By collecting information related to
PCPs perceptions, attitudes and beliefs about PCOS and their roles in treatment and
management, and comparing these factors across a variety of practice settings, this
dissertation research will attempt to identify target areas where future interventions that
support best practices can be most meaningful.
Unique Considerations in the Adolescent Patient with PCOS
Communication
There are several unique considerations in managing PCOS in adolescents
compared with adults that need to be considered when investigating the behaviors of
pediatric PCPs. First, the challenge of triadic communication is unique to the adolescent
population. Triadic communication is the term given to communication that takes place
between patient, parent/guardian, and provider. Since adolescents are under age 18 years
of age, the involvement of a parent or guardian is still required to some degree. Research
related to triadic communication over the past decade highlights that adolescent’s
contributions to their own care is often limited (Van Staa, 2011). Triadic communication
can be problematic in addressing sensitive and complex topics related to PCOS such a
lifestyle modifications, mental health, quality of life and reproductive health concerns.
A second consideration unique to addressing PCOS with adolescents is providerpatient communication regarding sensitive topics of fertility and sexual behavior.
Concerns around reproductive health in PCOS are divergent. On one side is concern with
risk of infertility. Adolescent girls with PCOS have been found to be 3-4 times more
concerned about future fertility when compared to peers without PCOS (Kudesia et al.,
2017) and concerns with future fertility has been found to have a negative impact on
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quality of life among adolescents (Trent et al, 2003; Hahn et al., 2005). In contrast, some
research has found that some adolescents with PCOS may engage in risky sexual
behavior. One study highlighted that adolescents with PCOS who are sexually active
have a low baseline rate of contraception use (Malcolm et al., 2015).
Some research has found that while adolescents are interested in discussing
reproductive health topics with their health care provider, health care providers are more
likely to not engage in these discussions (Kudesia et al., 2017). Kudesia and colleagues
(2017) presents an algorithm with a suggested script to provide guidance for health care
providers engaging in discussions around fertility awareness with adolescents. The
development of this algorithm was not specifically focused on adolescents with PCOS.
Nonetheless, it is relevant to this inquiry as pedPCPs can play a key role in addressing
fertility awareness and sexual behaviors as an important part of PCOS management in
adolescents.
Transition of Care
Lastly, management and treatment goals for PCOS related outcomes should be
consider both short and long-term. As adolescent patients approach adulthood, long-term
management should include considerations of transition to adult primary care. PCOS is a
life-long condition that may require long-term therapies as well as life-long screening for
comorbid conditions. While there is a lack of literature related to transitions of care for
adolescents with PCOS, there is research related to transitions of care for adolescents
with chronic illnesses, such as T1DM, that can be considered within the context of
PCOS. Research related to transitions of care in T1DM patients highlight several factors
that may lead to gaps in care following transfer to adult care. These include loss of long-
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standing comfortable relationships with pediatric providers, shorter clinic visits in adult
care, and changing or loss of health insurance (Monaghan et al., 2013). Communication
with health care providers is important for transition to adult care as providers have a role
in educating patients about their medical condition and long term health care needs
(Monaghan et al., 2013). Adolescents with PCOS require guidance from their pedPCPs
prior to transition in order to develop the knowledge and skills need to be advocates for
their own health needs as their experience with PCOS related complications will
inevitably alter individual treatment goals over time.
Health Disparities
Discussion in the PCOS literature support ethnic and racial variations in the
presentation of PCOS (Wang & Alvero, 2013), but there is a lack of population studies to
specifically assess racial and ethnic disparities in the prevalence of PCOS. There are
studies that have examined differences in complications associated with PCOS, such as
metabolic syndrome and risk factors for cardiovascular disease, between racial groups
with PCOS. In one study, a retrospective chart review of adolescents with PCOS at a
PCOS center compared age and race data matched from the National Health and
Nutrition Examination Survey (NHANES) from 1999-2006 (Hillman et al., 2014). This
demonstrated that Black adolescents had a significantly higher prevalence of metabolic
syndrome than White adolescents with PCOS. The most common characteristic of
metabolic syndrome founds in Black adolescents compared to White adolescents were
elevated BMI and hypertension (Hillman et al., 2014). Only non-Hispanic White and
non-Hispanic Black adolescents were included in this study population.
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A case-controlled study in non-Hispanic White and non-Hispanic Black adults did
not reveal the same findings in an adult population. While there were some racial
differences in PCOS characteristics between Black women and White women, they were
minor and some outcomes such as quality of life were more favorable in Black women
(Ladson et al., 2011). Moreover, in contrast to the adolescent population discussed in the
previous study, Black women had less risk factors for metabolic syndrome compared to
White women (Ladson et al., 2011)
In terms of socioeconomic status, one study of women aged 34-49 years, who
were part of a study on coronary artery risk development, demonstrated a link between
socioeconomic status (SES) and risk of PCOS. Specifically, the study found that women
who experienced low childhood SES, but later achieved higher education levels, had
significantly higher risk of PCOS, especially among women with obesity. Women of low
childhood SES who did not attain higher personal education did not have an increased
risk of PCOS (Merkin et al., 2011).
One study that reviewed data of the National Health Care Surveys to examine
behavioral health services associated with PCOS, demonstrated different findings related
to SES status. Specifically, a review of patients ages 11-60 years old who had a PCOSrelated medical visit between 2005-2010 revealed that a high proportion of PCOS-related
visits paid by private insurance were among White women, compared to those visits
without private insurance (Sanchez, 2018). Overall a larger proportion of PCOS-related
visits were by White women (Sanchez, 2018). These findings suggest potential disparities
in access to care if ethnic groups who may be more susceptible to PCOS than White
patients are not being seen for PCOS (Sanchez, 2018). Certainly, there are many
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unknown factors that can contribute to these findings as they relied on ICD-9 diagnostic
codes to identify patients with PCOS and, in regard to this research, the data was not
limited to adolescent populations. The study did not have results specific to mental health
services associated with PCOS, but did find that in general Hispanic adolescents are less
likely to be screened for depression than non-Hispanic White adolescents (Sanchez,
2018). This dissertation research provides the opportunity to ask providers about their
behaviors in screening adolescents with PCOS for depression and other mental health
disorders and investigate any differences between various settings and reported patient
populations.
The literature suggests that there may be differences in the impact PCOS has on
HRQoL across different cultures. While not specific to adolescents, Upadhya and Trent
(2007) carried out a review of the literature related to impact on quality of life and found
cross-cultural variations globally in whether or not aspects of PCOS (within physical,
psychological and sexual domains) have a negative impact on HRQoL. While some
studies suggest a correlation between quality of life and attributes of obesity, menstrual
dysfunction and fertility concerns, HRQOL did not correlate with specific clinical and
biological measures related to these attributes (Upadhya & Trent, 2007). The authors
suggest that the impact of PCOS on HRQOL may be influenced by individual patient
values, perception and culture. This study will not collect data about patients’ perceptions
and beliefs, but there is an opportunity to investigate whether individual providers’
perception and values influence whether or not they consider HRQOL in adolescents with
PCOS. As data is compared across a variety of settings potential findings may emerge to
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suggest differences in how subjective community norms within communities of practice
impact how providers view and address quality of life.
This review demonstrates a significant gap in knowledge of disparities in PCOS
care among adolescents. While this dissertation research will not include a patient
population study to determine disparities in prevalence or risk of complications of PCOS,
it will examine disparities in practice trends that have not previously been reported.
Investigating perceptions and behaviors of pedPCPs across a variety of settings (E.g.
urban, suburban and rural; private practices versus community based clinics, etc.) will
help to contribute new knowledge about potential disparities in access to comprehensive
care for adolescents with PCOS.
Practice Behaviors
The purpose of this dissertation is to explain practice behaviors of pediatric PCPs
in the diagnosis and management of PCOS, and identify barriers and facilitators to
addressing PCOS in a primary care setting. As discussed in the problem statement, there
is a lack of understanding the role of the primary care provider in the identification,
diagnosis and management of PCOS. Additionally, there is limited knowledge of the
potential barriers to overcome in order to optimize a comprehensive management
approach to PCOS in pediatric primary care practice.
Literature search terms were expanded from the original search to include a
combination of the following: polycystic ovary syndrome; pediatrics; physician behavior;
research utilization; practice improvement; physician behavior change; evidence-based
practice; evidence-based medicine; barriers; facilitators; clinical practice guidelines;
guidelines adherence; implementation; knowledge translation. Databases used for the
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literature search included PubMed, CINAHL and Scopus. There were few findings, from
the previous search and in this expanded search, of literature that addressed pediatric
primary care provider behaviors specifically to address PCOS. Therefore, literature was
considered regarding provider behaviors in addressing and documenting findings of
hirsutism and menstrual irregularities in an adolescent. Search terms were extended to:
menstrual cycle, documentation, primary care, pediatric in one search; hirsutism,
documentation, primary care, pediatric in another search.
A summary of the results is categorized in two sub-sections: (1) literature that
discusses current practice trends in the diagnosis and management of PCOS; (2) general
information about barriers to evidence-based practice and implementation of practice
guidelines.
Current Trends in Practice Behaviors
Ten articles were identified that aimed to obtain information relate to provider
practice for the diagnosis and/or management of PCOS. Five of them involved survey
research to inquiry about provider knowledge and behaviors regarding the diagnosis
and/or management of PCOS (Bonny et al., 2012; Conway et al., 2014; Dhesi et al.,
2016; Dokras et al., 2017; Teede et al., 2014); four were retrospective chart reviews
(Auble et al., 2013; Broder-Fingert et al., 2009; Powers et al., 2015; Sebastian et al.,
2018); and one was a qualitative study in Australia investigating physician perspective on
diagnosis PCOS (Copp et al., 2019).
The retrospective charts reviews all involved a population of providers who
address PCOS among adolescents. The research aimed to determine accuracies in
diagnosis and differences in management of PCOS among adolescents, and compared
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practice behaviors between different specialty clinics within an individual institution.
Significant variation in the diagnosis and treatment of PCOS was noted across specialties
(Auble et al., 2013; Powers et al., 2015; Sebastian et al., 2018). One study suggested an
over diagnosis of PCOS (Auble et al., 2013); whereas, another study, which compared
general pediatric practice with pediatric endocrinology, demonstrated an under evaluation
of PCOS within pediatric primary care practice (Broder-Fingert et al., 2009). Another
finding was related to screening for complications of PCOS, and found a general lack of
screening for known comorbid conditions across both the general pediatric practice and
specialty practices (Auble et al., 2013; Broder-Fingert et al., 2009; Powers et al., 2015;
Sebastian et al., 2018). Of note, none of the studies addressed screening for known
psychological implications of depression, anxiety and/or reduced measures of quality of life.
The target population for most of the survey studies were specialty physicians
with mostly an adult patient population; only one survey study focused on adolescents,
but the study population of providers were most specialists versus primary care providers
(Bonny et al., 2012). All of the survey studies demonstrated similar results with
significant heterogeinty in diagnostic evaluations and management, and limited
awareness of current diagnostic and management guidelines (Bonny et al., 2012; Conway
et al., 2014; Dhesi et al., 2016; Dokras et al., 2017). It is important to note however, that
there were not adolescent-specific guidelines published at the time of the study by Bonny
et al. (2012).
The research by Bonny and colleagues (2012) primarily investigated approach to
treatment among 127 providers who responded to a survey disseminated by the North
American Society for Pediatric and Adolescent Gynecology (NASPAG). Specialty
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providers who treated adolescents with PCOS identified oral contraception and life-style
modifications as the most commonly selected treatment, and less than 30% reported
prescribing metformin (Bonny et al., 2012). Research by Dhesi and colleagues (2016)
aimed to describe how often OBGYN providers screened for complication of metabolic
health associated with PCOS. Survey responses from 281 OBGYNs demonstrated that
they are not routinely screening for glycemic status and lipid profile among patients with
PCOS (Dhesi et al., 2016). Similarly, a study by Teede and colleagues (2014) that
explored the perceived risks of PCOS among 104 primary care providers in Australia,
found that less than half of the PCPs perceived that metabolic complications were
associated with PCOS. Only 4% of providers perceived that depression and anxiety are
also potential features associated with PCOS (Teede et al., 2014). In contrast, a survey
study by Conway and colleagues (2014), with mostly endocrinologist participating,
demonstrated that long-term metabolic risks for obesity and T2DM among patients with
PCOS was well recognized and addressed.
Dokras and colleagues (2017) surveyed members of American College of ObGyn
and American Society of Reproductive Medicine to identify gaps in knowledge and
practices among physicians. Results demonstrated significant gaps in knowledge related
to the diagnosis and complications of PCOS (Dokras et al., 2017). The study population
(n=630) did not include primary care providers and was not specific to providers who
care for adolescent populations. Nonetheless, this study provides a significant
contribution to this dissertation as the survey tool used is based on a previous survey
instrument from a PCOS center for research excellence in Australia that was informed by
a multidisciplinary panel and consumer input (Dokras et al., 2017). This instrument
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provided an evidence-based tool for reference in the development of the survey for this
dissertation study.
Qualitative inquiry by Copp et al. (2019) offers provider perspective on
diagnosing PCOS. Thirty-six clinicians in Australia participated in 1:1 interviews to
discuss their experience in diagnosing PCOS. Most clinicians were specialty providers
with an adult patient population, gynecologists and endocrinologists, and 15 were
primary care providers. The focus on the inquiry was specifically on diagnosing PCOS
and did not address management. Results of this qualitative study demonstrated that
providers have a range of uncertainty regarding the diagnosis of PCOS and concerns
about under- and over-diagnosis. In general, providers were aware of PCOS guidelines,
but the study did not discuss adolescent patients or adolescent specific guidelines (Copp
et al., 2019).
Limited parallels can be drawn from the aforementioned studies to understand
behaviors among primary care providers in addressing PCOS because all of these studies
were conducted prior to the updated PCOS guidelines from the Endocrine Society
specific to adolescence (Legro et al., 2013) and the international consensus first published
in 2015 (Witchel et al., 2015). Furthermore, most of the research only addressed basic
knowledge and did not include an investigation of provider attitude and beliefs, or
barriers and facilitators to the uptake of evidence from the existing PCOS literature at the
time of the study. Copp et al. (2019) added new information to the literature regarding
provider perspective regarding diagnosis. However, this was not specific to providers
with an adolescent patient population and did not inquire about practice behaviors beyond
diagnosing PCOS.
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An additional study was available to note behaviors to identify signs/symptoms
associated with PCOS. McShane et al. (2018) carried out a chart review for women ages
12-21 years old who were seen in either the department of pediatrics, family medicine or
adolescent medicine. Clinical notes were searched for elements of menstrual history
taken during annual well-visits to include: menarche, last menstrual period, length of
cycle, and presence or absence of associated symptoms of pain and/or excessive bleeding.
Findings revealed significant deficiency in taking a menstrual history in pediatric and
family practice settings compared to adolescent medicine setting. Specifically, adolescent
medicine was 6.44 times more likely to take a complete menstrual history than family
medicine and 5.89 times more likely than pediatrics (McShane et al., 2018). All findings
were found to be statistically significant. While this study was not specific to PCOS,
screening for menstrual abnormalities plays an important role in identifying reproductive
disorders such as PCOS. This literature illustrates a gap in the behaviors of pediatric and
family medicine physicians collecting adequate information related to menstrual history
and underscores the importance of this research to better understand pediatric PCP
behaviors as it relates to identifying and diagnosing PCOS.
PedPCPs are well positioned for the early identification and diagnosis of PCOS,
and to manage, or facilitate the management, of the multiple aspects of this disorder;
especially as it relates to screening for short and long-term metabolic and psychological
health complications associated with PCOS. There is a lack of literature to explore the
behavior of primary care providers in screening for these disorders among adolescent
patients with PCOS and their perceptions and beliefs about the risk of these
complications associated with PCOS. This dissertation research advances knowledge in

44

the field to better understand pedPCP’s behavior in diagnosis and treatment of PCOS,
screening for comorbid conditions associated with PCOS, and their perceptions about
impact on long-term health. Furthermore, sampling pedPCPs across a variety of settings
provided a unique perspective not previously captured in the literature. Previous studies
either carried out chart reviews from one institution, or survey research among a
homogenous group of specialty providers. Understanding a wider range of pedPCP’s
perspectives across a variety of practice settings provides valuable information to inform
practical interventions for practice improvement.
Barriers to Diagnosis and Management of PCOS in Adolescents
The literature does not address dissemination and uptake of current adolescentspecific practice guidelines for the diagnosis and management of PCOS. While the
discussion above reveals variations in practice trends, it is not in context of up to date
practice guidelines. Understanding the dissemination and uptake of guidelines among
pedPCPs and barriers and facilitators to their use is a vital component of this research.
Literature related to evidence based practice (EBP) highlights some of the main
barriers to the applications of guidelines into practice, specifically among pediatric health
care professionals. These include: lack of knowledge on subject area, lack of critical skill
to appraise research, lack of time to reference or read new research, and lack of interest
and/or motivation (Cline et al., 2017; Maaskant et al., 2013). Facilitators included
integration of guidelines into clinical tools and policies that provide time to read and/or
interact with colleagues in acquiring new knowledge (Maaskant et al., 2013).
Cabana and colleagues (1999) developed the Barriers to Adherence Framework
that outlines the various barriers to adherence guidance among physicians. This was
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developed from an in-depth literature review of articles that described at least one barrier
to uptake of clinical guidelines, policies or consensus statements. The framework offers a
spectrum of barriers under the categories of knowledge, attitudes, and behavior.
Knowledge, which includes familiarity and awareness, drive attitudes, which then
influences behavior. Certain attitudes, also influence whether or not physicians seek new
knowledge. The framework also suggests that physician behaviors are influenced by
external factors such as patient issues, guideline factors and environmental factors
(Cabana et al., 1999). This framework provides a basic understanding of the multiple
barriers that should be considered when determining provider adherence to and
implementation of guidelines.
Lack of knowledge of adolescent-specific guidelines for diagnosis and
management of PCOS is likely a barrier to provider practice in a primary care setting.
Previous discussed research, under Current Trends in the Diagnosis and Management of
PCOS in Adolescents, demonstrated lack of knowledge among specialty providers
regarding PCOS guidelines for adults, which have been published for several decades
(Dokras et al., 2017). ICPE 2017 Consensus Statement are newer and have had limited
dissemination outside of endocrinology specialty literature. For example, the American
College of Obstetricians and Gynecologists (ACOG) updated practice bulletin does not
address unique considerations in the diagnostic or management criteria of PCOS in
adolescents (ACOG, 2018). The American Academy of Pediatrics (AAP) published a
journal article to present the 2015 international consensus statement on the diagnosis of
PCOS in adolescents (Rosenfield, 2015), but AAP provides no other practice resources.
The American Academy of Family Physicians (AAFP) had a CME publication in 2016
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that endorses diagnostic guidelines that conflict with both the Endocrine Society
guidelines published in 2013 (Legro et al., 2013) and the 2015 international consensus
statement (Rosenfield, 2015). Specifically, AAFP promotes the ESHRE/ASRM
Amsterdam Consensus from 2012, which advises that all three Rotterdam criteria must be
met before a diagnosis of PCOS is made in adolescent patients (Williams et al., 2016).
Guided by the conceptual framework discussed below, this dissertation research
investigated factors beyond knowledge to explain barriers and facilitators to address
PCOS among adolescents in a primary care setting.
Conceptual Framework
The Barriers to Adherence Framework (Cabana et al., 1999; Cochrane et al.,
2007) provides a foundation for this dissertation in which a key aim is to identify barriers
to the diagnosis and management of PCOS in a primary care setting. However, there is no
clear evidence from existing literature to support if there is a deficit in adherence of
guidelines, or if there are other barriers to early identification and optimal management of
PCOS among adolescent patients in a primary care setting. Therefore, this basic
framework was not enough to meet the goals of this research.
The Theory of Planned Behavior (TPB) underpins the Barriers to Adherence
Framework (Cabana et al., 1999; Cochrane et al., 2007). TPB states that intentions to
carry out a certain behavior are influenced by attitudes, subjective norms, and perceived
control of one’s behavior and the ability to make a difference (Grol, 2013). However, this
does not address provider beliefs about the condition itself, how it relates to their practice
and impacts patient population. Therefore, a second model, the Health Belief Model
(Glanz et al., 2015), was combined with the TPB as the conceptual framework for this
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dissertation. A search of the literature on provider behavior mostly revealed systematic
reviews, similar to the reviews which generated the Barriers to Barriers to Adherence
Framework (Cabana et al., 1999; Cochrane et al., 2007), but lacks a richer exploration of
constructs known to influence behavior. The Health Belief Model (HBM) has
traditionally been applied to patient behaviors and no literature was found that has
applied this to provider behaviors (Glanz et al., 2015). The HBM is an older model,
dating back to the 1950s when the U.S. Public Health initiated the development of a
psychological model to enhance effectiveness of public health education programs (Glanz
et al., 2015). Research over several decades demonstrated significant links between
individual beliefs about susceptibility and severity of a disease or condition, and
anticipated benefit if they participate in a certain behavior (Glanz et al., 2015). Later,
research from the 1970s specifically aimed at studying constructs within the HBM,
demonstrated that susceptibility, severity and anticipated benefit are antecedents to the
belief that an individual had the ability to make an impact on health outcomes if they
engaged in certain behaviors (Glanz et al., 2015). This concept is also referred to as selfefficacy or perceived behavior control, which is a main construct in the Barriers to
Adherence Framework and TBP (Cochrane et al., 2007; Grol, 2013). However, the
Barriers to Adherence Framework and TBP do not adequately address the factors that are
found within the HBM to influence the construct of perceived behavior control. Glanz et
al. (2015) discuss the evolution of the HBM, which later added cues to action and
summarized two main aspects that influence the perception of behavior control: threat
perception and behavior evaluation. Threat perception includes perceived susceptibility
and disease severity. Behavior evaluation includes perceived benefit and barriers to
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enacting behavior (Glanz et al., 2015). In this dissertation, the HBM was applied to
provider perception. Where susceptibility and severity traditionally have been applied to
patient perspective (Glanz et al., 2015), it was applied to provider perspective about the
provider’s patient population. Figure 2 Conceptual Framework represents the
foundational framework developed to guide this dissertation research. The framework
combines constructs of the Barriers to Adherence Framework, a barrier assessment
framework that is underpinned by TBP (Cochrane et al., 2007; Grol, 2013), and HBM
(Glanz et al., 2015).
Figure 2
Conceptual Framework
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CHAPTER 3: METHODOLOGY
Research Methodology
The long-term goal of this research is to inform future interventions that will
optimize comprehensive care for adolescents with PCOS. The primary objective of this
dissertation is to describe practice behaviors of pediatric primary care providers
(pedPCPs) in the diagnosis and management of PCOS, and identify barriers and
facilitators in order to inform future interventions that support the translation of
adolescent specific guidelines for the diagnosis and management of PCOS in adolescents
into primary care practice. It is hypothesized that practice behaviors among pedPCPs in
the identification, diagnosis and management of PCOS are influenced by multiple factors
(to include knowledge, attitudes, beliefs and external factors such as access to specialty
resources), which may serve as a barrier and/or facilitator to addressing PCOS in the
adolescent population from the primary care perspective.
Specific aims for this dissertation research include:
Aim 1. Identify current practice behaviors among pediatric primary care providers
in the identification, diagnosis and management of PCOS in adolescents.
Aim 2. Evaluate the factors (provider knowledge, provider attitudes and beliefs,
and practice characteristics) that influence practice behaviors to address PCOS in a
pediatric primary care setting.
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Aim 3. Understand barriers and facilitators to the identification, diagnosis and
management of PCOS among adolescents in a primary care setting in order to inform
future interventions to influence practice behaviors.
Exploring current behaviors among pedPCPs helped to describe how providers
are currently engaged in the diagnosis and management of PCOS in the adolescent
population. Examining provider characteristics and inquiring about knowledge, attitudes
and beliefs about PCOS allow for evaluation of what influences individual behavior, and
what may be a barrier or facilitator in addressing PCOS in a primary care practice setting.
Knowledge, attitudes and beliefs are factors that can be modified in order to optimize
comprehensive management of PCOS among an adolescent population. Considering nonmodifiable factors, such as provider characteristics and practice location, provided
evidence to support whether future interventions should be targeted for specific context.
A pragmatic approach to this research allows for a comprehensive understanding
of the various factors that may influence pedPCPs behavior in addressing PCOS in
adolescents. A pragmatic ontology acknowledges that reality is influenced by a variety of
factors in real-world settings (Creswell et al., 2011; Menikoff et al., 2017). In the case of
PCOS there are several variables, both modifiable and non-modifiable, that may
influence how PCOS is address by pedPCPs. Non-modifiable variables relate to external
factors such as practice setting, practice location, and patient’s insurance status. This
results in multiple circumstances and perspectives that must be taken into account. There
will not be one single answer or finding that will be able to explain why a provider does
or does not engage in a specific practice behavior related to the diagnosis and treatment
of PCOS among adolescents. The research will not be deductive to identify a single,
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unbiased result that identifies best practices. Rather the research will be inductive in order
to identify different barriers and facilitators, a variety of potential influencing factors, and
consider both the simplicity and complexity of their interactions. Data collected through
the quantitative survey will identify the degree of involvement in the diagnosis and
management of PCOS, and explore differences between participants with more or less
involvement. Involvement is defined by engagement in the following behaviors:
diagnostic evaluation, treatment, and screening for complications of PCOS. This will
produce more questions that will be answered with both subjective and objective data
from providers in the study sample. This explains a pragmatic epistemology, which seeks
to obtain objective and subjective points of view, and supports the use of mixed methods
research (Creswell, 2013).
Research Design
A mixed-methods sequential explanatory study design that focused on provider
behaviors, knowledge, attitudes and beliefs was carried out to answer the following
research questions: (1) What are the practice behaviors of pediatric primary care
providers in the identification, diagnosis and management of PCOS in adolescents?
(quantitative inquiry)
(2) What factors, both modifiable and non-modifiable, influence practice
behaviors of pediatric providers to address PCOS in a primary care setting? (quantitative
inquiry)
(3) How do pediatric primary care providers experience barriers and facilitators in
the identification, diagnosis and management of PCOS among adolescents, and how can
they be addressed in order to optimize care? (qualitative inquiry)
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First, a survey was developed and administered to pedPCPs to answer research
questions 1 & 2. Survey development is further discussed below under research activities
for the quantitative study. Results from the quantitative survey and the conceptual
framework informed the development of interview questions used in the follow-up
qualitative arm. The qualitative arm involved semi-structured interviews with individual
pedPCPs who participated in the quantitative arm and agreed to be contacted for the
second phase of this research. The purpose of the qualitative research was to better
inform the results of the quantitative survey and explore nuances related to barriers and
facilitators for pedPCPs related to the diagnosis and management of PCOS from their
individual perspectives. A visual representation of the study design is represented below
in Figure 3 Study Design.
Figure 3
Study Design
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RQ2: What factors, both modifiable and nonmodifiable, influence practice behaviors to
address PCOS in a primary care setting?
•
•
•
•

Develop and distribute survey
Measure practice behaviors
addressing PCOS in primary care
setting
Analyze data descriptively and with
univariate analysis
Results inform qualitative interview

Qualitative study: RQ3: How do
pediatric primary care providers
experience barriers and facilitators in
the identification, diagnosis and
management of PCOS among
adolescents, and how can they be
addresses in order to optimize care?
•

•

Semi-structured
interviews with
sub-sample from
survey respondents
Code data and
identify themes

Interpret how
qualitative results
explain quantitative
results

Creswell, J. W., & Plano Clark, V. L., 2011
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Study Population and Setting: Inclusion/Exclusion Criteria
The population for this research included primary care providers who treat
adolescent patients 12-17 years of age in a primary care across Maryland, Virginia and
the District of Columbia, capturing urban, suburban and rural areas. Providers include
physicians, physician assistants (PA), and nurse practitioners (NPs). Eligibility was
determined based on three questions at the start of the survey: (1) Are you a licensed
physician (MD or DO), physician assistant (PA) or nurse practitioner (NP)? (2) Do you
practices in an outpatient primary care practice in the District of Columbia, Maryland or
Virginia? (3) Does your patient population include adolescent (<18 years of age)
females?
A definition of primary care practice was not provided and participants
determined whether or not they considered their practice to be primary care. Due to
variations in health care access across regions, often times settings such as urgent and
gynecology practice are considered primary care. Therefore, the type of primary care
practices extended beyond pediatric and family medicine practices in this study
population. Further discussion regarding recruitment and sampling is discussed below
under each arm, quantitative and qualitative, of this dissertation research.
Quantitative Study
The quantitative arm of this research addresses aims 1 & 2 and accompanying
research questions:
Aim 1. Identify current practice behaviors among pediatric primary care providers
in the identification, diagnosis and management of PCOS in adolescents. RQ1: What are
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the practice behaviors of pediatric primary care providers in the identification, diagnosis
and management of PCOS in adolescents?
Aim 2. Evaluate the factors (provider knowledge, practice characteristics, and
provider attitudes and beliefs) that influence practice behaviors to address PCOS in a
pediatric primary care setting. RQ 2: What factors, both modifiable and non-modifiable,
influence practice behaviors of pediatric providers to address PCOS in a primary care
setting?
Survey Development
The first activity of this dissertation research was to develop a survey instrument
(Appendix A) for the quantitative arm. Survey development was carried out in three
steps: (1) adaptation of an existing survey instrument to fit a pedPCP population and
adolescent-specific PCOS practice guidelines; (2) incorporation of questions relevant to
the conceptual framework regarding attitudes and beliefs; (3) cognitive validity
interviews to finalize the survey instrument.
Step 1: Questions related to provider knowledge and behavior were based upon
published research that measured knowledge gaps in diagnosing and managing PCOS
among an international community of gynecologists and reproductive endocrinologists
(Dokras et al., 2017). The survey published by Dokras et al. (2017) was adapted to fit the
study population of pedPCPs. Specific questions about provider knowledge and practice
behaviors were adjusted to align with adolescent-specific guidance based on the
International Consortium of Paediatric Endocrinology (ICPE) 2017 consensus statement
that is endorsed by the Pediatric Endocrine Society (Ibanez et al., 2017b).
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Step 2: Questions related to constructs within the Health Belief Model (Glanz et
al., 2015) and Theory of Planned Behavior (Cochrane et al., 2007), which inform the
conceptual framework for this research (Figure 2), were created to explore pedPCPs
attitude and beliefs regarding PCOS in their own patient population.
Step 3: Cognitive interviewing was carried out to refine the survey instrument and
verify clarity and understanding of the questions in the survey prior to distribution. Eight
providers completed cognitive validity interviews over a one month period. Of the
participants, two were specialty providers (gynecologist and pediatric endocrinologist),
two primary care physicians (one in pediatrics, one family medicine), two physician
assistants (family medicine), and two nurse practitioners (one in pediatrics, one family
medicine).
The specialty providers with expertise in PCOS helped to ensure accuracy of the
questions, statements and answer choices. The remaining six participants were pedPCPs
who all reported having adolescent patients in their practice, with or without PCOS, and
were identified through the researcher’s professional network. Variations of practice
regions (urban, suburban and rural areas) were considered to ensure that participants were
not a homogenous group from similar practice community.
The process of cognitive interviewing involved asking participants to read the
survey items aloud and share their thoughts and interpretations of the questions with the
researcher (Drennan, 2003). Confirming that the survey questions are well understood
from the provider perspective guided modifications to the survey instrument to ensure
that meaningful data was generated. In addition, feedback was sought related to the
length of the survey and succinctness of the questions.
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The resulting survey instrument grouped items into three main categories: (1)
Provider and practice characteristics; (2) Individual provider practice behaviors that relate
to the diagnosis and management of PCOS among adolescents; (3) Provider attitudes and
beliefs. Most of the questions in the first two categories presented multiple choice options
where participants either select the answer that best applied to them or their practice, or to
select all that apply as was appropriate to the inquiry. E.g. What treatment do you
prescribe/recommend? (check all that apply). Few questions asked providers to write in
specific percentages to describe their patient population in terms of insurance payer mix,
ethnicity and racial diversity. Table 4 Variables for Provider and Practice
Characteristics and Provider Behaviors, list the variables obtained from questions in
categories 1 and 2. Participants were able to write in answers when “other” was an
option. Survey items regarding attitude and beliefs asked participants to measure their
level of agreement with each statement in the scale, Table 5 Provider Attitude and Beliefs
Scale, using a 5-point Likert scale. Statements were grouped together to corresponded
with specific constructs of the conceptual framework.
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Table 4
Variables for Provider and Practice Characteristics and Provider Behaviors
Provider
characteristics
Provider type (MD, DO,
PA, NP)

Practice characteristics
Practice type and setting

Main Provider Behaviors

Practice location (DC, MD, VA)

Identification
Inquire about menstrual
irregularities

Region of practice (urban,
suburban, rural)

Diagnosis
PCOS diagnostic evaluation

% of adolescents in patient
population

Management
Treatment of PCOS

Patient characteristics
Insurance status

Screening for complications of
PCOS

# years in practice
Gender
Age
Practice specialty (E.g.,
pediatric, adolescent,
family medicine, internal
medicine)

Race/ethnicity make up of
patient population
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Table 5
Provider Attitude and Beliefs Scale
Item/statement

Related construct

PCOS is a condition that specifically impacts my adolescent
patient population.
PCOS is an important condition to identify among adolescent
patients.
PCOS is associated with significant health complications for
adolescents.
PCOS is associated with mental health complications of anxiety
and depression in adolescents.

Threat perception

There is benefit to patient health outcomes if PCOS is addressed in
adolescents.
Practice guidelines for the diagnosis and management of PCOS
are supported by evidence based medicine.
I have the ability to accurately diagnosis PCOS in adolescents.
I have the ability to effectively manage PCOS in adolescents.
I have the support needed in my practice to diagnosis and manage
PCOS in adolescents.
I have the support needed in my community to diagnosis and
manage PCOS in adolescents.

Behavior evaluation

Learning more about PCOS would change my practice behaviors.
Resources are available to me to learn more about the diagnosis
and management of PCOS in adolescents.

Cues to action

My colleagues in primary care practice are actively involved in the
diagnosis and management of PCOS in adolescents.
PCOS is mostly diagnosed ad managed by specialists.

Subjective norms

I would like to improve my practice behaviors in addressing
PCOS among adolescents in my practice.
I intend to change my practice behaviors in addressing PCOS
among adolescents in my practice.

Intention

Three months after the survey launch, changes were made to four survey items to
increase rate of survey completion. First, questions related to provider ethnicity and race

59

included an answer choice “prefer not to answer” (items #6 & 7 under Provider
characteristics section). Second, a survey items (#5 under Practice characteristics
section) that asked participants to write in the percentage of their patients in various ages
groups was changed to ask participants to select a range of the percentage of their patient
populations between the ages of 12-17 years of age. The intent of this question was to
have data to compare whether or not the number of adolescents in a practice influences
provider behavior in addressing PCOS among adolescents. Third, a survey item (#6 under
Practice characteristics section) that asked participants to write in the percentage of the
various insurance payers, was changed to ask participants to identify what percentage of
their patient population is either uninsured or covered by public insurance. The intent of
this question was to identify practices that serve a high uninsured or underinsured
population to investigate any potential disparities in access to care. The motivation
behind the aforementioned changes was to make these questions less burdensome to
answer, but still preserved the original intent and allowed for collection of meaningful
data. No data were lost due to these adjustments as data previously collected was
collapsed into the modified categories. See detail provided below under “Sampling and
Recruitment” that further explains the catalyst for these changes related to low survey
response after the initial distribution of the survey.
Sampling and Recruitment
The initial study sample utilized convenience sampling of pedPCPs from the
District of Columbia and states of Maryland and Virginia via professional membership
organizations. Convenience sampling is often used when the population of interest is
readily available (Portney & Watkins, 2015). Assumptions were made at the start of this
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research that emails sent via member listservs of professional organizations within the
professional network of the researchers (dissertation student and advisors) would generate
significant responses. It was recognized and acknowledged when designing this study that
there would be limitations in verifying the total number of members who received the
survey to calculate response rate; however, it was determined that this was an effective
strategy to reach and recruit a diverse group of participants. The study by Dokras et al.
(2017), which this dissertation research survey is based on, used a similar sampling
strategy and distributed the survey online to the member listserv for the American
College of Obstetrics and Gynecology and the American Society of Reproductive
Medicine. No compensation was provided for participation in the online survey.
Eleven state chapters of professional associations for pediatricians, family
medicine physicians, physician assistants and nurse practitioners in Maryland, Virginia
and the District of Columbia were contacted with a request to distribute the survey
instrument to their members. Communication was via email from the dissertation
research student to the executive administrative staff and/or member(s) of the association
board of directors. Two organizations distributed the survey to their member listserv via a
unique directed email. Three organizations distributed the survey via an announcement
within an electronic newsletter sent to member listserv. Five organizations reported
organizational policies that prohibited the distribution of the survey to their membership.
One organization reported that they would seek approval from their Board of Directors, but
did not follow up with a decision despite repeated email follow-up. Of the five
organizations that did distribute the survey, only two were willing/able to send a second
distribution/reminder about the survey.
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Associations who distributed the survey were asked to provide an approximate
number of members who the survey link was sent to in order to estimate a survey
response rate. All associations declined to provide an estimate number of their
membership. It is important to note that even with an approximate number of members, it
would not accurately reflect those providers who were eligible to participate.
Twenty-one respondents participated in the survey within the first three months.
Of these 21 respondents, 17 were eligible as per the inclusion/exclusion criteria, 13
completed the entire survey, and 8 provided contact information to be contacted for
follow-up qualitative interviews. While a large percentage of participants (8/13, 61.5%)
who completed the survey volunteered to participate in phase II of this research, over
twenty-percent of those who met inclusion criteria did not completed the entire survey
(4/17, 23.5%).
A review of the survey items identified a common area where eligible participants
discontinued the survey. This was the point where participants were asked to write in the
percentage of the various payers for, and the ethnic and racial makeup of, their patient
population. Furthermore, it was discovered that questions related to provider ethnicity and
racial identity did not allow participants to bypass this question, by providing a “prefer not
to answer” option.
Three months following initial survey launch, an IRB addendum was submitted to
request a change from convenience sampling to snowball sampling and to make few
changes to the aforementioned survey items. These changes were requested as a strategy to
increase survey participation. Snowball sampling is a method used to engage hard to reach
populations (Valerio et al., 2016). There are several reasons why participants for this study
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were considered a difficult to engage population. First, the target population was clinicians
with busy clinical practice schedules. Second, several of the professional organizations
contacted for survey distribution reported organizational policies that prohibited the
distribution of outside research to their membership. Third, providers who do not have a
significant interest in the topic or a connection to the research are likely less motivated to
participate. This study aimed to recruit a diverse sampling of provider types, among a
variety of practice settings and locations, with varying involvement in addressing PCOS.
Following IRB approval of the addendum, snowball sampling allowed the
dissertation research student to contact organizations where there was a professional
connection to colleagues to request participation and/or to forward the survey invitation and
link to other colleagues via email. Some contacts also sent survey information within
alumni groups or professional organizations via social media pages on Facebook and
LinkedIn. Organizations contacted included clinics, medical groups and alumni
organizations. These institutions represent a variety of settings, urban, rural and suburban,
across Maryland, Virginia and the District of Columbia, keeping with the original intent to
recruit a diverse group of pediatric primary care providers.
Overall, snowball sampling increase study participation to 78 participants. The
survey was open from September 16, 2019 thru June 30, 2020. Survey response rate is
unable to be calculated as snowballing sampling further reduced the ability to document the
number of eligible participants who received an invitation to participant in the survey
study.
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Study Procedure
IRB approved language was provided for an introductory email to potential participants
about the research, along with a link to the survey administered via REDCap. Once a
participant opened the link, they were taken to the Study Information Sheet that
addressed the study purpose, voluntary nature of the research, estimated duration to
complete the survey, anonymity (unless they volunteer to provide contact information at
the conclusion of the survey), potential risks, benefits and alternatives. If respondents
continued, they advanced to the inclusion/exclusion criteria. Inclusion criteria for
participation in the survey included: licensed and practicing as a physician (MD or DO),
PA or NP in the District of Columbia, Maryland or Virginia; practice in an outpatient
primary care setting; and adolescents (12-17 years of age) included in patient population.
If participants did not satisfy inclusion criteria, the survey closed. Participants who met
inclusion criteria continued on to the survey instrument. Completion of the survey
indicated consent. No compensation was provided for participation in the online survey.
Data Analytic Plan
The conceptual framework for this research underpins the study hypothesis and
provide a guide for data analysis. The overarching study hypothesis is that practice
behaviors among pedPCPs in the identification, diagnosis and management of PCOS are
influenced by multiple factors to include knowledge, attitudes, beliefs and nonmodifiable practice characteristics such as geographical region and makeup of patient
population. The conceptual framework, derived from the TPB and HBM, supports that
knowledge, attitude and beliefs influence practice behaviors in the diagnosing and
management of PCOS. Additionally, external factors, which in this research relate to
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practice characteristics, influence not only provider behavior, but can also have a direct
impact on knowledge, attitudes and beliefs.
Descriptive analyses were conducted using IBM SPSS statistical software version
26 to describe provider behaviors, knowledge, attitude/beliefs and practice
characteristics. Next, correlational analyses, with either independent t-tests, analysis of
variance (ANOVA) or Chi square analysis as appropriate, were conducted to evaluate
associations among each factor (knowledge, attitudes/beliefs, practice characteristics) and
provider behaviors in diagnosis and management of PCOS.
Aim 1. Analysis
Provider practice behaviors in addressing PCOS are the first key part for
investigation in this research. The survey instrument queried provider practice behaviors
across three phases or categories to address PCOS: identification, diagnosis and
management (treatment and screening for complications). Throughout the survey,
participants selected whether or not they engaged in various behaviors within their
practices. Survey items either inquired about engagement in a specific behavior (0= no;
1= yes), or ask providers to “select all that apply” when presenting several options for
items such as diagnostic tests or treatment. Responses were recorded as nominal data,
which was analyzed to report frequencies for each behavior. Additionally, where
appropriate, sums of specific behaviors in each category were calculate to use in data
analysis for Aim 2. /RQ2, to compare differences in practice behaviors across items
related to knowledge, attitudes/beliefs and provider/practice characteristics. Table 6
Provider Behavior, provides a list of the behaviors queried in the survey as it relates to
one of the three categories to address PCOS (identification, diagnosis and management),
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the type of responses and data collected, and indicates were sums were calculated to
create continuous data related to a specific behavior.
Additionally, provider demographic characteristics, collected as categorical data,
are described using descriptive statistics. Frequency counts of provider type (MD, PA or
NP), gender, age, ethnicity, race, practice specialty (pediatrics, family medicine, etc.),
and years in practice provide information about the diversity of the study population.
Table 6
Provider Behavior
Category for
Addressing
PCOS

Behavior Inquiry

Type of response/data
collected

Identification

Visit type for inquiry of menstrual regularity

Select all that apply/nominal

Diagnosis

Patients with diagnosis of PCOS
Selection of diagnostic tests
Sum score of diagnostic test selection*
PCOS diagnosis prior to 2 yrs. post menarche

Yes/No/dichotomous
Select all that apply/nominal
Sum score/continuous
Yes/No/nominal

Management

Whether or not provider treats PCOS
Treatment goals
Treatment selection
Referral/ specialist consultation
Screening for complications of PCOS
Selection of screening tests
Sum score of screening test selection*

Yes/No, dichotomous
Select all that apply/nominal
Select all that apply/nominal
Yes/No, dichotomous
Yes/No, dichotomous
Select all that apply/nominal
Sum score/continuous

*Designates data that were transformed into a sum score.
Aim 2. Analysis
Research question #2, more specifically addressed the study hypothesis by
evaluating the factors that influence practice behaviors and conducting correlational
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analysis to determine if there are strong associations among any specific factor(s) and
practice behaviors. First, descriptive statistics, reporting frequencies, were used to
analyze factors of knowledge and provider/practice characteristics. The indicator for
knowledge was familiarity with any diagnostic criteria for PCOS (yes/no), and then more
specifically, for Pediatric Endocrine Society (PES) adolescent-specific diagnostic
guidelines, which providers selected from list of six different diagnostic criteria with the
option to select all that apply. Provider response is recorded as a dichotomous value (1 if
selected; 0 if not selected).
Practice characteristics considered for analysis in Aim 2 include: pediatric versus
family medicine focus, practice setting, practice location, practice region, percent of
adolescent in patient population, percent of total patient population uninsured or
public/Medicaid insured, and ethnic and racial make-up of patient population. Either
independent t-tests, analysis of variance (ANOVA) or Chi square analysis was used as
appropriate for the data. Independent t-test was most appropriate for comparison related
to knowledge as familiarity of PES guidelines (1=yes, 0=no) is a dichotomous value and
diagnostic practice scores as continuous data (Portney & Watkins, 2015). ANOVA is
most appropriate when comparing behaviors of diagnostic practice scores and
management/screening score (continuous data) to provider/practice characteristics
(categorical data with two or more levels) (Portney & Watkins, 2015). Chi square
analysis is most appropriate to compare behaviors of management/treatment (yes=1,
no=1) as dichotomous data with provider/practice characteristics (categorical data with
two or more levels) (Portney & Watkins, 2015).
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Factors of provider attitudes and beliefs were analyzed by determining level of
agreement, on a five-point Likert Scale, with 16 items informed by constructs from the
conceptual framework for this research. Statements and related constructs from the
framework are listed in Table 5 Provider Attitude and Beliefs Scale. Cronbach’s alpha
reliability estimates was calculated to determine internal consistency of the overall scale
(16 items). Cronbach’s alpha is an appropriate statistical method to use for these items
related to attitudes and beliefs as it is known to be an estimate of the reliability of a
psychometric test (Portney & Watkins, 2015). Next, provider agreement with each
statement was reported descriptively with mean item scores, standard deviation and
range. The three highest and three lowest mean item scores for level of agreement were
identified.
Multiple independent sample t-test were carried out to with scale and subscale
scores to compare means between groups of providers with high vs. low diagnostic
practice scores, providers who treat vs. do not treat, and providers who screen for
complications vs. those who not screen. Independent sample t-test is an appropriate test
to compare means between groups where the variable for provider behaviors are
represented as categorical data (Portney & Watkins, 2015).
The quantitative component of this research provided extensive information about
pedPCP’s practice behaviors, filing a gap in the literature regarding the diagnosis and
management of adolescents with PCOS in a primary care setting. Comparing behaviors
across multiple variables will help to identify areas to target future interventions and
reveal potential disparities. Collectively, the information obtained from analysis of the
quantitative data helped to informed qualitative inquiry that seeks to understand barriers
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and facilitators to the identification, diagnosis and management of adolescents with
PCOS in a primary care setting.
Qualitative Study
The qualitative arm of this research addresses aim #3 and accompanying research
questions. Aim 3. Understand barriers and facilitators to the identification, diagnosis and
management of PCOS among adolescents in a primary care setting in order to inform
future interventions to influence practice behaviors. RQ 3: How do pediatric primary care
providers experience barriers and facilitators in the identification, diagnosis and
management of PCOS among adolescents? RQ 4: How can barriers and facilitators be
addressed in order to optimize care for adolescents with PCOS?
Qualitative Research Activities
Following the collection of data from the quantitative phase of this research, a
smaller sample of pedPCPs were contacted for semi-structured qualitative interviews to
better understand the context and conditions related to the responses captured in the
provider survey. Semi-structured interviews are a main tool in qualitative research that
allows the researcher to illustrate how participants make meaning, understand meaning
within context and identify unanticipated consequences (Patton, 2015). Qualitative
research in this mixed-methods study is necessary to obtain a complete and nuanced
understanding of current practice behaviors and barriers and facilitators to change
behaviors among primary care providers.
An interview guide (Appendix B) was developed based on the conceptual
framework for this research and the results of the quantitative survey. First, questions
were developed that aligned with key constructs within the Theory of Planned Behavior
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(TPB) and the Health Belief Model (HBM). Specifically, this included questions related
to: knowledge about guidelines and current practice behaviors; attitudes and beliefs about
PCOS in adolescents; intention and motivation to change; and inquiry about external
factors that influence practice. Questions were them modified and refined based on
results from the from the survey results. As interesting findings emerged from the survey
data that either supported or rejected the study hypothesis around pedPCPs knowledge
and practice behaviors, the qualitative interview allowed for follow up to gain a more
nuanced perspective. Additionally, individual participant survey data was available for
reviewed prior to the interviews, which allowed the interviewer to address outliers and
seek additional information to explain variations within the sample.
Interview questions followed guiding principles of interview questions: ask
question that are open-ended and require a descriptive answer; ask questions that are
clear; communicate clear transitions in the interview guide when changing topics or
ideas; allow time for follow-up to probe unexpected responses (Patton, 2015). Interviews
were scheduled from June 18 – August 24, 2020. A total of twenty interviews were
completed.
Sampling and Recruitment
The study population was a purposeful sample of pedPCPs in Virginia, Maryland,
and the District of Columbia who completed the quantitative survey and agreed to be
contacted to participate in the qualitative phase of this study. Survey respondents
provided limited contact information at the conclusion of the on-line survey, which asked
if they were willing to be contacted at a later date for the follow up phase of the research.
Providing their contact information was completely voluntary and was not a required
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field on the survey.
Inclusion criteria for participation in the qualitative phase of this research
included: completion of the on-line survey (and therefore meeting the initial inclusion
criteria of a physician, PA or NP in primary care practice); verbal fluency in English;
having a valid email address; and have access to a computer or phone.
Exclusion criteria include providers who did not complete the survey
disseminated prior to this study; practice in a specialty vs. primary care oriented setting
(E.g. endocrinology); providers who do not currently practice/see patients in Virginia,
Maryland or the District of Columbia, even if they hold a medical license in those
jurisdiction; and providers who do not have access to a reliable phone line or computer
with Wi-Fi to participate in the interviews.
Prior to initiation of this study, the literature was reviewed for exemplars of
qualitative interviews with health care providers to estimate an ideal sample size based on
previous research. Guidance on a reasonable number of participants was sought rather
than suggesting theoretical saturation in order to ensure diversity in the sample
population. There are limited examples of qualitative research with health care providers
that include physicians, but a study of palliative care health care professionals involved in
pediatric palliative care from 2015 utilized a sample size of 17 (Lotz et al., 2015). The
palliative care study relates to this dissertation research as it aimed to inform future
interventions for support and education of health care professionals (Lotz et al., 2015).
This dissertation study recruited twenty-seven survey participants who indicated
that they were willing to be contacted for follow up. All twenty-seven pedPCPs were sent
emails between June thru August 2020 to request an interview. Two emailed the
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researcher indicating that they no longer wished to participate in the interviews, twenty
scheduled and completed interviews, and five had no response. Participants with no
response were contacted a total of three times between June-August 2020.
Participants received a small incentive ($25 gift card to Target) in appreciation for
their time. The gift cards were sent via mail. A tracking sheet was maintained and
participants were contacted via email to alert them when the gift cards were mailed.
Participants were asked to reply if they had not received the gift cards within one week of
mail date. No email response indicated that the gift cards was received.
Procedure
Participants who provided their contact information for follow up were contacted
via email with a request to schedule an individual interview. The email was approved by
IRB, as well as the Study Information Sheet attached to the email. IRB determined this
study to be minimal risk; therefore, a Study Information Sheet was used in place of
signed Informed Consent. Participants were able to schedule interviewers via a link to a
Google calendar associated with the researcher’s email, which displayed available
appointments. An email was generated to the researcher once the interview was
scheduled. At that time a follow up email was sent to inquire if the participant preferred
an interview meeting via phone or Zoom videoconference. This method allowed
individuals to participate from distant areas without having to make travel a limiting
factor in recruiting for this phase of the study. If phone preference, the participant was
asked to provide a phone number for the researcher to call at the scheduled date/time. If
videoconference was preferred, participants were emailed an on-line meeting link unique
to their individual interview.
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At the start of each interview, the Study Information Sheet was reviewed in detail
regarding the purpose of the research, the voluntary nature of the study and that the
interviews would be recorded for purposes of transcription. The participate was asked if
they had any questions or required clarification before the interview began. Interviews
were limited to 30 minutes in length.
Interview recordings were then transcribed by a transcription service. For the
interviews carried out via videoconference, only the audio recording was saved and
shared for transcription. Once transcribing was complete, the researcher reviewed each
transcript while listening to the recording to verify each transcript. The verified transcript
was sent to each participant via email, allowing them the opportunity to clarify any
information they provided. This strategy, called member checking, helps the researcher to
ensure accuracy of the data (Creswell, 2013). Participants were not obligated to review
the transcription document. A specific date, ten days from the time the transcription was
emailed, was provided by which changes should be received. No response from the
participant indicated that they did not have any additional comments for clarification.
Only one participant replied that there were a few terms that they thought were
“incorrect”, but that it did not change the meaning of the interview and they did not
provide any specific annotations for correction.
Data Analysis
First, seven transcripts were coded manually, using opening coding in the first
coding cycle to identify barriers, facilitators and ways to address practice behaviors,
attitudes and beliefs. These seven transcripts were purposively selected to ensure the
diversity of the sample was represented to maximize potential for new codes in the initial
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coding process. Selection considered provider type, practice focus and setting, provider
engagement in diagnostic and management of PCOS, and provider behavior evaluation
and intention to change as per their response on the attitude/beliefs survey items. The
researcher collaborated with a peer reviewer to check for agreement on the initial codes
generated from the first cycle of coding for barriers, facilitators and ways to address
practice gaps.
A second cycle of manual coding used descriptive coding (Saldana, 2016) to
describe the barriers, facilitators and ways to address that were identified in the first cycle
of coding. The first two cycles of coding utilized an inductive approach to allow concepts
to be developed from the raw data. A third cycle of coding took a deductive coding
approach to consider the concepts within the conceptual framework for this research.
While there was no predefined code book, considering the unique constructs from the
TBP and HBM ensured that there were no outliers in the qualitative data that were not
captured in the codes that emerged from the inductive coding process. The third cycle of
coding resulted in refinement of codes and subcodes, and development of categories that
considered both the initial results of open coding and the guiding framework. Subcodes
were maintained under some of the general codes in order to provide more nuanced
analysis and preserve input from the participant that was specific and unique (Saldana,
2016).
At the completion of the manual coding a codebook was developed based on
themes identified (Appendix B). The peer reviewer, who participated in the first cycle of
coding, reviewed codes and categories with the researcher for agreement on a codebook
to be used for coding remaining transcripts. The finalized codebook was entered into
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NVivo 12 (Release 1.3) qualitative data analysis software to code the remaining
transcripts. Thematic analysis was then applied to generate themes that best represent
thoughts and experience shared by the participant/interviewee as guided by the frequency
of categories and codes (Saldana, 2016). Figure 4 Study Schema provides a visual
summary of the study activities, procedures, and outputs.
Figure 4
Study Schema
Procedures

Explanatory Sequential Mixed Method Design
Survey Development

•
Quant: Survey Data Collection
and analysis (Aim 1 & 2)

•
•
•
•
•
•

Interview Protocol
Development and participant
selection

Qual: Interview data collection
and analysis (Aim 3)

•
•
•

Integration of Quantitative and
Qualitative Results

•

Outputs

Informed by previous survey instruments, FW
for barriers to adherence and HBM
Cognitive validity interviews

•

Pilot survey
Convenience sampling
Distribution of survey
Quantitative Data analysis
Develop interview questions
Purposeful sampling

Semi-structured interviews with individual
providers
Coding and thematic analysis
Interpretation and explanation of the
quantitative and qualitative results
Identification of differences across
provider/practice characteristics and/or
geographical regions

v Finalized survey instrument

v Descriptive statistics: of provider and practice
characteristics; to report frequencies of specific
behaviors; to report provider assessment/agree with
statements related to knowledge, attitudes and
beliefs
v Analysis of how independent variables may explain
differences in behavior
v Analysis of how attitudes and beliefs may explain
differences in behaviors
v Semi-structures interview guide informed by quant
analysis
v Participant sample for semi-structured interviews
v Discussion of themes in context of barriers and
facilitators identifying, diagnosing and managing
PCOS in adolescents in a primary care setting
v Suggestions for next steps; identify target areas for
intervention aimed at efforts to translate
knowledge into policy and practice
v Identify potential areas for disparities in health
care delivery

Template adapted from Creswell, J.W. & Shope, R. (2017, September). Mixed Methods Research in the Health Sciences. Workshop, Faculty Development for Health Sciences, School of
Medicine and Health Sciences. The George Washington University, Ashburn, Virginia.

Accuracy
Internal validity is obtained by using survey instruments based on existing
literature and established theoretical models/frameworks. Completion of cognitive
validity interviews prior to distribution of the survey further contributes to rigor of the
survey instrument. External validity is maintained by sampling providers across a variety
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of practice settings and geographical locations. Sampling was not limited to a specific
group of providers as population validity is a threat to external validity.
Values of trustworthiness considered for accuracy of qualitative findings include
credibility, dependability, transferability, and confirmability (Lincoln & Guba, 1985).
Credibility is addressed by utilizing evidence from previous qualitative research and
publications on qualitative research to guide qualitative methods (Shenton, 2004). As
stated above under activities in the qualitative description of the study, guiding principles
from experts in qualitative research (Patton, 2015) informed the development of the
interview guide. Additionally strategies for credibility that were used in this dissertation
research include:
- Triangulation of data (Shenton, 2004) - Quantitative data in this mixed-methods
study supports results that emerge from the thematic analysis of the qualitative
interviews, as well as qualitative data helps to better explain quantitative findings.
- Frequent debriefing session - the researcher for this dissertation received
guidance and mentorship via frequent debriefing sessions (Shenton, 2004) with the
PI/dissertation chair and a committee member, with qualitative research expertise, as the
qualitative research was carried out.
- Member checks – member checks were carried out by asking participants to
review final transcripts of the interview dialogue (Shenton, 2004). Participants had the
opportunity to provide feedback to ensure that the type transcript match the words and
ideas they intended to convey (Shenton, 2004).
- Peer scrutiny – the dissertation research student worked with a peer reviewer to
provide feedback during the qualitative research process and to verify codes, categories,
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final codebook and emerging themes from the qualitative data (Shenton, 2004).
- Examination of previous research findings (Shenton, 2004)
- Dependability relates to the reliability of the work (Shenton, 2004). In this study,
dependability was addressed by detailing the process of how the qualitative research was
carried out, such that a reader has a guide to replicate this study (Shenton, 2004). In
addition, ensuring alignment of the methods with the research questions support
dependability. This was addressed by having researchers, from the dissertation
committee, review the alignment (Figure 5 Maxwell’s Alignment and process of the
research (Creswell, 2013; Maxwell, 2013)).
-Transferability is addressed by providing detailed information of the existing
evidence that supports this research and thick, rich descriptions of the phenomenon (the
experience of pedPCPs in addressing PCOS) being study (Lincoln & Guba, 1985). This
will be addressed by providing descriptions and memos during the process of qualitative
data collection and analysis.
-Confirmability is addressed by detailing the process of data collection, analysis
and interpretation, and taking time to reflect, and document reflection, on how the
researcher’s background may have influenced the findings (Patton, 2015; Shenton, 2004).
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Figure 5
Maxwell’s Alignment
Methodology & Research Alignment
Goals
Describe practice behaviors of
pediatric PCPs in the diagnosis and
management of PCOS, and identify
barriers and facilitators to inform
interventions to change practice
behaviors.

Methods
Survey and semi-structured
one-on-one interviews with
primary care providers who
care for an adolescent
population

Conceptual Framework
Theory of Planned Behavior and Health
Belief Model as a comprehensive
foundation to differentiate between
current behaviors and intended behaviors.
Research Questions
(1) What are the practice behaviors of
pediatric primary care providers in the
identification, diagnosis and management
of PCOS in adolescents? (2) What factors
influence practice behaviors of pediatric
providers to address PCOS in a primary
care setting? (3) How do pediatric primary
care providers experience barriers and
facilitators in the identification, diagnosis
and management of PCOS among
adolescents, and how can they be
addressed in order to optimize care?
Validity
Literature review of previous surveys;
survey questions guided by framework;
cognitive validity interviews; member
checking, memos, triangulation of data,
solid conceptual framework and
established methods
Figure 1.1. An Interactive Model of Research Design, (Maxwell, 2005)

Protection of Human Subjects
Research protocols for IRB review were submitted separately for each
phase, quantitative and qualitative, of this study.
Quantitative Research
Children’s National and the George Washington University Institutional Review
Board provided approval for this study (Pro00012251). The survey research was
determined exempt under DHHS regulatory category 2. Children’s National was the IRB
of record, and George Washington University IRB provided concurrence. Participation in
the study was voluntary and risk to subjects was minimal. Providers did not experience
any adverse events if they decline participation. Alternative to study participation was
non-completion of the survey. No names were collected and no identifying information
linked to survey results, except for those participants who volunteered to provide their
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contact information to participate in the qualitative phase of this research. For
participants who provided contact information, only the research team has access to their
contact information and link with the study data in a secure password protected folder.
Only aggregate data is analyzed without naming any individuals or providing potentially
identifying information, such as naming the institutions where they practice. Participants
did not and will not receive any direct benefits. Potential benefit is that knowledge gained
from this study will inform future interventions to modified practice behaviors to
optimize the role of the primary care provider in the identification, diagnosis and
management of PCOS among adolescents. No compensation was provided.
IRB approval was not applied to the cognitive validity interviews that preceded
survey distribution and data collection. The purpose of the cognitive validity interviews
was for survey development and personal data was not collected. Providers simply read
the survey questions out loud and providing feedback on clarity of the question to the
researcher. As per federal regulations 45CFR46.101(f), this part of the research activities
did not meet the definition of “about whom”.
Qualitative Research
The IRB of record for this research is Children’s National IRB, which provided an
expedited review and determined the qualitative study to be no more than minimal risk
(Pro#00013265). A Reliance Agreement was required with George Washington
University Committee on Human Research, Institutional Review Board in order to
designated GWU as an external site. The request for a Reliance Agreement was
submitted and approved using the SMART IRB.
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For the qualitative semi-structured interviews, a Study Information Sheet was
provided to all participants and the following key elements were highlighted prior to the
interview: voluntary nature of the research; study purpose; duration and research
procedures; risks, benefits and alternatives. Risk to study subjects was minimal.
Participation in the interviews was completely voluntary, but there is a minimal risk of
loss of confidentiality since information related to the identity of the participant is known
to the researcher and their information can be linked with their survey responses. In order
to reduce potential risk associated with loss of confidentiality, the researcher has
followed routine precautions to protect participant privacy, including password protection
and encryption of electronic data files and de-identification of interview transcripts. The
link between participants with their survey responses is only known to the researcher and
destroyed after completion of the analysis. Participants had the opportunity decline to
participate at any time, even if the interview had already started, with no risk of adverse
events. Alternative to study participation was not participating in the qualitative
interviews.
Participants did not receive any direct benefit from participating in this research.
Potential indirect benefit is that knowledge gained from this study will inform future
interventions to modified practice behaviors to optimize the role of the primary care
provider in the identification, diagnosis and management of PCOS among adolescents.
$25 Target gift cards were provided to interview participants in appreciation for their
time.
Beneficence throughout the entirety of this research was considered and addressed
by reducing risk to individuals through anonymity of the surveys and taking measures to
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maintain privacy and confidentiality in the interviews. This included keeping
documentation linking participants contact information with the study and their survey
responses in a password protected file on Dropbox, only accessed by the researcher.
Interviews were conducted either via phone or Zoom videoconferencing with unique
password protected meeting links. Participants were informed that recordings of
interviews would be used for thematic analysis only and were destroyed after
transcription was verified. Transcripts have been stored in a password protected computer
drive and do not contain any name or other identifiers of the interviewee. Only members
of the research team, named on the IRB application, have access to the data.
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CHAPTER 4: RESULTS

An on-line survey to identify practice behaviors and evaluate factors that are
associated with behaviors among pediatric primary care providers (pedPCPs) in the
identification, diagnosis and management of PCOS in adolescents was distributed to
pedPCPs in the District of Columbia, Maryland and Virginia. Seventy-eight (78)
providers responded to the survey invitation by opening the link and reviewing the study
information sheet. Seventy-four (74) respondents completed inclusion/exclusion criteria;
12 were not eligible to participate. Of the remaining 62 participants, 10 had incomplete
responses that could not be analyzed, resulting in 52 completed survey responses that
were available for analysis.
Follow-up individual interviews were conducted via phone or videoconferencing
to better understand barriers and facilitators to addressing PCOS among adolescents in a
primary care setting. Twenty-seven participants volunteered to be contacted for
interviews and provided contact information. Twenty interviews were completed. This
chapter will provide the results related to each research question and mixed-methods
analysis.
Quantitative Results
Demographics
Provider Characteristics
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The majority of participants were PAs (n=29/52, 55.8%), with physicians (MDs)
representing 23.1% (n=12/52) of the sample, and NPs 21.1% (11/52). Responses for
areas of practice included: general pediatric (n=15), adolescents medicine (n=3), internal
medicine (n=6), family medicine (n=22), urgent care (n=1), health department
reproductive health clinic (n=1), general gynecology (n=3), and primary care (n=1).
Table 7 Provider Demographics and Characteristics, presents provider demographics
and individual characteristics. Individual characteristics include: practice specialty and
years in practice.
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Table 7
Provider Demographics and Characteristics
Physician
Assistants
(PAs)
n
%

Physicians
(MDs)
n
%

Nurse
Practitioners
(NPs)
n
%

Full
Sample
n
%

Gender
Female
7
13.5
26
50
9
17.3
42
80.8
Male
5
9.6
3
5.8
2
3.8
10
19.2
Age
20-39 years
7
13.5
23
44.2
4
7.7
34
65.4
39-59 years
5
9.6
6
11.5
7
13.5
18
34.6
Ethnicity
Hispanic/Latino
0
0
1
1.9
0
0
1
1.9
Not Hispanic/Latino
12
23.2
27
51.9
11
21.2
50
96.2
Prefer not to answer
0
0
1
1.9
0
0
1
1.9
Race
White
7
13.5
24
46.2
6
11.5
37
71.2
Black
4
7.7
1
1.9
3
5.8
8
15.4
Asian
1
1.9
0
0
0
0
1
1.9
Two or more races
0
0
4
7.7
2
3.8
6
11.5
Specialty
General pediatrics
10
19.2
4
7.7
1
1.9
15
28.8
Adolescent medicine
0
0
0
0
3
5.8
3
5.8
Internal medicine
1
1.9
4
7.7
1
1.9
6
11.5
Family medicine
1
1.9
15
28.8
6
11.5
22
42.3
Other
0
0
6*
11.5
0
0
6
11.5
Years in Practice
1-10 years
7
13.5
21
40.4
8
15.4
36
69.2
11-20 years
1
1.9
5
9.6
3
5.8
9
17.3
>20 years
4
7.7
3
5.8
0
0
7
13.5
*Other PA specialties included: urgent care (n=1), health department reproductive health clinic
(n=1), GYN (n=3), and one designated as “primary care” (n=1)

Practice Characteristics
Practice characteristics include: practice location (District of Columbia, Maryland
or Virginia), practice region, practice focus and setting, and patient characteristics of
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insurance status, ethnic and racial groups, and percent of adolescents within patient
population.
Practice Location and Region. Practice locations (DC, MD and VA) were
distributed across urban, suburban and rural areas, with three participants stating their
practice was divided between two different regions; Figure 6 Practice Location and
Region.
Figure 6
Practice Location and Region

18
Practice Region
Urban

16
14

Suburban

Count

12

Rural

10
8

Divided
between more
than one region

6
4
2
0
District of Columbia

Maryland

Virginia

Practice Location

Practice Setting and Patient Population. Practice setting includes both practice
focus (pediatric vs. family medicine) and type of practice setting such as private or group
practice. Practice focus was taken from provider specialty data and collapsed into either
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pediatric focused practice or family medicine focused practice. Practice specialties in
internal medicine, primary care, health department clinic, urgent care or general
gynecology have a family medicine perspective with populations that include both
adolescents and adults, versus pediatric practice focus with adolescents and younger
patients.
Original categories for type of practice setting in the survey were collapsed into
the following categories: solo private practice (single-physician owned) (n=3); group
practice (either owned by physician group, corporation or hospital system) (n=28); an
outpatient clinic that is affiliated with an academic medical center (n=6); public or
community health clinic (including health department clinic and a school-based clinic
that is part of a Federally Qualified Health Center (FQHC) (n=9); and urgent care clinic
(n=6). (Of note, this is different than the single provider who indicated “urgent care” as a
specialty as noted in Table 7 Provider Demographics and Characteristics. There is not a
medical specialty for “urgent care”. In this study, urgent care is a setting where providers
have a family medicine focus.)
Inquiry to discern between public and private insurance payer mix asked
participants if less than or greater than 50% of their patient population had
Medicaid/public insurance or were uninsured. Twenty-four of fifty-two participants
(46.2%) responded that >50% of their patients were either uninsured or Medicaid
beneficiaries; and 28/52 (53.8%) had less than 50% of their patient population in this
insurance payer group.
Next, participants wrote in estimated percentages for categories of ethnicity and
race represented in their patient population. Ethnicity and race data was collapsed into

86

categories designating whether minority populations of interest in this study, Hispanic
and Black/African American, accounted for 50% or greater of the patient population.
Collapsed data into categorical values allowed later analysis to explore disparities,
previously reported in the literature, in the context of this research regarding provider
diagnostic or management behaviors. Other races reported by providers and the average
reported among the sample included: Asian 6.6%, Native American 0.6%, Pacific
Islander 0.6%, more than two races 9.9% and other 6.7%. For “other” participants wrote
in Middle Eastern, Indian, and Hispanic as a race. Due to small percentages among a
small dataset, categorical values were not assigned for additional race data beyond White
and Black/African American.
Finally, the majority of the providers (n=38/52, 73.1%) reported that adolescents
make up less than 25% of their patient population and 25% of the participants (n=13/52,)
reported that adolescents make up greater than 25% percent of their practice population.
Data is summarized in Table 8 Practice Characteristics Across Practice Settings.
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Table 8
Practice Characteristics Across Practice Settings

Private
solo
practice
(n=3)
n
%

Outpatien
t group
practice
(n=28)
n
%

Academic
medical
center
affiliated
clinic
(n=6)
n
%

0
3

10
18

35.7
64.3

5
1

83.3
16.7

3
6

33.3
66.7

0
6

0
100

18
34

34.6
65.4

% Patients Uninsured or Public Insurance
≤ 25%
2
66.7 13 46.4
26-50%
0
0
5
17.9
>50%
1
33.4 10 35.7

1
0
5

16.7
0
83.3

2
0
7

22.2
0
77.8

2
3
1

33.3
50
16.6

20
8
24

38.5
15.4
46.2

% Patient Population Hispanic**
<50%
3
100 26
≥ 50%
0
0
1

4
2

66.7
33.3

7
2

77.8
22.2

4
1

66.7
16.7

44
6

84.6
11.5

50
50

8
1

88.9
11.1

6
0

100
0

40
11

76.9
21.2

0
33.3
66.7

2
6
1

22.2
66.7
11.1

1
4
0

16.6
66.7
0

16
22
13

32.7
42.3
25

Practice focus
Pediatric
Family Med

0
100

92.9
3.6

% Patient Population Black/African American*
<50%
2
66.7 21
75
3
≥ 50%
1
33.4 6
21.4
3
% Adolescent Patients*
<10%
2
66.7
11-25%
0
0
>25%
1
33.4
*One missing value
**Two missing values

11
10
7

39.2
35.7
25

0
2
4

Public/
Comm.
Health
clinic
(n=9)
n
%

Urgent
care
(n=6)
n
%

Total
(n=52)
n
%

Research Question #1: What are the practice behaviors of pediatric primary care
providers in the identification, diagnosis and management of PCOS in adolescents?
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Behavior: Identification of PCOS
Fifty-two (52) complete survey responses were available for analysis related to
behaviors to identify PCOS. The survey first asked providers to identify at which visit
type they inquired about menstrual irregularities in adolescent patients. Since menstrual
irregularities is one of the main criteria for diagnosing PCOS in adolescents, inquiring
about menses is a key behavior to identify patients who may be at risk. Survey
respondents were able to select all that apply to indicate when they inquiry about menses,
and also had the option of “I never inquire about menstrual irregularities.
Figure 7 Encounters When Providers Inquire About Menses highlights the type of
visits where providers inquire about menstrual irregularities and the percentage of
respondents indicating this behavior. No participants indicated that they “never inquire
about menstrual irregularities”. Respondents who choose “other”, wrote in that they
inquire about menses for appointments related to abdominal pain, vaginal discharge,
vaginal bleeding, sexual transmitted infection and birth control appointments.
Next, providers were asked whether or not menstrual irregularities among
adolescents is a frequent finding in their practice that would potentially require further
follow. Twenty-six out of fifty-two respondents (50%) estimated that 11-25% of their
adolescent patient population have menstrual irregularities; 8/52 (15.4%) respondents
estimated <10%; 14/52 (26.9%) estimated 26-50%; 3/52 (5.8%) estimated >50%; and one
respondent selected “unknown”.
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Figure 7
Encounters When Providers Inquire About Menses
100.0%
90.0%

Percent Selected

80.0%
70.0%
60.0%
50.0%
40.0%
30.0%
20.0%
10.0%
0.0%

All encounters

At well visits

Menstrual cycle
complaints

Metabolic
abnormality

Other

Type of Encounters
Providers (n=52) selected all that applied

Behavior: Diagnosis of PCOS in Adolescents
All participants were asked if they had patients with a diagnosis of PCOS.
Participants who indicated that they had patients with a diagnosis of PCOS branched into
specific questions about their practice behaviors for the diagnosis and management of
PCOS. Eight of fifty-two respondents (15.4%) stated that they did not have adolescent
patients with a diagnosis of PCOS. These 8 participants were then directed to another part
of the survey to inquiry about knowledge and attitude/beliefs, but no further information

90

was collected regarding practice behaviors. Reasons stated for not having adolescents
with a diagnosis of PCOS included: lack of patients who meet diagnostic criteria (n=4);
lack of knowledge needed to diagnosis PCOS (n=1); lack of confidence (has knowledge,
but not comfortable) to diagnosis PCOS (n=3).
For the remainder of items regarding practice behaviors, survey responses from
the subset of 44 providers who have patients with PCOS were available for analysis.
Table 9 Estimate Number of Patients with PCOS Annually, represents provider estimates
of the number of adolescent patients with PCOS seen annually.
Table 9
Estimate Number of Patients with PCOS Annually

Number of patients
< 25
25-50
>75

Pediatric focused
practice
n
%
10
22.7
3
6.8
1
2.3

Family medicine
focused practice
n
%
26
59.1
3
6.8
1
2.3

Total
n
36
6
2

%
81.8
13.6
4.5

Behavior of providers who have adolescents with PCOS (n=44) was first analyzed
for their selection of laboratory and/or imaging tests for PCOS diagnostic evaluation. The
selection of diagnostic tests is important as PCOS is a diagnosis of exclusion without
specific tests to make a definitive diagnosis. Additionally, in contrast to other PCOS
diagnostic criteria that are applicable to the adult population, routine use of
ultrasonography to identify polycystic ovarian morphology is discouraged in the PES
adolescent specific guidelines. The survey presented laboratory test options that are
recommended in adolescent-specific guidelines to document biochemical
hyperandrogenism (free and total testosterone) and to rule out other conditions that can
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also be associated with the clinical manifestations of PCOS. Providers were able to select
all that applied. Eight respondents stated that they did not carry out evaluations for PCOS
in their practice. All responses are shown in Figure 8 Diagnostic Tests Selected, which
indicates the percentage of respondents that utilize each laboratory test or procedure.
Figure 8
Diagnostic Tests Selected
100%

Percent Selected

90%
80%
70%
60%
50%
40%
30%
20%
10%
0%

Diagnostic Tests
Providers with PCOS patients (n=44), select all that apply

Finally, providers were asked if they made the diagnosis of PCOS within two
years of menarche. Adolescent specific diagnostic criteria recommend that the diagnosis
of PCOS not be made within two years of menarche as irregular menses (necessary for
the diagnosis of PCOS) can be a normal part of pubertal development. Nine providers did
not answer this question, 22 providers stated that they did not diagnosis adolescent
patients with PCOS within two year of menarche, 7 selected that they did diagnosis
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adolescent patients with PCOS within two year of menarche, and 6 stated that they did
not make the diagnosis of PCOS.
A sum score for behavior in diagnosing PCOS (diagnostic practice score) was
calculated to identify providers who have high vs. low engagement in carrying out
adequate diagnostic evaluations as per PES endorsed adolescent-specific diagnostic
guidelines. Analysis focused on nine specific behaviors that are outlined in the PES
guidelines as key for diagnostic evaluations. Key behaviors to diagnose PCOS are listed
in Table 10 Key Behaviors to Diagnose PCOS. In the survey instrument, participants
selected all behaviors that they engaged in with 1=Yes and 0=No. Sum of the
dichotomous data for each behavior resulted in a score, labelled as diagnostic practice
score, for each participant. Since no provider stated that they never inquire about
menstrual irregularities, score ranged from 1-9. A summary of the distribution of the
practice score is represented in Figure 9 Diagnostic Practice Scores and Table 11
Distribution of Practice Scores.
Table 10
Key Behaviors to Diagnose PCOS
Clinical evaluation
1. Evaluation of menstrual irregularity (inquiry about menstrual irregularities at any visit).
2. Irregular periods must be persistent two years after menarche prior to making a
diagnosis of PCOS.
3.
4.
5.
6.
7.
8.
9.

Laboratory evaluation
TSH
Prolactin
Testosterone levels (total and/or free)
17-OHP
DHEAS
FSH
LH
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Abbreviations: Thyroid Stimulating Hormone (TSH); 17 Hydroxy-Progesterone (17OHP); Dehydroepiandrosterone Sulfate (DHEAS); Follicle Stimulating Hormone (FSH);
Luteinzing Hormone (LH).
Figure 9
Diagnostic Practice Scores
9
Frequency (# of Providers, n=44)

8
7
6
5
4
3
2
1
0
1

2

3

4
5
6
Sum of Diagnostic Evaluations

7

8

9

Table 11
Distribution of Practice Scores
N
44

Mean Median
5.55

6.00

SD

Min

Max

2.74

1

9

Variance Skewness
7.51

-.421

With a median of 6, score of 6 and above was the range set of what is considered
to be a high practice score, reflecting optimal participation in behaviors to evaluate a
patient for a diagnosis of PCOS. Twenty-six out of forty-four participants (59.1%) had a
practice score between 6- 9 (labelled as high practice score) and 18/44 (41%) had a
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practice score between 1-5 (labelled as low practice score). Eight of the forty-four
participants (18.2%) had a maximum score of 9. Despite optimal practice scores, 2/8
respondents with high diagnostic practice scores reported that they do not make the
diagnosis of PCOS.
Behavior: Management of PCOS in Adolescents
Management of PCOS includes treatment and screening for complications of
PCOS.
Treatment
Providers were first asked if they engaged in treatment of PCOS. Twenty-nine out of
forty-four providers (65.9%) indicated that they treat PCOS and 15/44 (34.1%) indicated
that they do not engage in the treatment of PCOS. Figure 10 Provider Identified
Treatment Goals, represents treatment goals from the provider perspective, and Figure 11
Provider Treatment Selection, depicts provider selection of treatment. Most providers
(≥50%) noted that normalizing BMI, regulating menses and improving markers of
cardiometabolic health were treatment goals in addressing PCOS in adolescents. Sixtysix percent of providers recommend lifestyle modifications as a mainstay of
treatment/management of PCOS; and 50% or more are prescribing hormonal
contraception and/or metformin. Most of the providers (23/44, 52.3%) stated that they
refer to specialist for consultation in treating PCOS.
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Figure 10
Provider Identified Treatment Goal
100%
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Percent Selected
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Treatment Goals
Providers with PCOS patients (n=44), select all that apply
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Other

Figure 11
Provider Treatment Selection
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Treatment Options
Providers with PCOS patients (n=44), select all that apply

Screening for Complications
Screening for complications of PCOS is an important component of the
management of PCOS. PCOS is associated with long-term complications to include
obesity, insulin resistance, T2DM, depression and anxiety. Thirty of the forty-four
providers (68.2%) stated that they screen for complications of PCOS, while 14/44
(31.8%) reported no screening. Figure 12 Screening for Complications of PCOS
represents specific complications that providers indicated they carry out screening for as
recommended by PES adolescent-specific PCOS guidelines. Providers were able to select
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all that apply. Data were not collected to inquiry about methods or frequency of screening
(E.g. monthly versus annual screening).
Figure 12
Screening for Complications of PCOS
100%
90%

Percent Selected
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0%

Complications
Providers with PCOS patients (n=44), select all that apply

All of the above complications are recommended for screening in adolescents
with PCOS (Ibanez et al., 2017). A screening practice score, with one point given for
each complication/condition screened for, was calculated to identify providers who have
high vs. low engagement in carrying out recommend screening to use in further analyses.
Thirteen of forty-four providers (29.5%) have a maximum score of 7, and 14/44 (31.8%)
a minimum score of 0, which represents the 14 providers who stated that they did not
engage in screening for complications of PCOS. Table 12 Distribution of Screening
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Practice Scores reports the mean and distribution of screening practice scores and Figure
13 Screening Practice Scores the frequency of screening practice scores.
Table 12
Distribution of Screening Practice Scores
n

Mean Median

44

4.20

6.00

SD

Min

Max

2.99

0

7

Variance Skewness
8.96

-.632

Figure 13
Screening Practice Scores
16

Frequency (# of Providers)
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4
2
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Sum of Complication Screening Tests

Table 13 Frequency Table Practice Behaviors summarizes all provider behaviors
across various practice characteristics, which were presented above under demographics.

99

Table 13
Frequency Table Practice Behaviors

Provider/Practice
Characteristics
Practice Focus
Pediatric
Family Medicine
Practice Setting
Solo
Group
Academic Med
Public/Comm.
Urgent Care
Practice Region
Urban
Suburban
Rural
Practice between
more than one
region

Low
Diagnostic
Score
(1-5)
n=18
n
%

High
Diagnostic
Score
(6-9)
n=26
n
%

Do Not
Treat
PCOS
(n=15)
n
%

Treat
PCOS
(n=29)
n
%

No
Screening
(n=14)
n
%

Screen for
Complications
(n=3)
n
%

1

2.3

13

29.5

5

11.1

9

20.5

4

9.1

10

22.7

17

38.6

13

29.5

10

22.7

20

45.5

10

22.7

20

45.5

2
7
1
3
5

4.5
15.9
2.3
6.8
11.1

0
16
5
5
0

0
36.3
11.1
11.1
0

1
6
2
1
5

2.3
13.6
4.5
2.3
11.1

1
17
4
7
0

2.3
38.6
9.1
15.9
0

1
4
4
2
5

2.3
9.1
9.1
4.5
11.1

1
19
2
6
0

2.3
43.2
4.5
13.6
0

6
10
1

13.6
22.7
2.3

9
8
7

20.5
18.2
15.9

5
6
2

11.1
13.6
4.5

10
12
6

22.7
27.3
13.6

5
6
1

11.1
13.6
2.3

10
12
7

22.7
27.3
15.9

1

2.3

2

4.5

2

4.5

1

2.3

2

4.5

1

2.3

38.5
15.4
46.2

7
3
5

46.7
20
33.3

11
4
14

37.9
13.8
48.3

4
2
8

28.6
14.3
57.1

14
5
11

46.7
16.7
36.7

88
12

12
2

85.7
14.3

25
3

89.3
10.7

11
3

78.6
21.4

26
2

92.9
7.1

Percent Uninsured or Medicaid Patients
≤ 25%
26-50%
>50%

8
3
7

44.4
16.7
38.9

10
4
12

Percent Patient Population Hispanic
<50%
≥ 50%

15
2

88.2
11.8

22
3

Percent Patient Population Black/African American
<50%
≥ 50%

17
1

94.4
5.6

18
7

72
28

14
1

93.3
6.7

21
7

75
25

12
2

85.7
14.3

23
6

79.3
20.7

% Adolescent Patients
<10%
9
11-25%
8

52.9
47.1

6
10

23.1
38.5

4
8

28.6
57.1

11
10

37.9
34.5

3
7

23.1
53.8

12
11

40
36.7

100

>25%

0

0

10

38.5

2

14.3

8

27.6

3

23.1

7

23.3

Referral to Specialty Care
Providers who reported having patients with PCOS (n=44) were also asked about
referral to specialty care for consultation in diagnosing or treating PCOS. Most (38/44,
86.4%) reported referring for specialty care, including referral for multi-disciplinary care
such as nutrition and behavioral health services. Specific specialty referrals include:
endocrinologist (n=21), gynecologist (n=28), dietician/nutritional counseling (n=5),
behavioral health specialists (n=4), adolescent medicine provider (n=4) and/or
pediatrician (n=1). Providers who did not refer, indicated that they were “confident in
their own ability to diagnose and treat most cases of PCOS” (n=6). None of the providers
selected “lack of specialty resources in my community” as a reason for not referring.
Knowledge Seeking Behaviors
Providers were also asked if they engaged in any professional activities, such as
continuing medical education (CME), on the topic of PCOS within the past year, and if
they are interested in learning more about PCOS in adolescents. Table 14 Continuing
Education Activities, represents provider responses regarding continuing education
activities. Frequency data is represented within the subgroups of those providers who
reported having adolescent patients with a diagnosis of PCOS and those who do not have
patients with a diagnosis of PCOS. There is one missing value under “desire to learn
more about PCOS in adolescents” in the patients with PCOS subgroup. Activities that
providers reported engaging in within the past year include: reading journal articles
(n=4), online CME (n=4), and attending in-person lecture (n=3). Format for future
activities that respondents stated they would prefer to participate in included: reading
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journal articles, podcast, online CME/webinar, in-person conference lecture, and/or onsite training/in-service activity.
Table 14
Continuing Education Activities
Patient with PCOS
(n=44)
Inquiry regarding
educational activities

No patients with
PCOS (n=8)

n

%

n

%

Participation in professional activity
on topic of PCOS in
the past year

Yes

6

13.6

0

0

No

38

86.4

8

100

Desire to learn more about PCOS in
adolescents

Yes

34

77.3

8

100

No

9

20.5

0

0

Aim 1 Key Points
•

All participants (n=52) report inquiring about menses. However, when they
inquire, at what type of visit, varies. 19.2% (n=10/52) of the providers stated that
they inquire about menstrual irregularities at all encounters, regardless of the
reason for the visit.

•

84.6% (n=44 out of 52) of the providers in the sample (n=52) report having
adolescent patients with a diagnosis of PCOS.

•

Of the subset of providers (n=44) with patients with a diagnosis of PCOS, 81.8%
(n=36) reported carrying out some or all of the diagnostic evaluations for PCOS
in their adolescent patients.
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•

Of the subset of providers (n=44) with patients with a diagnosis of PCOS, 29/44
(66%) reported engaging in some form of treatment for PCOS.

•

Of the subset of providers (n=44) with patients with a diagnosis of PCOS, 30/44
(68.2%) reported screening for some complications associated with PCOS such as
T2DM.

Research Question #2
What factors, both modifiable and non-modifiable, influence practice behaviors of
pediatric providers to address PCOS in a primary care setting?
Hypothesis: Practice behaviors among pedPCPs in the identification, diagnosis and
management of PCOS are influenced by multiple factors to include knowledge, nonmodifiable practice characteristics such as geographical region, and attitudes/beliefs.
Sub-hypotheses include:
•

PedPCPs will report low knowledge of adolescent specific guidelines for the
diagnosis and management of PCOS supported by the Pediatric Endocrine
Society.

•

Investigation into differences between provider behaviors may reveal potential
disparities in how PCOS is being addressed among different settings and
geographical regions.
Further analysis of quantitative survey data explored potential associations of

knowledge, practice characteristics, and provider attitude/beliefs with provider behaviors.
Results are presented below in respective sections of: provider knowledge, provider
characteristics, and provider attitude/beliefs.
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Provider Knowledge
Specific knowledge explored in this study related to knowledge of pediatricspecific diagnosis criteria. This knowledge is vital to identify and diagnosis PCOS in
adolescents, and prevent missed or over-diagnosis. All providers in this study (n=52)
were queried as to whether or not they are aware of diagnostic criteria for PCOS. If they
responded yes, they were asked to select which criteria they are familiar with. Table 15
Knowledge of Diagnostic Criteria notes number and percentages of providers who report
knowledge of any diagnostic criteria and PES adolescent-specific criteria compared
between groups of providers who have patients with PCOS and those who do not. Figure
15 Knowledge of Diagnostic Criteria, represents the specific diagnostic criteria that
providers indicated familiarity.
Table 15
Knowledge of Diagnostic Criteria
Patient with PCOS
(n=44)

No patients with
PCOS (n=8)

Are you aware of diagnostic criteria
for PCOS?
Yes

n

%

n

%

31

70.5

2

25

No

13

29.5

6

75

8

18.2

0

0

36

81.8

8

100

Familiar with PES criteria?
Yes
No

PES=Pediatric Endocrine Society
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Figure 14
Knowledge of Diagnostic Criteria
12

Amount Selected

10
8
6
4
2
0
NIH

Rotterdam

Endocrine Society Pediatric Endocrine
Society

other*

PCOS Diagnostic Criteria

*Other criteria included the following write-in responses: “combination of all stated (n=1)”, and
“I don’t know them by name.” (n=1)

Further analysis of the subgroup of 44 providers who have patients with PCOS
was carried out to test if knowledge is a factor that influences behavior. First, an
independent sample t-test was performed to compare the means of diagnosis practice
score (range1-9) between providers who indicated knowledge of any PCOS diagnostic
criteria versus those who indicated no knowledge of any PCOS diagnostic criteria. The
group with knowledge of any PCOS criteria (31/44) had a mean diagnostic practice score
of 5.94 (SD= 2.61). By comparison, the no knowledge group (13/44) had a mean
diagnostic score of 4.62 (SD= 2.93). For the t-test, assumption of homogeneity of
variance was tested and satisfied via Levine’s F test, F(42) = .880, p= .354. The
independent sample t-test did not demonstrate a statistically significant difference, t (42)
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= 1.478, p=.147. Diagnostic practice scores were not different between providers with or
without knowledge of any diagnostic criteria.
Second, an independent sample t-test was performed to compare the means of
diagnostic practice score (range 1-9) between providers who indicated knowledge of PES
endorsed adolescent-specific diagnostic criteria for PCOS versus those who indicated no
knowledge of PES endorsed diagnostic criteria. The group with knowledge of PES
criteria (8/44) had a diagnostic practice score M= 5.88 (SD= 3.36). By comparison, the
no knowledge group (n=36) had a diagnostic score M=5.47 (SD= 2.64). For the t-test,
assumption of homogeneity of variance was tested and satisfied via Levine’s F test, F(42)
= .58, p= .449. The independent sample t-test did not demonstrate a statistically
significant effect, t (42) = .37, p=.712. Thus, knowledge of PES endorsed adolescentspecific diagnostic criteria was not associated with a difference in practice behaviors
related to diagnosis of PCOS.
Statistical analysis was not performed to measure differences in whether or not a
provider treated PCOS or screening scores based on knowledge of adolescent-specific
PCOS diagnostic guidelines. This is because the question in the survey was specifically
inquired about guidelines as it related to diagnosis and not management.
Practice Characteristics
Descriptive statistics were used to describe practice behaviors across variables of
practice characteristics for the subset of providers (n=44) who report having patients with
a diagnosis of PCOS. Frequency data for behaviors related to the diagnosis and
management of PCOS is reported in Table 13 Frequency Table Practice Behavior. Next,
analysis of variance (ANOVA) was performed to explore the relationship between
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practice characteristics and practice behaviors. Specific provider characteristics
considered as independent variables included: pediatric versus family medicine focus,
practice setting, practice region, percent of adolescent patients in practice population,
percent of adolescent patients who are uninsured or public/Medicaid insured, percent of
adolescent in patients who are Hispanic, and percent of adolescent in patients who are
Black/African American.
Analysis of Diagnostic Behaviors
ANOVA was performed to compare diagnostic practice scores (continuous data)
to variables for the aforementioned practice characteristics (categorical data with two or
more levels). Statistically significant difference in the mean for diagnostic practice scores
was identified for characteristics of practice focus, practice setting, percentage of
adolescents in practice, and percentage of adolescent patient population identified as
Black/African American. Table 16 Analysis of Variance for Diagnostic Practice Score
and Practice Characteristics, displays the results for the findings in the analysis, and
Table 17 ANOVA Post Hoc Tests. Post hoc tests were not performed for less than three
independent variable groups.
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Table 16
Analysis of Variance for Diagnostic Practice Score and Practice Characteristics
Characteristic
Practice Focus

Practice Setting

Practice Region

% population
adolescent

n

Mean
(95% CI)
7.43
(6.37-8.48)
4.67
(3.67-5.66)

SD

SE

F

p

1.828
2.670

.488
.487

F(1,42)
12.228

.001

Pediatrics
Family Med.

14
30

Solo

2

4.50
(-1.85-10.85)

.707

.500

Group

23

6.39
(5.28-7.50)

2.572

.536

6

6.67
(4.83-8.50)

1.751

.715

Public
health/comm.

8

5.25
(3.26-7.24)

2.375

.840

Urgent care

5

1.20
(.64-1.76)

.447

.200

Urban

15

5.60
(3.97-7.23)

2.947

.761

Suburban

18

5.11
(3.68-6.55)

2.888

.681

Rural

8

6.38
(5.12-7.63)

1.506

.532

More than
one

3

5.67
(-4.68-16.01)

4.163

2.404

<10%

15

4.60
(3.28-5.92)

2.384

.616

11-25%

18

5.00
(3.65-6.35)

2.722

.642

Academic

>25%

10

8.30
(7.54-9.06)
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1.059

.335

F(4,6.9)
30.151

F(3,40)
.382

F(2,26.2)
19.484

<.001*

.767

<.001*

% population
uninsured/public
insurance

<25%

18

26-50%

7

>50%
% population
Hispanic

% population
Black/African
American

2.590

.610

3.302
(2.23-8.34)

3.302

1.248

10

2.794
(4.50-7.19)

2.793

.641

<50%

37

5.70
(4.79-6.62)

2.747

.452

≥ 50%

5

5.00
(1.83-8.17)

2.550

1.140

35

5.09
(4.15-6.02)

2.726

.461

8

7.38
(5.54-9.21)

<50%
≥ 50%

5.33
(4.05-6.62)

2.700

F(2,41)
1.89

.828

F(1,40)
.292

.592

F(1,41)
4.882

.033

.778

* Homogeneity of variance was violated for analysis; results based on Welch ANOVA. Results of
Games-Howell Post hoc test in Table 17. SD=Standard Deviation; SE=Standard Error

Table 17
ANOVA Post Hoc Tests
Mean
difference

SE

Sig

95% CI

Practice
Setting
Urgent Care*

% population
adolescent*
>25%

Solo
Group
Academic
Public
Health/Comm.

-

3.30
5.191
5.467

.539
.572
.742

.146
.000
.002

-

-

4.050

.863

.011

-

<10%
11-25%

3.70
3.30

.701
.724

.000
.000

10.78-4.18
6.87- -3.51
8.29- -2.64
-

7.05- -1.05

1.93-5.47
1.49-5.11

* Homogeneity of variance was violated for analysis; results based on Welch ANOVA and
Games-Howell Post hoc test. SE=Standard Error
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Comparison of means of diagnostic practice score between areas of practice focus
(pediatric vs. family medicine) demonstrated statistical difference. F(1,42)=12.228,
p=.001. Pediatric focused practice had a statistically significant higher mean value for
diagnostic practice score (M=7.43, SD=1.828) compared to family medicine focused
practice (M=4.67, SD=2.670).
Comparison of means of diagnostic practice score between practice settings
demonstrated statistical difference in the urgent care setting. F(4,6.9)=30.151, p<.001.
Homogeneity of variance was violated with this analysis; therefore, results are based on
Welch ANOVA. Post hoc testing with Games-Howell analysis revealed that urgent care
settings had a statistically significant lower mean value for diagnostic practice score
(M=1.20, SD=.447) compared to public/community health center (M=5.25, SD=2.375),
group practice (M=6.39, SD=2.572) and academic medical center affiliated clinic
(M=6.67, SD=1.751). There was not a significant difference between urgent care and solo
practice (M=4.50, SD=.707).
There was a significant difference in diagnostic practice scores among the three
groups representing different percentage of adolescent patients in the practice population,
F(2,26.2) = 19.484, p<.001. Homogeneity of variance was violated with this analysis;
therefore, results are based on Welch ANOVA. Post hoc testing with Games-Howell
analysis revealed difference between providers reporting adolescent patients as <10%
(M=4.60, SD=2.38) and 11-25% (M=5.0, SD=2.72) having lower diagnostic practice
scores than providers reporting adolescent patients as >25% (M=8.30, SD=1.06).
Comparison of means of diagnostic practice score between percent of
Black/African American patients in population (< 50% vs. ≥ 50%) demonstrated
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statistical difference. F(1,41)=4.882, p=.033. Providers who reported that Black/African
Americans made-up ≥ 50% of their adolescent patient population had a statistically
significant higher mean value for diagnostic practice score (M=7.38, SD=2.20) compared
to providers who reported < 50% of their patient population were Black/African
American (M=5.09, SD=2.73).
Analysis of Treatment Behaviors
Analysis to determine if there was an association between practice characteristics
and behaviors was not conducted given limitations in the small sample size and the fact
that treatment was only measured as a dichotomous value (1 = treats PCOS, 0 = does not
treat). ANOVA was not an appropriate test for comparing treatment behavior among
groups, as treatment behaviors were only measured as dichotomous data that was unable
to be converted into a continuous value to measure mean differences. Chi square analysis
was proposed in original data analysis; however, the small population size violates the
rule that no more than 20% of the cells can have an expected value <5. Fisher’s Exact test
is not appropriate as an alternative due to multiple levels within the factor variables
representing practice characteristics.
Analysis of Behaviors to Screen for Complications of PCOS
ANOVA was performed to compare screening practice scores (continuous data)
to practice characteristics (categorical data with two or more levels) list in Table 13
Frequency Table Practice Behavior. No statistically significant differences were found in
screening practice scores across the key practice characteristics included in the analyses:
pediatric vs. family medicine focus, practice setting, practice region, percent patient
population uninsured or Medicaid, percent patient population Hispanic, percent patient
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population Black/African American, and percent patient population made up of
adolescents.
Provider Attitudes and Beliefs
A psychometric scale, Table 5 Provider Attitude and Beliefs Scale, in Chapter 3
Methods, was developed to capture provider’s attitudes and beliefs about PCOS in
adolescents. The scale contains 16 items and respondents were asked to rate their level of
agreement with each item based on a 5-point Likert Scale. Item development was guided
by the conceptual framework for this research, which includes the Theory of Planned
Behavior (TPB) and Health Beliefs Model (HBM). Items were grouped to corresponded
with specific constructs of the framework: Threat Perception, Behavior Evaluation, Cues
to Action, Subjective Norms and Intention to Change Behavior.
Inventory of items for attitudes and beliefs was first evaluated with Cronbach’s
alpha reliability estimate to determine internal consistency of the overall scale of 16
items. The attitudes and belief scale was presented to all participants in the survey, n=52.
Four items had one missing value, for a total of four missing value across the entire scale,
resulting in 99.5% of the data valid for this analysis. One reverse code variable was
created for item #14: PCOS is mostly diagnosed and managed by specialists to align with
positively keyed items related to primary care providers addressing PCOS. Cronbach
alpha of the entire 16 item scale was .795. Internal consistency is a reflection of the
correlation among the 16 items. Cronbach alpha index ranges from 0.00-1.00. Values
approaching 0.9 are considered high, with ideal values between 0.7-0.9 (Portney &
Watkins, 2015). A moderate correlation within this range is supported by the notion that
if a correlation is too high, the items are likely redundant (Portney & Watkins, 2015).
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Table 18 presents the Psychometrics Properties for the Attitude and Belief Scale and
Subscales. Table 19 Attitude and Belief Scale Analysis, presents the average score for
each item and highlights items with the highest and lowest mean item score.
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Table 18
Psychometric Properties for Attitude and Beliefs Scale and Subscale (n=52)
Scale
Attitude and Beliefs

Mean
item score
3.74

SD

Range

.45

2.88-4.75

Cronbach’s
alpha
.795

Subscales
Threat Perception

4.23

.52

3-5

.771

Behavior Evaluation

3.64

.72

2.17-5

.792

Cues to Action

3.88

.65

2.5-5

.031

Subjective Norms

2.72

.88

1-4.5

.553

Intention to Change

3.96

.83

2-5

.860
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Table 19
Attitude and Belief Scale Analysis (n=52)
Item
Threat Perception

Range

Mean

SD

PCOS is a condition that impacts my adolescent patient population.

2-5

4.08

.710

PCOS is an important condition to identify among adolescent patients.

3-5

4.45

.577

PCOS is associated with significant health complications for
adolescents.

3-5

4.29+

.667

PCOS is associated with mental health complications of anxiety and
depression in adolescents.

3-5

4.08+

.763

There is benefit to patient health outcomes if PCOS is addressed in
adolescents.
Practice guidelines for the diagnosis and management of PCOS are
supported by evidence based medicine.

1-5

4.29+

.848

2-5

4.06

.669

I have the ability to accurately diagnosis PCOS in adolescents.

1-5

3.31

1.076

I have the ability to effectively manage PCOS in adolescents.

1-5

3.06^

1.139

I have the support needed in my practice to diagnosis and manage
PCOS in adolescents.

1-5

3.33

1.178

I have the specialty support needed in my community to diagnosis and
manage PCOS in adolescents.

1-5

3.75

1.082

Learning more about PCOS would change my practice behaviors.

2-5

4.06

.958

Resources are available to learn more about the diagnosis and
management of PCOS in adolescents.

2-5

3.69

.812

My colleagues in primary care practice are actively involved in the
diagnosis and management of PCOS in adolescents.

1-5

2.90^

1.089

PCOS is mostly diagnosed and managed by specialists. *

1-5

2.54^

1.019

Behavior Evaluation

Cues to Action

Subjective Norms

Intention
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I would like to improve my practice behaviors in addressing PCOS
among adolescents in my practice.

2-5

4.13

.793

I intend to change my practice behaviors in addressing PCOS among
adolescents in my practice.

1-5

3.79

.977

+

Three highest mean item scores
^ Three lowest mean item scores
*Item reverse coded

The independent t-test was used to compare total item scores for the entire scale
and subscales within each category of practice behaviors for the subset of 44 participants
who have patients with PCOS. Although all 52 respondents completed the survey, data
for practice behaviors is only available for the 44 respondents who reported having
patients with a diagnosis of PCOS in their practice. The specific behaviors (independent
variables) for comparison of scale and subscale total mean scores (dependent variables)
are outlined in Table 20 Variable for Mean Comparisons of Attitude and Belief Scale and
Subscales.
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Table 20
Variable for Mean Comparisons of Attitude and Belief Scale and Subscales
Grouping
(Independent
Variables)

Level 1
Condition

Level 2
Condition

Diagnostic
Practice Score

High
(score 69)

Low
(score 15)

Attitude and Belief scale sum score (16 items)
Treat Perception subscale sum score (4 items)
Behavior Evaluation subscale sum score (6 items)
Subjective Norms subscale sum score (2 items)
Intention to Change subscale sum score (2 items)

Engaged in
Treating
PCOS

Yes

No

Attitude and Belief scale sum score (16 items)
Treat Perception subscale sum score (4 items)
Behavior Evaluation subscale sum score (6 items)
Subjective Norms subscale sum score (2 items)
Intention to Change subscale sum score (2 items)

Screening for
Complications

Yes

No

Attitude and Belief scale sum score (16 items)
Treat Perception subscale sum score (4 items)
Behavior Evaluation subscale sum score (6 items)
Subjective Norms subscale sum score (2 items)
Intention to Change subscale sum score (2 items)

Test (Dependent)Variable

Identification as a behavior was not considered as a separate independent variable,
as the indicator used for identification, inquiry about menstrual regularity, is one of the
components of the diagnostic evaluation included in diagnostic behavior measurements.
Cues to action subscale was not included as dependent variables for this analysis due to
the low Cronbach alpha score (.031), indicating poor internal consistency as a subscale
(UCLA, 2020).
See Tables 21-23 for results. Each test below met the assumption for equal
variance by the Levine’s test.
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Table 21
Comparison of Attitudes/Beliefs Scale/Subscale Scores with Diagnostic Behaviors
Grouping Variable

Scale

High diagnostic
practice score
(6-9) n=26

Low diagnostic
practice score
(1-5) n=18

M

SD

M

SD

t statistic

p value

Attitude and Beliefs
Scale

61.1

6.699

56.61

8.09

t(42)=2.0

.05

Threat Perception
Subscale

17.12

2.03

16.56

2.43

t(42)=.80

.41

Behavioral Evaluation
Subscale

22.81

Subjective Norms
Subscale

5.85

1.72

4.83

1.69

t(42)=1.92

.06

Intention to Change
Subscale

7.77

1.82

8.0

1.78

t(42)=-.42

.68

3.41
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19.83

4.78

t(42)=2.41

.02

Table 22
Comparison of Attitudes/Beliefs Scale/Subscale Scores With Treatment Behaviors
Grouping Variable

Scale

Treatment
n=29

No Treatment
n=15
p
value

M

SD

M

SD

t statistic

Attitude and Beliefs
Scale

61.21

7.07

55.47

7.18

t(42)=2.54

.02

Threat Perception
Subscale

17.1

2.12

16.53

2.36

t(42)=.77

.44

Behavioral Evaluation
Subscale

22.9

3.69

19.1

4.2

t(42)=3.11

<.01

Subjective Norms
Subscale

5.86

1.68

4.6

1.68

t(42)=2.36

.02

Intention to Change
Subscale

7.79

1.92

8.0

1.56

t(42)= -.36

.72
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Table 23
Comparison of Attitudes/Beliefs Scale/Subscale Scores With Screening Behaviors
Grouping Variable

Scale

Screening
n=30

No Screening
n=14
t statistic

p
value

M

SD

M

SD

Attitude and Beliefs
Scale

59.77

6.92

58.14

8.92

t(42)=.66

.51

Threat Perception
Subscale

16.90

2.11

16.86

2.45

t(42)=.06

.95

Behavioral Evaluation
Subscale

22.40

3.70

19.86

4.91

t(42)=1.91

.06

Subjective Norms
Subscale

5.67

1.71

4.93

1.86

t(42)=1.30

.20

Intention to Change
Subscale

7.57

1.79

8.50

1.65

t(42)=-1.65

.11

Higher scores for Behavior Evaluation subscale, is the only attitude/belief
measure that demonstrated a statistically significant difference in total mean score for
behaviors related to the diagnosis of PCOS. Higher scores for the entire attitude belief
scale, behavior evaluation subscale and subjective norms subscale demonstrated a
statistically significant difference in total mean score with positive (yes vs. no) provider
engagement in treating PCOS in adolescents.
Aim 2 Key Points
•

15.4% (8/52) respondents indicate knowledge of the adolescent-specific
guidelines for the diagnosis and management of PCOS in adolescents endorsed by
the Pediatric Endocrine Society.
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•

Providers who practice in a pediatric focused practice have statistically significant
higher diagnostic practice score for addressing PCOS in adolescents.

•

Providers from urgent care settings demonstrated statistically significant lower
diagnostic practice behaviors compared providers from other practice settings.

•

Providers who reported that adolescents make up >25% of their patient population
demonstrate statistically significant higher diagnostic practice behaviors
compared to other practices with <25% of adolescents in their patient population.

•

Providers who reported that Black/African American patients make up ≥ 50% of
the adolescent patients in their practice had statistically significant higher
diagnostic practice behaviors compared to other providers with <50% Black/
African American adolescent patient population.

•

There are no significant differences between clinics that have high versus low
uninsured or public/Medicaid insured patient populations in diagnostic or
screening behaviors to address PCOS in adolescent patients.

•

There are no significant differences between clinics that have high versus low
Hispanic populations in diagnostic or screening behaviors to address PCOS in
adolescent patients.

•

PedPCPs with high diagnostic practice scores reported higher mean scores for the
Behavior Evaluation subscale.

•

PedPCPs who treat adolescent patients with PCOS reported higher mean scores
for the Attitude and Belief scale, Behavior Evaluation subscale and Subjective
Norms subscale.
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Qualitative Results
Research Question #3
How do pediatric primary care providers experience barriers and facilitators in the
identification, diagnosis and management of PCOS among adolescents, and how can they
be addressed in order to optimize care?

Participant Characteristics
Twenty-seven pediatric primary care providers (pedPCPs) who completed the
quantitative survey expressed interest in participating in follow up individual semistructured interviews. All 27 participants were contacted via email to schedule a 30minute interview via phone or via secure Zoom video conferencing. Twenty participants
responded, scheduled and completed an interview; 2 indicated via email that they were no
longer available for an interview; 5 did not respond to three requests sent via email over a
three-month period. Most of the interview participants were PAs (n=14); 2 were
physicians (MDs) and 4 were NPs from pediatric or family medicine focused practices in
a variety of settings. Table 24 Provider Demographics and Practice Characteristics of
Interview Participants, displays provider demographics and practice characteristics for
the 20 interview participants.
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Table 24
Provider Demographics and Provider Characteristics of Interview Participants (n=20)

Variable

#

%

Provider type

Variable

#

%

Years in practice

MD

2

10

1- 10 years

14

70

PA
NP

14
4

70
20

11-20 years
> 20 years

5
1

25
5

17
3

85
15

Practice location
District of Columbia
Maryland
Virginia

4
6
10

20
30
50

20-29 years
30-39 years

5
9

25
45

Practice practice region
Urban

5

25

40-49 years
50-59 years

3
3

15
15

Suburban
Rural

8
4

40
20

Divided between more than one

3

15

Percent of adolescents in patient
population
<10%
11-25%
26-50%
>75%

4
10
5
1

20
50
25
5

Percent uninsured/public insurance
≤25%
26-50%
>50%

7
5
8

35
25
40

Provider gender
Female
Male
Age

Ethnicity
Not Hispanic
Prefer not to answer

19

95

1

5

Race
Black
White
Asian
Two or more races
Practice focus
Pediatric
Family Medicine

3
12
1
5

7
13
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15
60
5
25

35
65

Participant Behaviors and Attitudes/Beliefs
In the survey, seventeen of the twenty participants reported having patients with a
diagnosis of PCOS. Data related to their current behaviors in addressing PCOS is
provided in Table 25 Interview Participant Knowledge and Behaviors. Mean item score
for all twenty interview participants’ responses to attitude/belief scale and subscales for
threat perception, behavior evaluation, and intention to change are displayed in Table 26
Interview Participants Attitude and Beliefs. These scores are similar to the overall sample
(Table 18 Psychometric Properties for Attitude and Beliefs Scale and Subscale (n=52)),
where mean items scores for the entire scale, threat perception subscale, behavior
evaluation subscale, and intention to change subscales were 3.74, 4.23, 3.64 and 3.96
respectively.
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Table 25
Interview Participant Knowledge and Behaviors

Knowledge or Behavior
Have adolescent patients with diagnosis of
PCOS (n=20)
Yes
No
Awareness of PCOS diagnostic guidelines
(n=20)
Awareness of any diagnostic criteria
Yes
No
Awareness of PES guidelines
Yes
No
Diagnostic Practice Scores (n=17)
High (≥6)
Low (<6)

#

17
3

13*
4
5
15
9
8

Providers who treat PCOS (n=17)
Yes
No

11
6

Screen for complications of PCOS (n=17)
Yes
No

12
5

*three missing data
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Table 26
Interview Participants Attitude and Beliefs

Mean item score for attitude and belief scale
Mean item score for threat perception subscale
Mean item score for behavior evaluation subscale
Mean item score for intention to change

Mean
3.75
4.31
3.52
4.15

SD
.48
.52
.83
.8

Min
3.13
3.50
2.17
2

Max
4.75
5.00
5.00
5

Interview Data
Seven interviews were completed via Zoom and 13 via phone. Average interview
length for all participants was 21.8 minutes, with a range of 11.6 minutes to 33.7 minutes.
Interview length varied among providers who did not have patients with PCOS or did not
engage in diagnosis or treatment, versus providers who had adolescent patients with
PCOS and were actively engaged in diagnosis and/or treatment. Participants who
reported that they do not have patients with a diagnosis of PCOS (n=3) or do not engage
in any behaviors to diagnose or treat PCOS (n=3) had shorter mean interview duration of
16.3 minutes (range= 11.6-21.7) as compared to a mean interview duration of 24.1
minutes (range =13-33.7) among 14 participants who reported engagement in diagnosis
or treatment of PCOS.
Thematic Analysis
Three overarching themes emerged related to barriers and facilitators in the
identification, diagnosis and management of PCOS among adolescents. The themes
connect seven categories of descriptive codes for barriers, facilitators and ways to address
barriers (Figure 15 Categories and Overarching Themes). Each theme is presented below
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with supporting evidence from applicable categories and codes. Qualitative data
informing “ways to address” identified barriers is discussed as it relates to each theme.
Appendix B. reflects all the categories and codes that informed three overarching themes
and identifies them as barriers or facilitators.
Figure 15
Categories and Overarching Themes

Establishing the
Diagnosis

Delay in identification and hesitancy to make the
diagnosis of PCOS in adolescents without specialty input.

Access to Specialty
Care

Practice structure
and organizational
policies
Provider behavior
evaluation

Divergent experiences managing adolescent PCOS in a
primary care setting shaped by provider collaboration
and practice structure and policies.

Ways to Address

Provider
Interactions

Behavior evaluation and challenges unique to
addressing PCOS in adolescent population.

Provider perception
of patient factors

Theme #1
Delay in identification and hesitancy to establish the diagnosis of PCOS in
adolescents without specialty input. Establishing a diagnosis of PCOS requires both
recognition of clinical manifestations of PCOS and knowledge of appropriate diagnostic
laboratory evaluations. All participants discussed an understanding of the clinical signs of
PCOS in adolescents, but various factors influence whether or not they are identified in
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practice. Many pedPCPs discussed ordering laboratory evaluations for diagnosing PCOS
once clinical manifestations have been identified; however, most rely on specialists to
establish the diagnosis. Reliance on specialists requires patient referrals, which may delay
diagnosis if there is limited access to specialty care within respective practice
communities. Code categories related to theme #1 include: Establishing the diagnosis,
Access to Specialty Care, and Ways to Address.
Establishing the Diagnosis
Participants discussed barriers and facilitators to establishing a diagnosis. Barriers
include delay in identifying clinical manifestations of PCOS, confusion about diagnostic
guidelines, concern with missing other endocrine disorder, and concern of threat to
adolescent well-being by labelling them with a diagnosis of PCOS.
Delay in Identification. PedPCPs identified the following barriers that result in a
delay in identification: under recognition of clinical manifestations of PCOS, normalizing
irregular menses, or symptoms are masked by other medications, such as contraception
use.
“I think it’s very under-recognized. I feel like that people don’t really put that
high on the differential if people are coming in with these complaints, maybe
overweight, maybe depressed, maybe irregular cycles, that kind of thing, people
don’t put that at the top of their differential typically.” (ID32, NP, family, S)
“As providers we’re not always the best at asking about last menstrual cycle
when people come in for acute things or it could be something like… I always tell
my staff ‘that’s a vital sign too you know.’“(ID19, PA, family, S)
“Would definitely say I’m sure we don’t really do that enough [to diagnosis
PCOS]. And part of it if we don’t ask and they don’t want to bring up the periods
or their vague or we just think it’s just your period being abnormal because
you’re a teenager then it probably doesn’t get addressed quite as often as it
should because obviously some of them have PCOS and we probably don’t
know.” (ID71, PA, family, S)
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“…I think there’s kind of like a delay in workups sometimes. I wish we looked
earlier for, or tested more people I guess I would say because I feel like once
you see like someone comes in with hirsutism and they’re having menstrual
irregularities and they’re over weight that becomes oh maybe it’s this and we can
work it up. But when you have that patient who’s just a little bit overweight and
they’ve got some acne and their menstrual periods are regular but they’re already
on birth control or they have Nexplanon and they just think it’s that. I do think
that we could test for it more because I do think it is more common then.” (ID29,
PA, family, R)
“I think we normalize an irregular menstrual period or we normalize a little
bit of overweight when they’re still young; eleven, twelve, thirteen but then
by the time they’re sixteen and it’s more of a significant issue it’s already fostered
itself for a while so making it a part of that regular conversation that we have
with kids a little earlier.” ID25, PA, peds, R)
Confusion with Diagnostic Guidelines. PedPCPs reported confusion with
diagnostic guidelines and/or lack of confidence with their knowledge of the appropriate
diagnostic evaluations.
“I do think every physician will probably tell you like a different lab
workup that they do initially and would definitely be like I have to look that up.
Every time, I get confused; I’m not sure which one.” (ID69, MD, pediatrics,
urban)
“I think it’s kind of difficult, and this could just be myself that I haven’t really
found the best resources, adolescents versus adults I think it’s kind of hard
to find distinguishing factors to do that.” (ID29, PA, family med, rural)
Concern with Missing Other Endocrine Disorders. Some providers also
expressed concerns with misdiagnosis or overlooking other similar conditions. PCOS is a
diagnosis of exclusion and requires ruling out other disorders. PedPCPs indicated a
preference to obtain specialty input to ensure that they do not miss another diagnosis as
the underlying cause for a patient’s symptoms.
“I think anything with endocrinology feels a little bit like oh we’re already
getting into something a little scary or a little like nebulous and a little confusing
I think that part of it is not wanting to miss other things that can mimic PCOS and
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just not having that kind comfort and so feeling like they should see a specialist
whether it’s adolescent or endocrinology first. I think that feels like a barrier.”
(ID69, MD, pediatrics, urban)
Harms of Labeling. Many pedPCPs expressed concern about the consequences
of a diagnosis of PCOS on adolescent well-being.
“So, I kind of have mixed feelings about it. I think from an overall health
aspect it’s really important but I also think that the diagnosis comes with a
psychological component that I worry that my adolescent patients don’t
handle as well as if they were older so I think that’s always a tough
conversation.” (ID29, PA, family, R)
“…from a mental health standpoint of placing this in their mind that there
can be something wrong when it may not be an actual diagnosis”. (ID31)
Most interview participants discussed utilizing point of care tools, such as
UpToDate, to obtain guidance for carrying out diagnostic evaluation for PCOS. Point of
care resources serve as facilitators to carry out diagnostic evaluations for providers who
may have limited experience with or uncertainties about appropriate laboratory tests.
Point of Care Resources.
“So I really I go to UpToDate which has the guidelines from I think it’s
the adolescent health, no maybe it’s the endocrinology guidelines.” (ID69,
MD, pediatrics, urban)
“So typically I’ll get, and usually I have to, because I don’t do this I would
say it’s not something that I’ve seen every single day usually I do have to
look at UpToDate.” (ID47, MD, pediatrics, suburban)
Access to Specialty Care
Reliance on expert guidance during the diagnostic evaluation for PCOS can delay
or support pedPCPs in establishing a diagnosis depending on access to specialty care in
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their community. Factors that impact access to specialty care include: specialty provider
shortages as a barrier and close proximity to specialty practices or larger health systems
as a facilitator.
Specialty Provider Shortages.
“There are only 2 endocrine physicians in town. Takes 9-12 months for a
new patient appointment.” (ID15, PA, family medicine, suburban)
“We don’t have Peds endo in the county so it’s within the health system
locally but they would have to drive for that out of county...” (ID16, PA,
family medicine, suburban)
Proximity to Specialists.
“The big hospital systems are here and then we do have some outpatient
whether it be endocrinology or OBGYN, there’s a lot of private practices
too. And I feel like most of the practices are larger and so I think that they
[patients] are able to get in easier than perhaps some other places.”
(ID50, PA, pediatrics, suburban and urban)
“I think a lot of the doctors have affiliations with [large academic medical
center in urban area] and [a suburban clinic] so a lot of the physicians
will work amongst the two institutions so it becomes a lot more convenient
in terms of referrals for them [patients] to go there versus a lot of times
having to go to main campus.” (ID47, MD, pediatrics, suburban)
Ways to Address
Most pedPCPs discussed utilizing point of care resources, such as UpToDate, to
guide diagnostic evaluations. Many pedPCPs identified a need for improving content of
and access to point of care resources and/or establishing practice protocols to serve as a
guide for diagnostic evaluation. Providing opportunities for provider education/training
was also recognized for pedPCPs to gain a better understanding of adolescent-specific
guidelines and distinguishing the diagnosis of PCOS in adolescents from adults. Table 28
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Ways to Address provides qualitative data for applicable codes that align with providers’
suggestions for addressing barriers related to theme #1: Education and Training and Point
of Care Protocols.

Theme #2
Divergent experiences managing adolescent PCOS in a primary care setting
shaped by differences in provider interactions and practice structure and policies.
Provider interactions with other providers, access to specialty care, and practice
structure/organizational policies are key factors that impact whether a provider
experiences barriers or facilitators in the management of adolescents with PCOS. Figure
16 Divergent Experiences in the Management of PCOS highlights the specific barriers
and facilitators that drive the divergent experiences of pedPCPs in managing PCOS
among adolescents. Code categories related to theme #2 include: Provider Interaction,
Access to Specialty Care, Practice Structure and Policies, and Ways to Address.
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Figure 16
Divergent Experiences in the Management of PCOS

Barriers to
Management

Facilitators to
Management
Guidance from Senior Providers

Specialty Provider Shortages
Limited Options for Multidisciplinary Care

Provider
Interactions

Collaboration with Peers
Practice Relationship with Specialists
Proximity to Specialists

Limited Interactions with Specialists
Restrictive Practice Policies
Patient Exposure (types of patient visits)

Structure/
Policies

Health Care Safety Net Programs
Patient Exposure (types of patient visits)

Provider Interactions
Collaboration and communication, internally between practice colleagues and
externally with gynecologist, endocrinologists and other experts, become very important
to manage PCOS in the adolescent patient. Many pedPCPs highlighted the importance of
guidance from senior providers and/or collaboration with their peers to guide
management. Some providers also highlighted established relationships between their
primary care practice and specialty practices within their community that allowed for
direct specialists to provider interaction. Table 27 Barriers and Facilitators to
Management highlights some of the key data related to guidance from senior providers,
collaboration with peers and collaboration with specialists.
Access to Specialty Care
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Access to specialists influences whether or not pedPCPs rely on specialists to
manage PCOS or if they have the opportunity for collaboration. Participants who
reported a significant presence of specialists within their community are able to easily
refer patients for management or obtain guidance with management recommendations. In
contrast, some pedPCPs reported not only a shortage of specialists in their community,
limiting the opportunity for referrals, but also specialists who may not be comfortable
managing PCOS in adolescents. PedPCPs shared that specialists will send the patient
back to the primary care clinic with little to no guidance for management.
Additionally, many pedPCPs discussed limited options for multi-disciplinary
management of PCOS. Lifestyle modifications is a mainstay of management and
guidelines recommend a multi-disciplinary management approach. Very few pedPCPs in
this research reported engagement of a multi-disciplinary team except for unique practice
structures (to be discussed under Practice Structure and Policies) where support services
for multi-disciplinary care are built into their practice setting. Most pedPCPs reported
limiting factors to engage an inter-professional team, such as nutritionists and behavior
health professionals, in the management of PCOS. Barriers included both shortage of
nutrition or behavior health services and lack of health insurance coverage for nutrition
counseling or behavior health care. Table 27 Barriers and Facilitators to Management
highlights some of the key data related to specialty provider shortages, limited options for
multidisciplinary care and proximity to specialty care.
Practice Structure and Organizational Policies
Practice settings vary, and the concept of primary care has broad application
beyond traditional pediatric or family practice settings. Structure and policies unique to
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each practice may support or limit the opportunity for primary care providers to
management adolescents with PCOS.
First, patient exposure and types of patient visits can be a barrier or a facilitator to
managing PCOS in adolescents. As adolescent health needs vary, some pedPCPs will
have limited exposure as adolescents return for fewer well-child visits or more exposure
if their primary care practice is more oriented to adolescent health. Some pedPCPs shared
that they have a unique focus in their practice, such as primary care for teenage mothers,
which would shift their focus from addressing conditions such as PCOS.
Second, practice policies that frame provider roles and set standards for patient
care can be restrictive to providers engaging in and building experience in managing
PCOS in adolescents. For example, some pedPCPs report policies that do not allow PAs
or NPs to have their own patient panel, thereby limiting their follow up to prescribe and
manage interventions to address PCOS. Other providers reported a practice setting that is
split between urgent care and primary care and practice policies determine when they can
engage in long-term management versus having to refer.
Lastly, some pedPCPs describe programs in their practice setting that increase
primary care capacity to address PCOS. In this study, these were providers who practice
in health care safety net programs such as health department clinics, Federally Qualified
Health Centers (FQHCs) and Medicaid clinics. Despite being located in a low resource
setting with limited access to specialty care and uninsured or underinsured patient
populations, special programs, such as school based health clinics managed by an FQHC,
are facilitators to managing PCOS among adolescents. Table 27 Barriers and Facilitators
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to Management highlights some of the key data related to patient exposure, restrictive
practice policies and health care safety net programs.
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Table 27
Barriers and Facilitators to Management

Limited Options for
Multidisciplinary Care
“It is 3-6 months for a mental
health appointment in the
community. I have never
considered a mental health
appointment for PCOS. I would
like to use nutrition services,
but those are not easy to
access. There is only one
nutritionist at the hospital,
other than private pay nutrition
services”. (ID15, PA, family,S)
“I do not generally refer to
nutritionists or dietitians; I

“Yeah I think I learned a lot
in my own, in the practice that
I’m in because we have
providers who have been
there for thirty years and, you
know, our program tends to
stay on top of, you know,
latest research and we try to
implement or at least
communicate what’s new, and
so there’s always someone
that you can bounce a case off
of or discuss with.” (ID42,
NP, pediatrics, U)
Collaboration with Peers
“…when I started, the other
PA and I did not really know
a lot about PCOS, but
working together we kind of
did a little of our own
research and kind of bounced
ideas off of each other and I
think we got a little bit better
at it.” (ID07,PA, family, R)
Collaboration with
Specialists
“…because of us having
pretty decent relationships
with a lot of specialists we do
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Category: Provider

“And then we also live quite a
distance from specialty care so
most of our pediatric specialty
care can be, or some of it can
be up to an hour’s drive. And
then in those instances we try
to keep those families in house.
So we do have some other
providers in our offices that
are a little more comfortable
and provide more GYN
services it’s just sometimes
we’ll lean on them internally to
get some help for those
families.” (ID25, PA, peds, R)

Facilitators
Guidance from Senior
Providers
“…there’s one of the other
physicians that I work with,
she does much more with
women’s. So she had created
a little flow chart of
management.” (ID29, PA,
family, R)

Interaction

Category: Access to Specialty

Barriers
Specialty Provider Shortages
“In my area, some of the GYN
don’t like to manage PCOS
they would rather that a
primary care or an
endocrinologist manage that.
…they refer back to the
primary”. (ID 19, PA,family,S)

would like to, but, not just for
PCOS, I find that a lot of
patients aren’t able, you know,
their insurance does not cover
it”. (ID07,PA, family, R)

manage a little bit more of
our complex conditions at
least to an extent. We manage
a lot of conditions with either
consultation by phone with
the specialists or even just
consultation with some of the
providers here that have been
working in the area since the
eighties I believe is the
earliest.” (ID50, PA, peds,
R&U)

Category:
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Access to

Proximity to Specialists
“…we reach out to the local
hospital systems, they both
have endocrinology, so they
can kind of take over things
once we’ve done that initial
evaluation. Or in some cases
they’ll say “hey do you mind
starting an oral
contraceptive?” Or “I feel
like this patient would benefit
from metformin.” And we
might do that and then hand
off that from there.” (ID50,
PA, peds, R&U)

Category: Practice Structure and

Restrictive Practice Policies
“PAs and NPs do not have
their own panel of patients.
[This is]one of the reasons that
I do not see a lot of adolescents
and adolescents with PCOS.
PAs and NPs will get moved
around. Ideally I would have I
follow up with patients who I
have ordered a diagnostic work
up for or started treatment. I
feel that it [PCOS] is under
diagnosed, due to limitations
as above in both the practice
setting I am in”. (ID15, PA,
Fam, S)
“The practice that I mainly
work in is urgent care.
Percentage wise overall the
company does twenty-eight
percent of primary care. And
really [we] would be a first
line to detect any potential
diagnosis of a hormone
imbalance and the potential for
PCOS. But right now how our
protocol is set up is if it’s a
suspected PCOS we would do
those three labs and then
refer.” (ID31, PA, family, U)

Patient Exposure
“I think at our clinic we see a
lot of teens and I think people
are more comfortable dealing
with teen adolescent issues
but in general I know
pediatricians tend to like, you
know, the ones who like teens
are doing adolescent health,
and so, in general. There are
a number of us who really do
like working with adolescents
and dealing with adolescent
life issues”. (ID69, MD, peds,
U)
Healthcare Safety Net
Programs
“Fortunately we can follow
our kids through our school
based health center so we
have that continuity care with
them. I think that with a lot of
our chronic conditions
including just obesity in itself
we have a much better way of
managing it when we use our
school based health centers
within our own FQHC for our
kids that we provide primary
care to just because it is more
individualized, it’s more oneon-one. They have more
access to providers than they
would just a regular clinic”.
(ID25, PA, peds, R)
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Category: Practice Structure and Policies

Patient Exposure
“I think we’re really focused
on contraception with those
teens [teen moms] it’s like a
focus so a lot of them are on
contraception so evaluating
their menstrual cycles is a little
bit difficult. So I don’t think it’s
common to be thinking about
or talking about PCOS”.
(ID69, MD, peds, U)

Ways to Address
Many pedPCPs highlighted a need to have further collaboration and guidance
from specialists in order to improve their comfort level and capacity to address PCOS
among adolescents. This includes both establishing a partnership for collaboration and
engaging experts to provide training for pedPCPs and clinical staff.
Some pedPCPs shared that a change in practice policy is needed in order to
change their practice situation in which policies restrict them from having patient follow
up and continuity of care. Recognizing however that these changes may not be feasible,
pedPCPs offered suggestions for other ways that practice organizations can provide
support to increase their capacity to manage PCOS among adolescents. Specifically,
providers made recommendation for improving follow up by flagging patients in the
EMR. If the initial provider who saw the patient for PCOS is not able to follow up with
that patient, at least a system to flag patients can alert another member of the clinic staff.
Table 28 Ways to Address provides qualitative data for applicable codes that align with
providers’ suggestions for addressing barriers related to theme #2: Improve Practice
Support, Education/training and Collaboration with Specialists.
Theme #3
Behavior evaluation and parent/caregiver influence.
PedPCP’s comfort with treatment options for PCOS and perception of benefit
may serve as a barrier or facilitator in the management of PCOS. Additionally, pedPCPs
discussed patient factors that they experience as either a barrier or facilitator to
management. Code categories related to theme #3 include: Provider Behavior Evaluation,
Provider Perception of Patient Factors, and Ways to Address.
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Behavior Evaluation
Some providers reported limitations in their own comfort level with treatment
options for POCS. Other providers reported confidence with prescribing various
treatments and perception of benefit.
Provider Discomfort with Treatment Options.
“I’m not sure from a management perspective that a lot of providers are really
comfortable with the management of it. I think we’re comfortable with talking
about it, we’re comfortable with addressing it and pointing out features or things
that we notice that may lead us to be suspicious. But I think once it becomes more
of a management of it or we get close to a diagnosis then I think a lot of us feel
more comfortable to refer. I know it a be a lot easier if we could feel a little
more comfortable managing it ourselves.”(ID25, PA, peds, R)
“I think it is an area where pediatricians don’t feel that much comfort. I think it
would be great to feel more empowered to more easily diagnose and treat it”.
(ID69, MD, peds, U)
“And I think that’s more of a reluctance to prescribe medications off label in a
younger population if it’s not really implicated”. (ID16, PA, family, S)
Provider Confidence with Treatment.
“Oh, and the people actually do really well and the Metformin along with diet
changes just helps people control those cravings better. They have less fatigue
and brain fog and just to start feeling overall better.” (ID01, PA, family, S)
“But for a lot people their concern is this irregular menstrual cycle and so one
thing that’s easy to start with is just like this [contraception] will help make your
menses more regular and so they’re more predictable and so you’re kind of like,
people feel reassured when they’re having a monthly menstrual cycle.” (ID69,
MD, peds, U)
“And then I would say just the response of patients or the concerns that they have
I think is the biggest thing. I try to make sure that I’m addressing their concerns
and not just mine and so I try to listen to not only the teenagers but their parents
and brothers and sisters, relatives that are there for them. I try and listen to what
their concerns were, how they’d like to manage things differently.” (ID50, PA,
peds, S&U)
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Provider Perception of Patient Factors
Participants recognized patient factors that may be barriers or facilitators to
addressing PCOS among adolescents. Adolescent health is unique as providers consider
the balance of empowering adolescents to have control of their health and
parent/caregiver influence.
Parent/Caregiver Influence.
“The disadvantage is parent involvement in this age group and the insertion of
their opinion on their child.” (ID15, PA, family, S)
“So I think there’s sometimes a hesitancy to talk about it because there really
isn’t a solution or the family at least doesn’t see there is one.” (ID25, PA, peds
R)
“Yeah I would think, yeah, yeah, birth control first parents it’s a really hard thing
because they’re like ‘I don’t want my daughter to be promiscuous on birth
control. That’s not something we’re ready for at this time.”(ID19, PA, family, S)
“I think parents just really associate Metformin with saying my child has diabetes
so I find that they tend to be, or parents have personal experience of being on it.”
(ID47, MD, peds, S)
PedPCPs recognize facilitators to addressing PCOS when an adolescent is
motivated to address symptoms of PCOS. Providers shared that this is often when they
experience undesirable characteristics of PCOS such as facial hair growth.
Patient Health Seeking Behavior.
“I’d say probably the biggest complaint that we have is girls who come in usually
with facial hair growth that they’re concerned about. But sometimes we also just
get late teens who girls, who have menstrual irregularities or amenorrhea and
then you have more of a metabolic syndrome kind of picture but I would probably
say hirsutism is probably the biggest presenting symptom. Hirsutism is probably
the biggest thing that prompts the lab work and so that’s something that I find
that girls are very self-conscious about and very much want to work up and get
rid of.” (ID29, PA, family, R)
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“Most patients are willing to try it because again if they’re overweight,
maybe they have some other abnormal labs whether it’s cholesterol or
something like that that they are willing to try something to see if it makes
a difference in their, just how they feel energy wise. Or if the weight loss is
a goal that they have sometimes they’re willing to try that just for that
possible weight loss that Metformin can have. And I always tell them that
my goal in seeing them is ‘if we can make you happy and healthy now
you’ll be happy and healthy later’ and so they tend to understand that
and are okay with putting in the work.” (ID50, PA, peds, S&U)
Finally, pedPCPs discussed challenges in addressing complex topics surrounding
PCOS with adolescent patients. As adolescent patients approach adulthood, pedPCPs
recognize the need to counsel patients about long-term health risks associated with
PCOS. However, pedPCPs discussed challenges in how to communicate these complex
topics, and the need to tailor them for age-appropriate communication.
Addressing Complex Topics.
“Disadvantages are just the hard topics that we have to go through. The
weight piece is always a struggle.” (ID25, PA, peds, R)
“Disadvantages is in how you do it [counsel patient] going back to the
fertility thing and the weight thing, you don’t want to freak them out for
lack of a proper term and or freak out the family. You don’t want it to
be something that they’re going to obsess about, oh I’m not going to be
able to have a kid in ten years or I’m going to be obese in ten years.
Try not to give them, making sure they have a positive outlook, letting
them know that there are some risks or there can be some long-term
effects but that it’s not definitely going to happen.”(ID71, PA, family, S)
“I think that a lot of girls when you talk to them about it, the only thing
they know about it when they Google it really quick is that they’re
not going to be able to get pregnant someday, which is just not true at all
because we’ve got so many great management options for that and
many women with PCOS don’t even have a problem getting
pregnant. So I think that that is maybe one of the biggest downfalls of
information that is available to patients. And I don’t want twelve to
eighteen-year old girls worrying about that for in the future.” (ID01,
PA, family, S)
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“I’ve also been finding anecdotally in a lot of the teenagers with irregular
periods with or without a diagnosis with PCOS seem to believe that they cannot
get pregnant now, like in the moment. And so this was a number of patients. I’m
not sure how they got that into their head and so I try and do some counseling
related to that and address the education and medication and physiologic kind of
needs of from PCOS.” (ID40, NP, peds, U)
Ways to Address
PedPCPs identified a need for more education/training and increased patient visit
duration. Recognizing that increasing provider time with patients may not be feasible,
some providers suggested greater engagement of clinical staff to more effectively address
PCOS in primary care practice. Clinical staff can help with identifying adolescents at risk
for PCOS, ensuring follow up with diagnostic evaluations, helps with patient and
parent/caregiver education and counseling in managing PCOS, and ensure follow up with
referrals if specialty or multi-disciplinary consultation is requested.
Finally, some pedPCPs recognized their own limitation in communication
complex topics around PCOS with adolescents and their parents or caregivers. Providers
suggested training that is specific to communicating complex and sensitive topics and
resources that are appropriate for adolescents of different ages. Table 28 Ways to Address
provides qualitative data for applicable codes that align with providers’ suggestions for
addressing barriers related to theme #3: Improve Practice Support, Provider
Education/Training, Resources for Communication with Patients and Caregivers
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Table 28
Ways to Address
Code: Improve Practice Support
Subcode: Change in practice policies
“Change in practice culture and policy. It is never going to change.” (ID15), PA, FM, S
“I think something to show[to practice leaderships] the benefits of it, why it’s [addressing
PCOS in primary care setting] important just something that I could bring to the table when
we have our provider meetings and stuff to say “you know hey we should probably look into
managing this a little bit better when we see it,” that would be helpful.” (ID 73), PA, family,
R&S
Subcode: Increase Patient Visit Duration
“In my ideal world I would have an hour time to talk to the teen and the parent about PCOS
and be able to, you know, listen and educate and make sure they understood what they heard.”
(ID42), NP, peds, U
Subcode: Engagement of Clinical Staff
“…potentially having one of our providers or nurses or someone be a point person for that.
Because I know we have point people for depression and suicidality and we have someone who
really focuses on Autism screening and developmental delays. And so if we could have
someone who almost kept us accountable for that I think that would be helpful.” (ID50), PA,
peds, S&U
Subcode: Process for Patient Follow-up
“One, I think that there could be a better way of flagging any patient at risk. So any time
anything like acne or irregular period or obesity comes up that that would be some way to flag
every patient so that no one really gets missed” (ID54), PA, peds, S
Code: Education/training
“I sort of would love to just have, have like an educational professional development session
from an adolescent doctor or an endocrinologist of like this is what I do and make sure that it
aligns with what I do or feel more empowered...” (ID69), MD, peds, U
“I think some sort of training, yeah I think a training. And my supervising physician has also
mentioned that if she could go through a training, like at Children’s or something that would
make us much more comfortable.” (ID54), PA, peds, S

Code: Point of Care Protocols
“I think it would be nice to have just more just almost like an algorithm that people are
following just more regularly in the community I think.” (ID47), MD, peds, S
“It really is just implementing a more specific flow sheet.” (ID31), PA, family, U
Code: Collaboration with Specialists
“I guess what I would change [pause] is being a little bit quicker to treat and at the same time
what I would love to do is just feel more confident and have, and that requires just some more
knowledge and guidelines from the experts.” (ID69), MD, peds, U
Code: Resources for Provider-Patient/Caregiver Communication
“… just learning about how to have that conversation with them; even better in the young
population.” (ID07), PA, family, R
NP=Nurse Practitioner; MD= Medical Doctor; PA=Physician Assistant; peds=pediatric practice focus;
FM=family medicine practice focus; R=rural practice region; S=suburban practice region; U= urban
practice region

Qualitative Summary
Main barriers to addressing PCOS among adolescents in a primary care setting are
related to uncertainties in diagnosis, lack comfort with treatment options, and provider
perception of challenges communicating complex topics to adolescent patients. Main
facilitators include provider collaboration and specialty guidance. Interview participants
identified five main actions or interventions that would address barriers and/or support
facilitators already in place: Improve practice support; education or in-service training for
providers and clinical staff; develop/improve point of care resources; develop a pathway
for provider-specialist collaboration and communication; and develop provider training
on communicating complex topics to adolescent patients with PCOS.
All interview participants recognized the importance of addressing PCOS in the
adolescent population, despite barriers or limitations that pedPCPs may experience in
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their own practice. Additionally, some participants indicated their belief that pedPCPs are
on the front-line for identification, diagnosis and management of PCOS.
“I think it’s really misdiagnosed, underdiagnosed and affects quality of life
dramatically. I think we can be more on the frontline instead of getting
specialists involved.” (ID31, PA, family, U)
“I think it’s actually pretty critical that it’s addressed in adolescents only because
of the possible complications that can occur later on it. And that’s usually where
patients are picked up and addressed and by then sometimes it’s actually well
passed the time they needed to have an intervention and then you get into higher
costs and it just makes more sense to really address it in the adolescent age.”
(ID36, PA, family, U)
“Well I think that if those patients get missed they get set up for a lot of sequela
that might be very difficult to treat later on. And I think it’s important for these
kids to get diagnosed from a behavioral health standpoint because with all of
the things that are happening to their bodies, you know the excess hair
growth, the weight. Kids can be rather cruel so I think the faster we get to
diagnosis and treatment I think the better off they are.” (ID57, NP, family,
S&R)
“Well it’s a syndrome of a lot of things. So, first of all menstrual irregularities
can be really difficult on an adolescent girl. If she’s let’s say not sure when she’s
going to get her menses or it’s very irregular, she doesn’t know that can just
psychologically take a toll on her. And then acne and hirsutism obviously will
take a toll on how they feel about themselves and of course obesity. And then with
obesity and metabolic syndrome everything else that comes along with that I think
this whole syndrome is important to address. And then of course the infertility,
in the future.” (ID54, PA, peds, S).
Mixed Methods Results
Results from the qualitative study explain some key findings from the survey
research in this sequential explanatory mixed-methods study design. The primary
objective of this research was to identify practice behaviors of pedPCPs, and explain
factors that influence pedPCP behaviors through the lens of a barriers to practice
framework. Understanding how barriers and facilitators shape practice behaviors of
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pedPCPs in this research, contributes knowledge to better understand the role of the
pedPCP and target areas for future learning or behavior change interventions to optimize
care of adolescents with PCOS. An overview of mixed-methods results is presented in
Table 29 Mixed Methods Results.
Table 29
Mixed Methods Results
Quantitative Results
(Aims 1&2)

Qualitative Results (Aim 3)

Integration of Results

All participants (n=52) reported
inquiring about menstrual
irregularities, but only 21.2%
inquire at all encounters regardless
of reason for visit.

PedPCPs discussed unrecognition of
symptoms of PCOS. Inquiry about
menses is not addressed at every visit.
Concern that providers “normalize”
irregular menses in adolescents.
Qualitative codes: Under recognition
of symptoms; treatment masking
symptoms; normalizing symptoms.

PedPCP are not regularly
inquiring about menses.
There may be knowledge
gap in understanding
when irregular menses is
considered as part of the
normal physiology of
puberty versus when to
consider abnormal.

84.6% of the pedPCPs in the
sample (n=52) report having
adolescent patients with diagnosis
of PCOS. Of the subset of 44
providers, 81.8% (n=36) indicated
that they carry out some or all
diagnostic evaluations for PCOS in
their adolescent patients. However,
selection of diagnostic test varied
and the most commonly selected
tests did not align with key
laboratory evaluation needed to
diagnose PCOS and to rule out
other endocrine disorders (Ibanez et
al., 2017)
Few respondents (8 out 52; 15.4%)
indicate knowledge of ICPE 2017
internal consensus statement,
supported by the Pediatric
Endocrine Society (PES). There
was no difference in diagnostic
behavior scores between pedPCPs

PedPCPs reported confusion about
diagnostic guidelines, concern with
missing other endocrine disorders and
harms of labelling an adolescent with
PCOS if they are uncertain about the
diagnosis. Most rely on specialist to
establish the diagnosis. Qualitative
codes: Confusion about diagnostic
guidelines, concern with missing
other endocrine disorders, harms of
labelling.

PedPCPs reported utilizing point of
care resources, such as UpToDate
inform practice.
Qualitative codes: Point of Care
Resources.
Some providers also discussed
receiving guidance from more
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Limited knowledge of
adolescent-specific
criteria is a potential
barrier to diagnosis.
Collaboration with and/or
guidance from senior
providers, peers and
specialists help facilitate
the diagnostic process
even when there is lack of
awareness of guidelines.
PedPCPs also reference
online point of care
resources with the
expectation that they
include up to date
evidence-based guidance.

Quantitative Results
(Aims 1&2)

Qualitative Results (Aim 3)

who do or do not have knowledge
of PES guidelines.

experienced providers in the practice,
collaboration with peers, or
collaboration with specialists who
have an established relationship with
the practice. Qualitative codes:
Proximity to specialists, guidance
from senior providers, peer
collaboration, collaboration with
specialists.

Providers who practice in a
pediatric focused practice have
significantly higher diagnostic
practice score for addressing PCOS
in adolescents than providers with a
family medicine focused practice.
Providers who reported that
adolescents make up >25% of their
patient population demonstrate
significantly higher diagnostic
practice behaviors compared to
other practices with <25% of
adolescents in their patient
population.

PedPCPs in urgent care settings
demonstrated significantly lower
diagnostic practice behaviors
compared to other practice settings

There were no significant
differences in diagnostic or
screening behaviors for pedPCPs
who reported a higher percentage of

These two findings from the
quantitative research are likely
related. Of the participants in the
qualitative study, those who practiced
in pediatric focused practice had a
significant focus on adolescent
patients versus a general pediatric
population. Qualitative code: patient
exposure

PedPCPs in urgent care reported
restrictive practice policies that do not
allow them to carry out diagnosis or
participate in the management of
PCOS. Regardless of their knowledge
or motivation to address PCOS, they
are limited by their practice policies.
Qualitative code: restrictive practice
policies

Non-traditional practice settings of
community/public health clinics
highlighted unique structures and/or
policies that serve as a safety-net and
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Integration of Results

Patient exposure to a
higher population of
adolescents likely impacts
pedPCP experience in
building knowledge and
skill to address PCOS.
Consider appropriate
intervention approaches
for practices that have
less exposure to
adolescent patients.
Identify opportunities for
case based learning that
will have a greater impact
on behavior change.

Providers who practice in
non-traditional settings
should not be overlooked
when implementing
future interventions to
change practice
behaviors. However,
restrictive practice
policies may be a
significant barrier to
behavior change.

Qualitative findings
regarding
structure/policies for

Quantitative Results
(Aims 1&2)

Qualitative Results (Aim 3)

Integration of Results

uninsured or Medicaid patients, or
with a higher percentage of ethnic
minority populations (Hispanic).
However, pedPCPs who reported
Black/African American population
of ≥ 50%, had a significantly higher
diagnostic practice score compared
to pedPCPs with <50%
Black/African American patient
population.

expand capacity for addressing the
complexity of PCOS in adolescents.
For examples, community health
clinics have partnerships between
public health entities to ensure that
uninsured and underinsured
populations have access to multiple
treatment options. Another example is
school-based health clinic where
having daily access to patients allows
for continuity of care, especially
when considering complex aspects of
treatment such as counseling on
lifestyle modifications. Qualitative
codes: healthcare safety net programs,
patient exposure.

safety-net programs may
explain why the
quantitative data did not
reveal evidence of
potential disparities in
how PCOS was addressed
among low income
populations or in minority
groups. Further research
should investigate care
delivery models and
team-based structure
within safety-net
programs to inform future
models for
comprehensive care.

The most common treatment
selected by pedPCPs participants
aligns with adolescent-specific
guidelines that recommend lifestyle modifications as the main stay
of treatment, with the addition of
hormonal contraception or
metformin, depending on an
individual patient’s clinical
presentation (Ibanez et al., 2017).
Only 34% of participants did not
engage in any treatment of PCOS.

There was a divergent theme in the
qualitative research regarding pedPCP
comfort level and confidence in the
treatment options to manage PCOS.
For example, some pedPCPs report
comfort with OCP to treat irregular
menses, but are not comfort with
metformin, while other report the
opposite. Qualitative codes: provider
discomfort with treatment, provider
confidence in treating.

PedPCPs with high diagnostic
practice scores and who treat
PCOS, have higher mean scores for
the behavior evaluation subscale.
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PedPCPs have varying
comfort levels in treating
PCOS. Results from this
research demonstrates
that pedPCPs have
awareness of metabolic
complications of PCOS,
but may be less
comfortable with utilizing
medication such as
metformin. Since PCOS
is an endocrine disorder
with significant impact on
metabolic health,
consider targeting
education/training
specific to addressing the
metabolic complications
of PCOS in adolescents.

Quantitative Results
(Aims 1&2)

Over half of pedPCPs participants
reported that they refer to specialty
providers. PedPCPs mostly reported
to referring to gynecology (64%),
with 48% referring to
endocrinology. Fewer providers
referred to nutritionists (11.4%) or
behavioral health specialists (9.1%)
to address diet modifications or
mental health complications
respectively.

Qualitative Results (Aim 3)
In the qualitative research, several
providers discussed initiating
treatment while also referring to
specialists, and some reported
provider-to-provider phone
consultations to assist in treatment
selection.
Other providers discussed barriers
due to limited access to specialty
providers. Limitation in access was
due to both proximity to specialty
care, and to specialty providers who
do not management adolescent
patients with PCOS.

Integration of Results

Future interventions need
to address access to care
issues and engage a
multi-disciplinary group
of health professionals to
address PCOS.

PedPCPs also discussed limited
options for multidisciplinary care,
which explains why a low percentage
of survey participants selected
referrals to nutritionist or behavioral
health specialists.
Qualitative codes: specialty provider
shortages, limited options for
multidisciplinary care, proximity to
specialists, collaboration with
specialists.

A majority of the pedPCPs
indicated that they screen for
complications of PCOS. Over
50% of pedPCPs indicated that
they screen for all complications
recommended in the adolescentspecific guidelines
(hyperlipidemia, obesity, T2DM,
hypertension, depression and
anxiety). Only 32% of pedPCPs
stated that they do not carry out
any screening.

PedPCP recognize long-term
complications associated with
PCOS, but those who do not carry
out screening for complications
report restrictive practice policies
that do not allow adequate follow
up to test and/or screen for
complication. Qualitative code:
restrictive practice policies.
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In general, pedPCPs are
aware of long-term
complications of PCOS
and are engaged in
screening. Those who
do not engage have
barriers related to
practice policies that
dictate what a provider
practice.
Future interventions
should reinforce the
role of the primary care
provider to screen for
complications of
PCOS.

Quantitative Results
(Aims 1&2)

Qualitative Results (Aim 3)

Integration of Results

Over 80% of the survey
participants (42 out of 52)
identified an interest to improve
knowledge and skill regarding
PCOS in adolescents. When
queried about interest in
continuing education on PCOS,
participants endorsed interest in:
reading journal articles, podcast,
online CME/webinar, in-person
conference lecture, and/or onsite training/in-service activity.

PedPCPs indicated a desire to
improve practice behaviors in
addressing PCOS. PedPCPs
proposed specific interventions to
include: designating an office
PCOS champion; developing
practice protocols; and carrying
out training programs for
clinicians and staff. Qualitative
code: Ways to Address

Future interventions for
learning should include
clinic staff beyond just
providers, provide
practical tools to be
used in practice, and
establish a foundation
to improve practice
support so as to impact
practice level behavior
change.

Mean items score for items in
the Intention to Change subscale
(within the attitude beliefs scale)
were: 4.13 for “I would like to
improve my practice behaviors”
and 3.79 for “I intend to change
my practice behaviors.”

The difference in mean items score
for “like to improve” vs. “intend to
change” may be explained by
barriers of restrictive practice
policies. One participant, who
reported being in a setting with
restrictive policies, stated that in
order to change practice behavior,
practice culture and policy would
need to change, but stated “It is
never going to happen”.

There may be a
discrepancy between
provider motivation to
change and intention to
change if providers
encounter barriers that
they perceive are
difficult to overcome,
such as restrictive
practice policies.

Additionally, the quantitative findings, and the participants from the survey who
volunteered to be a part of qualitative interviews, likely informed the qualitative findings
in several ways. First, the majority of interview participants were from a family medicine
focused practice (n=13/20, 65%) and had been in practice for ≤ 10 years (n=14/20, 70%)
(see Table 24 Provider Demographics and Provider Characteristics of Interview
Participants). Less practice experience and broad focus in family medicine may explain
why pedPCPs may seek specialty input in establishing the diagnosis of PCOS.
Second, practice settings of interview participants varied, with 8/20 (40%)
practicing in non-traditional practice settings. PedPCPs discussed significant variations in
practice policies among these practice settings, with providers in urgent care settings,
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which made up 20% (n=4/20) of the interview participants, highlighting the most
restrictive practice policies and protocols. This helps explain difference in interview
duration, where those providers who had less involvement in diagnosis and management
had shorter interview durations, and divergence in the qualitative themes.
Lastly, despite difference in practice settings, structure and policies, most
interview participants agreed or strongly agreed with statements for provider attitude and
beliefs related to threat perception and intention to change. This highlights a motivated
group of interview participants, which likely explains the depth of insight offered by
providers related to their own confidence and perspective on patient factors as they desire
practice-level change.
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CHAPTER 5: DISCUSSION

Introduction
The aim of this chapter is to discuss the major findings, limitations, and
translational application of this dissertation research. Major findings are discussed in the
context of the dissertation’s guiding conceptual framework for identifying and addressing
barriers to optimal care and current literature in the field. Figure 17 Barriers and
Facilitators to Addressing PCOS Among Adolescents in Primary Care highlights the
barriers and facilitators identified in this research within the conceptual framework that
informed study aims and research questions.
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Figure 17
Barriers and Facilitators to Address PCOS Among Adolescents in a Primary Care
Setting
Summary of Major Findings
Knowledge
- Lack of awareness of adolescentspecific guidelines

Intention

Attitude & Beliefs
- Provider discomfort with treatment
-/+Provider confidence
-/+Peer influence
+ Threat perceptions
+ Perceived benefit

+ providers motivated
to improve practice
behavior

Behavior

A
Practice Characteristics

Patient Factors

-Limited access to specialty care + Safety net program
+ Patient exposure
- Restrictive practice policies
+Provider collaboration

- Parent/caregiver Influence
- Communicating complex topics

This chapter explains barriers and facilitators presented in Figure 17 Barriers and
Facilitators to Address PCOS Among Adolescents in a Primary Care Setting, and
highlights the contributions of this dissertation to advancing knowledge about the role of
the pedPCP in identifying and treating PCOS, application of adolescent-specific
guidelines in practice, and practical evidence to inform future interventions to optimize
care of the adolescent patient with PCOS.
Major Findings of the Dissertation
This is the first known research in the United States that systematically evaluated
practice behaviors among pedPCPs in the diagnosis and management of adolescents with
PCOS. The study population included physicians, PAs, and NPs who practice in a

155

primary care setting in DC, MD, or VA. Over half of the pedPCPs in the study sample
addressed some aspect of PCOS in adolescent patients, including identification,
diagnosis, and treatment, despite few reporting awareness of adolescent-specific
guidelines. Level of engagement within each of these behaviors varied among pedPCPs.
Differences in provider confidence, collaboration with colleagues and/or specialists,
practice structure and policies, and pedPCPs’ perception of patient factors explain some
variations observed across different types of practices. Overall, pedPCPs believe it is
important to address PCOS in adolescents and that there is benefit to improving health
outcomes early in the course of this chronic condition. Most pedPCPs in this study
indicated motivation to change practice behaviors and desire to participate in future
educational activities to better inform their practice. Figure 17 Barriers and Facilitators
to Address PCOS Among Adolescents in a Primary Care Setting, highlights where
barriers and facilitators identified in this research may interconnect to influence behaviors
and behavior change. The findings of this research highlight several opportunities for
implementing knowledge translation interventions and provide a direction for the type of
interventions that will impact behavior change.
Behavior, Knowledge, and the Role of the PedPCP
In the only known study focused on pedPCPs’ behaviors addressing PCOS, this
dissertation research identified that a majority of respondents carry out some or all
diagnostic evaluations, or participate in the management of PCOS in adolescents.
However, not all reported behaviors align with current guidance and very few pedPCPs
reported knowledge of adolescent-specific guidelines for the diagnosis and management
of PCOS. Only 8 out of the total sample of 52 pedPCPs (15.4%) reported awareness of
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adolescent-specific PCOS diagnostic guidelines. Forty-four pedPCPs (44/52, 84,6%)
stated that they have adolescent patients with a diagnosis of PCOS. Thirty-six (36/44,
81.8%) of this sub-set of 44 pedPCPs stated that they carried out some or all of the
diagnostic evaluation for PCOS; 29/44 (66%) stated that they actively treat PCOS; and
30/44 (68%) screen for complications of PCOS. The most common laboratory tests
selected by pedPCPs for PCOS diagnostic evaluation included thyroid functions tests
(84%), FSH (68%), LH (64%), free testosterone (55%), and ultrasonography (52%). Less
than 50% of the sample selected additional tests that are important to rule out other
endocrine disorders listed in the guidelines as PCOS is a diagnosis of exclusion (Ibanez et
al., 2017). Qualitative results also revealed pedPCPs uncertainty about selection of
diagnostic tests and concern with missing another endocrine disorder. For example, one
participant highlighted: “I think anything with endocrinology feels a little bit like oh
we’re already getting into something a little scary or a little like nebulous and a little
confusing I think that part of it is not wanting to miss other things that can mimic PCOS
(ID69). Additionally, over half of the participants selected ultrasonography as part of the
diagnostic evaluation for PCOS, which is discouraged in adolescent-specific PCOS
diagnostic guidelines (Ibanez et al., 2017).
The most common treatment selected by pedPCPs in this dissertation research
were lifestyle modifications (66%), hormonal contraception (61%), and metformin
(50%); 55% reported that they refer to specialist. Over 60% of the pedPCPs identified
that they screen for the following complications of PCOS: hyperlipidemia (68%), obesity
(66%), T2DM (64%), hypertension (61%), depression (73%), anxiety (73%). This
demonstrates better alignment with guidelines, which promote lifestyle modifications,
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hormonal contraception and metformin as the most common treatment recommendations
(Ibanez et al., 2017). Over 60% of the pedPCPs indicated that they participate in all
screening considerations recommended in the guidelines (Ibanez et al., 2017).
Extant survey research regarding specialty provider practice behaviors to address
PCOS also shows significant heterogeinty in diagnostic evaluations for PCOS and related
management, and limited awareness of current diagnostic guidelines (Bonny et al, 2012;
Conway et al., 2014; Dhesi et al., 2016; Dokras et al., 2017). It is important to note that
the aforementioned research focused on different provider populations, largely specialty
providers addressing adults with PCOS (Conway et al., 2014; Dhesi et al., 2016; Dokras
et al., 2017); with the exception of one study, which targeted specialists in pediatric and
adolescent gynecology (Bonny et al., 2012). Recognition of similarities and differences
of major findings from specialty provider studies and this dissertation research is helpful
to discern the role of a pediatric primary care provider from that of specialty providers,
identify knowledge gaps among different providers, and provide direction for future
interventions.
Research by Bonny et al. (2012), with specialty providers who treat adolescents
with PCOS identified oral contraception and lifestyle modifications as the most
commonly selected treatment, and less than 30% reported prescribing metformin. This
contrasts the finding in this dissertation research where half of the respondents selected
metformin as a commonly selected treatment. This may be explained by the fact that the
Bonny et al. (2012) study mostly included gynecologists, who may not be as familiar
with addressing the metabolic complications of PCOS, as is suggested by a study by
Dhesi and colleagues (2016). A survey study of American College of Obstetricians and
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Gynecology fellows in 2016, demonstrated that most GYN providers were not
comfortable with addressing the metabolic complications of PCOS and referred patients
back to primary care to manage treatments such as metformin (Dhesi et al., 2016). This
highlights a potentially important role for the primary care provider in managing the
metabolic complications of PCOS.
Survey research by Dokras et al. (2017) queried specialty provider (gynecologists
and reproductive endocrinologists) knowledge related to potential complications for
PCOS. Specialty providers were aware of all complications of PCOS measured in this
dissertation survey, except anxiety. Less than half of the specialty providers were aware
of the association between PCOS and anxiety symptoms (Dokras et al., 2017), whereas in
this dissertation study 73% of pedPCPs reported screening for anxiety among adolescent
patients with PCOS. This may be a reflection of standard of care in primary care practice
to routinely assess mental health and unique concerns in adolescents.
Finally, a study by McShane and colleagues conducted a chart review for women
age 12-21 years of age to determine provider behaviors in obtaining a menstrual history
at annual wellness exams. The researchers compared menstrual histories taken by
adolescent medicine, pediatric, and family medicine practices. Pediatric and family
medicine practices demonstrated significant deficiencies in taking a complete menstrual
history compared to adolescent medicine practices, which were over 6 times more likely
to take a complete menstrual history (McShane et al., 2018). There were no differences
between pediatric and family medicine practices (McShane et al., 2018). This dissertation
research also revealed a potential deficiency in obtaining an adequate menstrual history
as not all pedPCPs reported inquiring about menses during annual visits 81% (n=42/52),
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and only 19.2% (n=10/52) of the participants reported inquiring about menses at all
encounters, regardless of the reason for the visit. Participants were not queried for the
details that they collected when inquiring about menstrual irregularities, however the
qualitative research provided further insight on this potential deficiency. Specifically, the
qualitative results captured pedPCPs’ concern that symptoms related to menstrual
irregularities are often under recognized or “normalized” by pedPCPs. The study by
McShane and colleagues (2018) did not have a study aim specific to PCOS, but does
support evidence of a practice deficiency among pediatric and family medicine providers
to identify irregular menses in adolescents. Identification of irregular menses is a key
criterion to diagnosis PCOS; if pedPCPS are not obtaining menstrual histories, this
presents a barrier to identification and diagnosis of PCOS.
In summary, pedPCPs are engaged in addressing some aspect of diagnosis and
management of PCOS among adolescents. Despite low awareness of adolescent-specific
guidelines, most of the pedPCPs in this study report management behaviors that align
with adolescent-specific guidelines. In contrast, behaviors to identify and diagnose PCOS
had less alignment with adolescent-specific PCOS diagnostic criteria. Over half of the
pedPCPs refer to a gynecologist or endocrinologist to contribute to the management of
PCOS, but there is evidence of a unique and important role of the pedPCPs where
specialty providers may have gaps in knowledge, including prescribing metformin to
manage metabolic complications and routinely screening for mental health complications
associated with PCOS. Future interventions should consider improving knowledge
around obtaining a menstrual history and adolescent-specific PCOS diagnostic criteria,
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and supporting the role of the pedPCPs to address metabolic and mental health
complications of PCOS.
Behavior and Attitude/Beliefs
PedPCPs perceive that PCOS is a threat to adolescent health and there is benefit
to treatment, but report low confidence in their ability to diagnose or treat PCOS. Results
from both the quantitative and qualitative data suggest pedPCPs believe in the importance
of addressing PCOS in adolescents, but also highlight lack of confidence in establishing a
diagnosis of PCOS and limited comfort with treatment options as barriers to addressing
PCOS in a primary care setting. Knowledge gaps, as discussed in the previous section,
can contribute to lack of confidence and discomfort with treatment options. However, the
conceptual framework for this dissertation posits that lack of confidence is an important
the attitudinal factor to be consider separately for its influence on behavior in the
knowledge to action process and can also be influenced by other factors beyond
knowledge. (Cochrane et al., 2007).
Qualitative data highlighted specific areas where there is low provider confidence.
In terms of diagnosis, factors associated with low confidence include: confusion about
diagnostic guidelines, concern with missing other endocrine disorders and concerns of
labeling an adolescent with a diagnosis of PCOS. The only other known qualitative study
focused on clinicians’ perspective in addressing PCOS demonstrated similar findings: a
diverse group of providers (specialists and generalists) reported uncertainties about
diagnostic criteria and caution with labeling as barriers to establishing a diagnosis (Copp
et al., 2019). This study was carried out in Australia and providers primarily treated adult
patients. Despite a different target population from this dissertation research, many of the
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findings and themes that emerged from the Copp et al. (2019) qualitative research are
similar to and reinforce the findings of this research.
Provider confidence with treatment options also varied as some pedPCPs in the
qualitative interviews stated they were comfortable with prescribing hormonal
contraception treatment but not metformin; for other providers, it was the opposite. Some
pedPCPs were not comfortable with or confident in their ability to prescribe any
treatment for PCOS, and some were confident with all treatment options.
Provider confidence with treatment may also be impacted by parent/caregiver
hesitation. During the qualitative interviews, several providers indicated that some
parents are resistant to treatment with hormonal contraception due to concern that it will
promote sexual promiscuity. Other pedPCPs reported that parents are hesitant to have
their child start metformin as they associate metformin with diabetes, or personally
experienced side effects when taking metformin.
PedPCPs’ confidence may also be impacted by challenges in addressing sensitive
topics with adolescents regarding reproductive health and potential complications
affecting fertility. Providers expressed difficulty balancing age-appropriate education
about reproductive health risks, not wanting to overly concern adolescent patients about
their future fertility, with the need to ensure that if they were sexually active they were
utilizing contraception and not assuming that they could not get pregnant because they
have PCOS. Several studies have shown that adolescents with PCOS are concerned about
their future fertility and that this can have a negative impact on quality of life (Hahn et
al., 2005; Kudesia et al., 2017; Trent et al., 2003). In contrast, some research has found
that adolescents with PCOS who are sexually active have a low baseline rate of
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contraception use (Malcolm et al.; 2015). During the qualitative interviews, pedPCPs
indicated a need for resources to help facilitate patient and parent/caregiver education,
which may impact their confidence in discussing and/or prescribing hormonal
contraception.
Understanding attitudes and beliefs of pedPCPs in addressing PCOS provides new
knowledge to target future interventions. This is the first known research to evaluate
pedPCP attitudes and beliefs regarding PCOS. Belief that PCOS is important to address
in adolescents and perceived benefit of treatment indicates that pedPCPs may have higher
levels of motivation to change behaviors. Future interventions should focus on
opportunities to increase provider confidence and comfort with diagnostic guidelines and
treatment options, and providing resources for evidence-based patient and
parent/caregiver education.
Behavior and External Factors: Practice Characteristics
Qualitative results informed salient factors that influence pedPCPs’ behaviors to
diagnose and manage PCOS in adolescent patients, including access to specialty care,
provider interactions, and practice structure and organizational policies. These findings
align with the Barriers to Adherence to Practice Guidelines Framework (Cochrane et
al.,2007), which identifies rigidity of practice protocols, lack of peer influences,
discrepancies in organizational structure as professional and system/process barriers to
implement evidence into practice.
Access to Specialty Care
Access to specialty care impacts whether or not providers are able to obtain expert
guidance in diagnosing and managing PCOS. This refers not only to having a specialty
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practice within close proximity to the primary care practice, but also whether or not the
specialty providers themselves are comfortable with addressing PCOS among
adolescents. During qualitative interviews, some pedPCPs discussed referring patients to
gynecologists who did not contribute to the management plan and referred the patient
back to pedPCPs for management without making any recommendations. Previous
research with specialty providers demonstrates significant knowledge gaps and variability
in practice behaviors among specialty providers in both diagnosis and management of
PCOS in both adolescent and adult patients (Bonny et al., 2012; Dokras et al., 2017).
In contrast, pedPCPs who are in close proximity to specialists or are within the
same health system report gaining easier access to specialists. Some participants
highlighted that even when a patient is not able to be seen in a timely manner, specialists
will provide guidance on diagnosis or initiating management. In the qualitative study,
many of the providers in pediatric-focused practices reported having ease of access to
specialty providers, which may explain why pedPCPs in pediatric practices had higher
diagnostic practice scores as compared to pedPCPs in family medicine focused practices.
In this dissertation study, access to specialty care also considered access to a
multi-disciplinary team of health care professionals to address lifestyle modifications
and/or mental health complications of PCOS. A majority of pedPCPs indicates that they
recommend lifestyle modifications for the treatment of PCOS (66%) and 73% screen
adolescent patients with PCOS for complications of depression and anxiety. However,
only 9.1% and 11.4% of the pedPCPs in this dissertation study reported referring to a
behavioral health specialist or a nutritionist, respectively. During the qualitative
interviews participants shared that there are limited options for multidisciplinary care in
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their community. Some reported that there is a shortage of behavioral health specialists,
and that visits to a nutritionist often will not be covered with a diagnosis of PCOS.
In summary, access to specialty care is not only limited by provider shortages, but
also deficiencies in practice behaviors and/or discomfort among specialty providers to
addressing PCOS in adolescence and lack of options for multidisciplinary care. Future
interventions should target areas where pedPCPs can fill gaps in care such as increasing
knowledge and confidence to address metabolic complications of PCOS. Additionally,
future interventions should empower clinical staff (such as nurses, community health
workers, clinical pharmacists, patients and caregivers) to obtain specialty training to offer
evidence-based programs for nutrition counseling, motivational interviewing and peer
support groups. An example from the literature includes a best practice toolkit that was
developed to address a deficiency in support for families of children with disability and
complex medical needs (Schippke, et al., 2017). In this example, best practices were
synthesized so that communities with limited resources for caregiver support could
develop and provide effective evidence-based peer support programs.
Provider Interactions
Qualitative findings showed that interactions with more experienced
providers/attending physicians with knowledge and experience in addressing PCOS, or
information sharing between peers, is a facilitator to the management of PCOS in a
primary care setting. A few providers also discussed having established practice
relationships with specialists who either have helped with building practice protocols or
offer provider-to-provider phone consultations.
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Meaningful provider interactions also included peer-to-peer interactions. PedPCPs
in the qualitative interviews discussed carrying out self-directed learning to acquire new
knowledge about PCOS along with a peer, or sharing knowledge among peers after
attending conferences. This relates to the construct in the conceptual framework of
subjective norms, which posits that provider behaviors are influenced by the behavior of
other peers (Cochrane et al., 2007).
Findings related to provider interaction were not evident in the quantitative
research findings, but the qualitative research indicated that such interactions are a major
facilitator to pedPCPs engaging in the diagnosis and/or management of PCOS. Future
interventions should consider opportunities to connect pedPCPs to other more
experienced providers or specialists. A model for connection between primary care
providers and specialists that has been well researched for effectiveness and impact on
patient outcomes is the Extension for Community Healthcare Outcomes (ECHO) model.
The ECHO model is a professional development module of education that utilizes
videoconferencing to connect leaners to specialists across distance and various settings
(Cuttriss, 2020).
Practice Structure and Policies
An unexpected finding in this dissertation research is the variety of practice
settings that providers identified as primary care. Several pedPCPs who participated in
this study were not from traditional pediatric or family medicine practice settings, but still
care for adolescent patients. Non-traditional practice settings include urgent care
practices, school-based clinics, and community or public health clinics. PedPCPs in
urgent care settings reported strict practice policies that prohibited them from carrying
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out diagnostic evaluations, providing treating, or screening for complications of PCOS in
their urgent care setting. Despite identifying patients who presented to the urgent care
with complaints related to PCOS, strict practice protocols required all diagnostic
evaluation and/or management of PCOS to be referred to specialty practice. Several of
these providers identified an additional barrier of limited access to specialty providers,
demonstrating that multiple external factors serve as barriers.
Providers in more traditional settings also shared similar barriers related to
practice structure and policies limiting patient exposure and opportunities for patient
follow up. Specifically, some pedPCPs reported a patient medical home model in which
practice policy did not allow for non-physician providers (PAs and NPs) to have their
own patient panel. This limited their follow up to gain experience in diagnosing and
managing PCOS, and also potentially resulted in patients being lost to follow up if they
did not have continuity of care with the same provider. PAs and NPs in this type of
practice setting also indicated limited provider-to-provider interaction, demonstrating
again that the interplay between multiple practice characteristics may be influencing
pedPCP behaviors.
Dissimilarly, pedPCPs in public health and community health settings reported
organization structures and policies related to healthcare safety-net programs that
increased the capacity of otherwise low-resource settings to address multiple aspects of
managing PCOS. The facilitator of safety net programs may explain why there was a lack
of association across different practice demographics and patient populations with quality
of provider behaviors.
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Restrictive practice policies limit provider-patient exposure and the opportunity to
build experience and expertise in addressing PCOS. Some of these policies are found in
nontraditional settings, but are also found in traditional settings where policies delineate
roles between physician and non-physician providers. Influencing practice policies may
be difficult, but caution should be taken to not overlook pedPCPs in these settings.
Improving provider knowledge and skill outside of practice may allow pedPCPs to bring
new knowledge to their practice setting and be a catalyst for change.
Behaviors and External Factors: Patient Factors
Providers acknowledged challenges in addressing complex and sensitive topics
related to PCOS with adolescent patients. This was mostly related to addressing weight
and also engaging in discussion around how PCOS may impact future fertility. These
conversations need to be tailored for different age groups and adolescent maturity levels,
balanced with parent/caregiver hesitation that may be associated with cultural beliefs and
social norms. Many pedPCPs shared during the qualitative interviews that they did not
feel confident in their ability to have difficult conversations with adolescents and their
parents/caregivers, nor did they have enough resources or patient education tools to
reference.
This finding is similar to a theme that emerged from qualitative research by Copp
and colleagues (2019). Although Copp et al.’s (2019) research investigated provider
perspective on diagnosis PCOS, and not barriers to practice, a theme related to tailoring
care and communication for patients with PCOS parallels this this research finding.
Clinicians in this study (Copp et al., 2019) emphasized the need for patient-centered
communications. This dissertation research builds on this finding and offers evidence that
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providers identify significant challenges in providing patient-centered communication
and highlights this as a barrier to be addressed in future interventions.
Other patient factors included parent/caregiver influence and that parent/caregiver
hesitation or misunderstanding about certain treatment options may limit pedPCPs’
ability to adequately address PCOS in an adolescent patient. Furthermore, adolescents
often have limited control over modifications to diet and physical activity if it is not a
change embraced by the entire family. Even when an adolescent is motivated to change
their behavior and exhibit health seeking behaviors, they may have limited ability to carry
out these changes due to their dependency on their parent/caregiver. PedPCPs in the
qualitative interviews also discussed families who normalize some of the complications
associated with PCOS such as obesity or diabetes, as these conditions are prevalent in
society. Future research should seek to capture patient and parent/caregiver perspective in
order to develop evidence-based patient-centered education resources.
Study Limitations
Primary limitations of this dissertation research are related to sample size and
sampling method for the quantitative survey research. After 9 months of recruiting
efforts, 78 responses were received, with 52 eligible and completed surveys available for
analysis. This modest study population resulted in limitations for quantitative data
analyses. Specifically, multivariable logistic regression was not able to be performed to
determine which factors, if any, related to practice characteristics affected the likelihood
of pedPCPs engaging in the treatment of PCOS in adolescents. This limited the ability of
this research to use covariates to identify modifiable factors associated with the diagnosis
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and management of PCOS among adolescents patients in a primary care setting. As a
result, the study results were unable to fully address research question #2.
The initial sampling method for the survey research was convenience sampling
via email to professional membership associations listservs, followed by snowball
sampling after an IRB-approved addendum to address low survey responses. It was
acknowledged in the study design that these sampling methods would not allow
verification of the total number of members who received the survey to calculate response
rate. Membership associations were not willing to provide data to indicate the number of
members on their listservs. Furthermore, not all members would have been eligible for the
study as the membership associations served a diverse group of providers to include both
unrelated specialties and primary care providers. Snowball sampling further reduced the
ability to track the number of eligible providers who would have received the survey link.
Adapted snowball sampling was an appropriate method to recruit a difficult to reach
population of primary care providers, but it increased the difficulty of calculating the
survey response rate. However, snowball sampling captured a diverse population of
practice providers who care for adolescents in both traditional and nontraditional settings.
Having providers included in this study from nontraditional settings presented new
considerations for the future direction of this research that may not have otherwise been
discovered.
The advantages of the recruitment strategy utilized for this dissertation research
are clear. In order to capture a diverse group of primary care providers, several different
membership organizations that capture a broad group of providers needed to be targeted.
The target area was limited to DC, MD, and VA so that the student researcher could
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collect information relative to the community where they practice and provide a
foundation for future work to implement interventions mapped to barriers within a local
region. Previous survey research in this field recruited study participants via specialty
organizations. While this resulted in a large study sample, the population is a more
homogeneous group of providers who were distributed over a wider region, limiting
opportunities to implement future targeted interventions. Additionally, this dissertation
research included PAs and NPs as providers, versus referenced research that only
targeted physician behaviors. Including non-physician providers is reflective of modern
medical practice and provides practical information to inform future interventions.
Given the difficulty in recruitment, it is possible that the data reflect selection
bias. Providers who were more knowledgeable about PCOS may have been more likely
to participate in this research. The email sent with the link to invite providers to
participate named PCOS as the point of interest in this study. It is possible that only
providers who were interested in the topic were willing to take the time to participate in
the survey. This may explain why all participants in this research reported high
agreement with the statements that PCOS is important to address in adolescents and high
motivation to change their behaviors.
Lastly, the survey instrument used for the quantitative arm of this research was
created specifically for this study. While the survey is based on previous survey research,
it is not a validated instrument to assess provider knowledge, behaviors, or
attitude/beliefs. The instrument was piloted and refined through cognitive validity
interviews, but it was not validated through a more rigorous process. The attitude and
beliefs scale is new as it was developed for this research and informed by the conceptual
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framework proposed for this research. Factor analysis to validate the scale was outside
the scope of this research. The survey instrument should be used in larger, more diverse
samples and linked with objective indicators of practice data in future research.
Despite difficulties in recruiting participants for the survey research and
limitations with low sampling, the majority of survey participants (27/52) did volunteer
to be contacted for the follow up qualitative interviews. This allowed for a relatively
large qualitative study population. With 20 pedPCPS who participated in follow-up
interviews, rich qualitative data was obtained to not only explain some of the gaps in the
quantitative research, but provide a more nuanced understanding of pedPCPs’ experience
in addressing PCOS. Additionally, diversity in the qualitative study population, with 40%
of the participants practicing in non-traditional primary care settings, likely contributed to
the divergence of themes. This allowed for the emergence of new knowledge that may be
applicable to a wider variety of medical practices. Qualitative data provided meaningful
insight regarding provider attitude/beliefs and influence of external factors related to
practice characteristics and patient factors that have not previously been reported for this
population in this field.
Recommendations/Directions for Translational Research
Two intervention strategies are proposed to address barriers identified in this research and
optimize the role of the primary care provider to address PCOS among adolescents: (1)
implementation of the ECHO platform to disseminate knowledge, increase access to
specialists, and improve provider confidence to drive individual behavior change and (2)
development and implementation of a PCOS Practice Toolkit to drive practice level
change. These interventions are supported by the literature and learning theories that best
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align with the barriers and facilitators identified in this dissertation research.
Additionally, there is alignment with research participant’s input for recommended action
to address barriers in their practice (Table 28 Ways to Address). Figure 18 Intervention
Mapping highlights the proposed intervention, barriers linked to the intervention, and
influence on behavior change.
Figure 18
Intervention Mapping

Intervention Mapping Continuum

Intervention

Impact on
Barriers and
Facilitators

ECHO Model

Provider knowledge
Provider confidence
Provider interaction
Access to specialists

Development of PCOS
Practice Toolkit
Knowledge creation
• Develop protocols /
algorithms
• Develop patient-centered,
age and culturally appropriate
education resources for
patients and
parents/caregivers
• Develop PCOS Champion
handbook

Individual Change

Implementation of
PCOS Practice Toolkit
Practice knowledge
Provider confidence
Patient-provider
communication
Interdisciplinary
interaction
Address limiting practice
structures / policies
Practice Change

Behavior Change

This dissertation research has established the important role of the primary care
provider to address PCOS among adolescents. Previous research studies highlight
significant gaps among specialty provider knowledge in addressing PCOS in both adult
and adolescent populations (Bonny et al., 2012; Conway et al., 2014; Dhesi et al., 2016;
Dokras et al., 2017). Recognizing similarities and differences between past study findings
and this dissertation research reveals an important role for primary care providers to
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address aspects of PCOS that may not otherwise be managed by gynecologists and/or
may be difficult to refer to endocrinologists due to provider shortages. Gaps in
knowledge among specialty providers are grouped around metabolic and mental health
complications of PCOS (Bonny et al., 2012; Conway et al., 2014; Dhesi et al., 2016;
Dokras et al., 2017); these two areas present significant concerns for long-term health and
are appropriate to be addressed in a primary care setting. Therefore, the proposed
interventions should be focused on establishing accurate diagnosis of PCOS among
adolescents in order to identify those at risk for long-term health complications and
management of metabolic and mental health conditions associated with PCOS.
Additionally, previous research has recognized a gap in understanding optimal models of
multidisciplinary care to address the complexity of PCOS in adolescents (Bonny et al.,
2012; Conway et al., 2014; Dhesi et al., 2016; Dokras et al., 2017). Future interventions
should include opportunities for interprofessional learning and collect data to inform
optimal models of care. Finally, the proposed intervention should link to the practice
barriers identified in the research (Straus et al., 2013). Key barriers identified in this
dissertation research that will be the focus of the proposed intervention include: lack of
knowledge, lack of pedPCPs confidence, limited access to specialty care, and rigid
practice policies.
ECHO Model
The ECHO model is a professional development module of education that utilizes
videoconferencing to connect leaners to specialists across distance and various settings
(Cuttriss, 2020). Several studies have demonstrated the effectiveness of the ECHO model
as an effective continuing professional development tool to improve provider knowledge,
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skill, confidence, and ultimately patient outcomes (Cuttriss, 2020, Zhou 2016, Arora,
2017, Stephens 2019; Furlan 2018). Similar to the population of interest for this
dissertation, the ECHO model has been supported in addressing diabetes in a pediatric
primary care setting where primary care providers needed to take on a more advanced
role in care delivery due to limited access to endocrine specialists (Cuttriss 2020). The
ECHO intervention links to the following barriers and facilitators identified in this
dissertation research: knowledge gap, lack of provider confidence, lack of access to
specialty care, and lack of opportunity for provider interaction.
The ECHO model engages providers/learners frequently over a designated period
of time to deliver the intervention via a videoconferencing platform. The specific
structure includes a brief lecture by an expert and case consultation that will take place
between a primary care provider and endocrine specialist. The brief lecture provides the
opportunity to disseminate knowledge regarding adolescent-specific PCOS guidelines.
Case consultation allows for provider collaboration and addresses barriers related to
access to specialty care.
The ECHO model aligns with adult learning theories that state that individuals
have better learning outcomes and are motivated to change their behavior when they are
exposed to a problem-based learning activity (Grol, 2013). ECHO would allow pedPCPs
to bring actual patient cases to discuss and receive guidance from specialty providers.
The ECHO model is effective to reach higher learning objectives and has proven impact
on provider behaviors. In fact, research on the ECHO model has demonstrated
effectiveness in increasing clinical capacity (Stephens 2019) and changes in practice
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behavior that have impacted both patient- and community-level health outcomes (Zhou
2016).
Specific objectives for the proposed ECHO activity include: (1) increase pedPCP
knowledge of adolescent-specific guidelines for the diagnosis and management of PCOS;
(2) apply adolescent-specific guidelines for the diagnosis and management of PCOS to
primary care practice; (3) improve pedPCP confidence in establishing the diagnosis of
PCOS and managing treatment of PCOS; (4) support collaboration among a
multidisciplinary team to manage PCOS in adolescents; (5) improve pedPCP capacity to
manage PCOS in areas with limited access to specialty care; and (6) improve adolescent
patient PCOS outcomes.
Development and Implementation of PCOS Toolkit
Experience and expertise gained by providers and clinical staff who participate in
an ECHO intervention could be scaled up to develop a PCOS practice toolkit as a second
phase of this intervention. A PCOS practice toolkit would contain point of care resources,
evidence-based patient education resources, and training materials to engage clinical staff
and other healthcare professionals in collaborative practice efforts to address PCOS.
Several resources and interventions proposed by pedPCPs as “Ways to Address” barriers
align with the proposed content of this toolkit: adolescent-specific practice algorithms,
patient and parent/caregiver educational resources that are age and culturally appropriate,
and a PCOS champion handbook (to develop practice PCOS Champions).
A PCOS practice toolkit will help to disseminate knowledge of adolescentspecific guidelines, and address barriers to applying knowledge to practice that have been
identified by this dissertation research. Additionally, the toolkit will address barriers that
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may not be addressed by the ECHO intervention. Specifically, this intervention is
mapped to address barriers related to knowledge, provider confidence, patient-provider
communication, lack of multidisciplinary care by increasing interdisciplinary interaction,
and limited practice structure/polices (see Figure 18 Intervention Mapping).
Development of the toolkit would require input from content experts and
additional research to inform its development. First, knowledge generated from this
dissertation research provides the first step in identifying barriers, understanding context,
and identifying the problems. These are key elements to a knowledge to action
framework (Ward et al. 2012). Second, a mix-method evaluation design to assess
activities of the proposed ECHO model could provide measures of effectiveness to
address initial barriers and impact behavior change. Third, patient and caregiver
perspective is vital. Suggested next steps for this research include phenomenology studies
to understand how adolescents and parents/caregivers experience the diagnosis,
management and living with PCOS. Additionally, a community-based participatory
research model could be used to incorporate the voices of adolescents, parents/caregivers,
and other stakeholders.
Schippke and colleagues (2017) provide an example of a toolkit developed to
provide support for parents of children with disability and complex medical needs.
Development of the toolkit included focus groups and community-based participatory
research to identify best practices in peer support programs to address an unmet need in
clinical practice (Schippke et al., 2017). Practice toolkits have been identified as a way to
effectively disseminate knowledge and effect change in clinical outcomes (Yamada et al.,
2015). It is vital, however, that the development of the toolkit be informed by high-
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quality evidence and targeted research to inform the content (Yamada et al., 2015), as
suggested above regarding future research.
It is also proposed that the PCOS toolkit will include training a practice PCOS
Champion who will help individual practices identify and improve their own gaps in care.
This also provides the opportunity for a dedicated staff member to become trained to
address some of the more complex topics related to PCOS such as lifestyle interventions.
This concept is similar to the Centers for Disease Control and Prevention diabetes
prevention programs and champion toolkit (CDC, 2020), where healthcare professionals
in a practice community receive specialized training to lead a lifestyle change program
for patients at risk for developing diabetes. Another example, more closely related to
adolescent health, is the Got Transition program (Got Transition, 2021). Got Transition is
a federally funded national resource center aimed at helping youth and young adults
transition from pediatric to adult care (Got Transition, 2021). Got Transition contains
online resources for patients and parents/caregivers, and clinician education and
resources.
Specialty and primary care focused professional organizations could be
approached to fund and lead this effort. PES (2017) has started to provide resources on
their website targeting primary care providers. Specifically, a brief guide has been
developed to inform primary care providers of the appropriate evaluation for adolescents
with suspected PCOS (Kamboj & Indyk, 2019). Knowledge gained from this dissertation
research can inform specialty organizations, such as PES, of the barriers and facilitators
to optimal care of adolescents with PCOS and help focus future efforts to collaborate
with primary care practices.
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Conclusion
PedPCPs can play an important role in the identification, diagnosis, and
management of PCOS in adolescence; especially in filling gaps in care to address
metabolic and mental health complications of PCOS. Application of a barrier assessment
framework, combined with behavior change models, revealed several factors, beyond
knowledge, that influence primary care provider practice in addressing PCOS among
adolescents. Interventions to overcome practice barriers, and optimize the role of the
pedPCP, should include continuing medical education activities that are case based and
allow pedPCPs to collaborate with experts. Long-term interventions should include the
development of evidence-based practice resource that can be utilized by a
multidisciplinary healthcare team and guide practice level change. Implementation of a
practical tool-kit that includes resources for providers and clinical staff as well as
patient/parent educational information can address barriers related to practice policies and
patient factors. Improving the capacity of primary care practices to diagnose and manage
PCOS in adolescence is key to optimize care for adolescents and reduce risks of
immediate and long-term complications of PCOS.
This dissertation research advances the knowledge in this field by demonstrating
the role of the primary care provider in the diagnosis and management of PCOS among
adolescents. The findings underscore a crucial need to not only disseminate emerging
knowledge regarding PCOS in the adolescent patient beyond the specialty literature, but
to also focus on primary care practice-level interventions to affect change that will
improve patient health and long-term population-health outcomes among adolescent
patients. This research provides new and valuable information regarding barriers and
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facilitators to practice, across a diverse group of providers and a variety of practice
settings that can be used to inform future research to investigate optimal models of care
for adolescents with PCOS.
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APPENDICES
Appendix A. Survey Instrument

Pre-survey questions to capture inclusion/exclusion criteria
1. Are you a licensed physician (MD or DO), physician assistant (PA), or nurse
practitioner (NP)?
2. Do you practice in an outpatient primary care practice in the District of Columbia,
Maryland, or Virginia?
3. Does your patient population include adolescent (12-17 years of age) females?
The survey will only continue after the participant responds yes to each of these
questions. If the participant respond “no” to any of these questions, they will receive a
message that they do not met inclusion criteria to continue the survey.
Provider Characteristics
1. What is the designation of your medical license?
MD
DO
PA
NP
Other______
2. How many years have you been in clinical practice (include residency or
fellowships years)?
__ Less than 1 year
__ 1-5 years
__ 6-10 years
__ 11-20 years
__ >20 years
3. Are you currently in a post-graduate clinical training program?
__ No
__ Yes
If yes: What type of training program?
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__Physician residency program
__Physician fellowship program
__PA/NP residency/fellowship program
4. What is the gender with which you most identify?
__Male
__Female
__Trans-female
__Trans-male
__Gender-fluid
__Agender
__Rather not say
__Other (please state) _______________
5. What is your age category?
__20-29 years
__30-39 years
__40-49 years
__50-59 years
__> 60 years
6. What is your ethnicity (check one)?
__Hispanic/Latino
__Not Hispanic/Latino
__Prefer not to answer
7. What is the race with which you most identify?
__White
__Black/African American
__American Indian/Alaskan Native
__Asian
__Native Hawaiian/Pacific Islander
__Two or more races
__Prefer not to answer
__Other (please state)__________
Practice characteristics- The next set of questions refers to your primary clinical position.
“Primary clinical position” refers to the clinic position at which you work the most hours
during the work week.
1. Which of the following best describes your primary area of clinical practice?
__General pediatrics
__Adolescent medicine
__Internal medicine
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__Family medicine
__Other_______
2. Which of the following best describes the type of practice setting where your
primary clinical position is located:
__Office-based private practice - solo
__Office-based private practice - single specialty physician group
__Office-based private practice- multi-specialty physician group
__Hospital (non-government) based outpatient clinic
__Hospital (government/military) based outpatient clinic
__Academic medical center clinic
__Military clinic
__Community health center (Federally Qualified Health Center)
__Community health or free clinic (non-federally qualified)
__Health department clinic
__Rural health clinic (federally certified)
__School clinic or college health center
__Urgent care
__Other_________________
3. What is the location of your primary practice setting?
_District of Columbia
_Maryland
_Virginia
__My primary practice is divided between more than one of the above.
Please specify________
4. Which of the following best describes the region of your primary practice?
__Urban
__Suburban
__Rural
___ My primary practice is divided between more than one of the above.
Please specify________
5. What percentage of the patients in your practice are between the ages of 12-17
years?
___1-25%
___26-50%
___51-75%
__ 76-100%

6. What percentage of adolescent patients (ages 12-17 years) in your practice are
either uninsured or covered under public/Medicaid insurance?
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___1-25%
___26-50%
___51-75%
__ 76-100%
7. Estimate the current percentage of your patients who are in the following ethnic
groups. (Responses must add up to 100%)
__Hispanic
__Non-Hispanic
__Other (please specify________)
8. Estimate the current percentage of your patients who are in the following racial
groups. (Responses must add up to 100%)
__White alone
__Black/African American alone
__American Indian/Alaskan Native alone
__Asian alone
__Native Hawaiian/Pacific Islander alone
__Two or more races
__Other (please state)__________
Provider Practice Behaviors - The next set of questions refers to female patients you see
in your primary clinical practice between 12-17 years of age.
1.Estimate the number of female patients age 12-17 years old that you see in your
practice annually?
__<50
__³50
2. When do you inquire about menstrual irregularities (check all that apply)?
__Well-patient visits
__ If there is a complaint related to the menstrual cycle
__If there are complaints related to metabolic abnormalities (E.g.
obesity)
__ All encounters regardless of complaint
__I never inquire about menstrual irregularities
__Other____________________
Estimate what percentage of patients have menstrual irregularities?
__0%
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__< 10%
__11-25%
__26-50%
__51-75%
__> 75%
__unknown
3. Do you have patients with a diagnosis of polycystic ovary syndrome (PCOS)?
__No (skip to part B)
__Yes
If yes, estimate the number of patients (age 12-17 years old) you see
with PCOS annually?
__ <25
__25-50
__51-100
__>100
4. What tests do you order in evaluating a patient for PCOS (check all that apply)?
__Thyroid function tests (TSH, free T4)
__Prolactin
__17-OH progesterone
__dehydroepiandrosterone sulfate (DHEAS)
---Random urine cortisol
---24-hour urine cortisol
__Adrenocorticotropic hormone (ACTH)
__Follicle stimulation hormone (FSH)
__Lutenizing hormone (LH)
__Estradiol
__free testosterone
__total testosterone
__Sex hormone-binding globin (SHBG)
__lipid panel
__fasting blood glucose
__hemoglobin A1C
__Ultrasonography (or other imaging of ovaries)
__Other_______
__I do not carry out my own evaluations for PCOS in my practice (skip to
question #6)
5. Will you diagnose PCOS within two years of menarche?
do not diagnosis PCOS

___Yes ___No __I

6. Are you aware of diagnostic criteria for PCOS? ___Yes ___No
If yes, what diagnostic criteria are you familiar with?
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__ NIH criteria (1990)
___Rotterdam criteria (2003)
__ __Androgen Excess Society criteria (2006)
__Amsterdam criteria (2012)
___Endocrine Society criteria (2013)
__Pediatric Endocrine Society criteria (2015)
__Other (please specify)
7. Do you the treat/manage PCOS in your practice?
___Yes
___No (skip to question # 10 )
8.What treatment do you prescribe/recommend? (check all that apply)
__Lifestyle/behavior modifications for weight loss
__Hormonal contraception
__Metformin
__Anti-androgens
__Cosmetic procedures such as laser depilation
__Referral to specialist
__Other_________
9. What are your treatment goal(s) for adolescent patients with PCOS? (check all
that apply)
__Normalize BMI (weight loss)
__Resolve facial hirsutism and/or hair loss
__Acne control
__Normalize menstrual cycles
__Decrease androgen levels
__Improve markers of cardiometabolic health
__I don’t know
__Other____________________________
10. Do you screen patients with PCOS for complications associated with PCOS?
Yes__
No__ (skip directly to #11)
If yes, what do you screen for? (check all that apply):
__Hyperlipidemia
__Obesity
__Insulin resistance
__type 2 diabetes
__Hypertension
__Depression
__Anxiety
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__Other__________
Do you screen patients with PCOS for complications of PCOS
regardless of BMI? Yes____ No____
11. Do you refer to a specialist for consultation in diagnosing or treating PCOS?
__Yes (go to question #12)
__No (skip to question #13)
12. What type of specialist do you refer to? (check all that apply)
__Endocrinologist
__Gynecologist
__Nutrition counselor/dietician
__Behavioral Health provider
__Adolescent medicine provider
__Other (please be specific)__________________
(then skip #13 and go to #14)
13. Which of the following best describes the reason that you do not refer to a
specialist? (select one that best applies)
__Lack of specialty resources in my community
__I feel confident in my practice to diagnosis and treat most cases of PCOS
__Other______________
14. Do you screen adolescents with PCOS for anxiety and depression? Yes__ No__
If yes, what screening tool do you use? (select all that apply)
__PHQ-2
__PHQ-9
__Columbia Depression Scale
__Kutcher Adolescent Depression Scale – 6 item
__Strengths and Difficulties Questionnaire (SDQ)
__Pediatric Symptoms Checklist (PSC-17 or PSC-35)
__PROMIS scale
__other_______
15. In the past year, have you participated in any professional activities (e.g. CME)
regarding PCOS in adolescents?
Yes____ No____
If yes, what was the activity:
__ reading journal article
__online CME
__ in person CME lecture
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__other________________
16. Would you like to learn more about PCOS in adolescents? Yes____ No____
If yes, what format/type of activity would you participate in?___________
Part B- for responses that indicate none of their patients have a diagnosis of PCOS.
5. Which of the following best describes why you do not have female patients 12-17
years of age in your practice with a diagnosis of PCOS? (select one that best
applies)
__Lack of patients who meet diagnostic criteria
__I do not have the knowledge needed to diagnosis PCOS
__I have the knowledge to diagnosis PCOS, but I am still not comfortable with
making the diagnosis
__Other________________________
6. Are you aware of diagnostic criteria for PCOS?

Yes____ No____

If yes, what diagnostic criteria are you familiar with?
__ NIH criteria (1990)
___Rotterdam criteria (2003)
__ __Androgen Excess Society criteria (2006)
__Amsterdam criteria (2012)
___Endocrine Society criteria (2013)
__Pediatric Endocrine Society criteria (2015)
__Other (please specify)
7. In the past year, have you participated in any professional activities (e.g. CME)
regarding PCOS in adolescents? Yes____ No____
If yes, what was the activity:
__ reading journal article
__online CME
__ in person CME lecture
__other________________
8. Would you like to learn more about PCOS in adolescents? Yes____ No____
If yes, what format/type of activity would you participate in?_________________
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Provider Attitudes and Beliefs
Please rank your agreement with the statement below (Likert Scale for level of
agreement):
strongly disagree (1); disagree (2); neutral (3); agree (4); strongly agree (5)
1.
2.
3.
4.

PCOS is a condition that impacts my adolescent patient population.
PCOS is an important condition to identify among adolescent patients.
PCOS is associated with significant health complications for adolescents.
PCOS is associated with mental health complications of anxiety and depression in
adolescents.
5. There is benefit to patient health outcomes if PCOS is addressed in adolescents.
6. Practice guidelines for the diagnosis and management of PCOS are supported by
evidence based medicine.
7. I have the ability to accurately diagnosis PCOS in adolescents.
8. I have the ability to effectively manage PCOS in adolescents.
9. I have the support needed in my practice to diagnosis and manage PCOS in
adolescents.
10. I have the specialty support needed in my community to diagnosis and manage
PCOS in adolescents.
11. Learning more about PCOS would change my practice behaviors.
12. Resources are available to learn more about the diagnosis and management of
PCOS in adolescents.
13. My colleagues in primary care practice are actively involved in the diagnosis and
management of PCOS in adolescents.
14. PCOS is mostly diagnosed and managed by specialists.
15. I would like to improve my practice behaviors in addressing PCOS among
adolescents in my practice.
16. I intend to change my practice behaviors in addressing PCOS among adolescents
in my practice.
A follow up phase of this study will involve individual interviews with primary
care providers to better understand barriers and facilitators to the identification, diagnosis
and management of PCOS among adolescents in a primary care setting. If you are willing
to be contacted for a follow up interview, please provider your name and preferred
contact information. Your contact information will be kept confidential and only used for
purposes of requesting your participation in a follow up phase to this research. It will not
be shared for other research or other purposes.
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Appendix B. Qualitative Interview Guide

Current behaviors
1. Tell me about your practice and how you are currently addressing PCOS in the adolescent
patient.
2. Describe the typical patient for whom PCOS is on your differential diagnosis.
• How do patients with a concern for or symptom of PCOS access care?
3. Tell me about your standard diagnostic work up for PCOS.
• What tests?
• What is the process?
• What informs the diagnostic tests you select?
4. How do you treat/manage PCOS in an adolescent patient in your practice?
• What is the process?
• What informs your management plan?
• How do patients and their parents/caregivers respond to treatment/management?
5. How do you address potential long term complications of PCOS with your adolescent
patients?
• How do patients respond to this?
6. What specialists do you engage with to address PCOS and what is that process?
• How do you think this works for patients?
• What other disciplines do you engage beyond clinical specialist (i.e.
dieticians/nutritionists, psychologists, alternative medicine professionals, etc. – if
other disciplines are not mentioned as specialists)
Attitude/beliefs
7. How important is it that PCOS is addressed in adolescents? Why?
8. What are advantages and disadvantages to addressing PCOS in adolescents?
Intention/Motivation to change
9. How would you like to change your current practice in regard to addressing PCOS?
• What would you need to change your practice?
External factors
10. How are your colleagues in your community addressing PCOS?
11. What factors, outside of your practice setting, influence how you address PCOS?
How do these factors influence you?
Other
12. Any further thoughts about the diagnosis and management of PCOS in adolescents?
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Appendix C. Qualitative Categories and Codes

Appendix B

Provider
Interaction

Practice
structure and
policies
Restrictive
practice policies

Provider
Behavior
Evaluation
Provider
discomfort with
treatment
options

Provider
perception of
patient factors
Parent/caregiver
influence

Provider
confidence
with treatment
options
(comfort plus
perceived
benefit)

Patient health
seeking behavior

Provider/
practice
education

Improve practice
support

Limited patient
exposure

Addressing
complex topics

Barriers

Categories and Codes
Establishing
the
Diagnosis of
Access to
PCOS
specialty care
Delay in
Specialty
identification Provider
Shortages
Confusion
with
Lack of options
diagnostic
for multiguidelines
disciplinary care
Concern with
missing other
symptoms

Proximity to
specialists

Ways to Address

Facilitators

Harms of
labelling
Point of care
resources

Point of care
protocols
Provider
education/
training

Guidance from
senior providers

Safety net
programs

Peer
Collaboration

Patient exposure

Provider
Education/
training

Collaboration
with Specialists
Provider
Education/
training

Collaboration
with Specialists

Collaboration
with Specialists
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Improve
Practice Support

Improve
practice
support

Resources for
providerparent/caregiver
communication

Appendix D. Qualitative Codebook
Category: Establishing the Diagnosis (Definition: Confusion and/or lack of knowledge about
guidelines, delay in recognition of key clinical manifestations of PCOS and concern about
missing a diagnosis as barriers to diagnosis. For facilitators, participants report utilizing point
of care resources, although there still may be ambiguity.)
Code: Delay in Identification
Subcode: Under recognition of symptoms (Providers do not inquiry about symptoms, and/or
overlook or normalize symptoms.)
I really, I think it’s very under recognized. I feel like that people don’t really put that NP,
high on the differential if people are coming in with these complaints, maybe
family,S
overweight, maybe depressed, maybe irregular cycles, that kind of thing, people
don’t put that at the top of their differential typically. (ID32)
I feel that a lot of time, menstrual cycle questions are often overlooked. For example,
if an adolescent is there for a sports physical, menstrual cycle is not normally a point
of question, it is a check box on a sports physical form if they have started their
period.(ID40)

NP,
peds, U

As providers, we’re not always the best at asking about last menstrual cycle when
people come in for acute things or it could be something like… I always tell my staff
“that’s a vital sign too you know”. (ID19)

PA,
family,S

I just think it doesn’t get addressed. I think it doesn’t come up. I think it gets missed a
lot and people just get their symptoms covered up one at a time. (ID01)

PA,
family,S

I think sometimes we have kiddos who are starting with symptoms of PCOS and even PA,
starting menstrual periods as early as eleven and so not waiting until they’re sixteen peds,R
and a little older to make those identifications. I feel like sometimes those kids could
have been identified a little sooner... (ID25)
Subcode: Treatment masking symptoms (Treatment used to manage other conditions and/or
patients utilizing cosmetic treatments mask signs/symptoms of PCOS)
We’re really focused on contraception with those teens [teen moms] it’s like a focus
MD,
so a lot of them are on contraception so evaluating their menstrual cycles is a little
peds,U
bit difficult. So I don’t think it’s common to be thinking about or talking about PCOS.
(ID69)
I do find that people who are over sixteen have been having this for years like they’re
used to having some of this stuff, the excess facial hair, the acne and so they don’t
necessarily bring it up and that’s when you’re asking about hirsutism they’ll like “oh
yeah I do like wax and do all these things and it is bothersome to me and the acne is
bothersome.”(ID69)
…I think there’s kind of like a delay in workups sometimes. I wish we looked earlier
for, or tested more people I guess I would say because I feel like once you see like
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PA,

someone comes in with hirsutism and they’re having menstrual irregularities and
family,
they’re over weight that becomes oh maybe it’s this and we can work it up. But when R
you have that patient who’s just a little bit overweight and they’ve got some acne and
their menstrual periods are regular but they’re already on birth control or they have
NEXPLANON and they just think it’s that. I do think that we could test for it more
because I do think it is more common then. (ID29)
I think sometimes PCOS gets a little bit lost in general adolescent health of
NP,
preventing pregnancy (ID40)
peds, U
Subcode: Normalizing symptoms (Providers normalize menstrual irregularities in the
adolescent population.)
Would definitely say I’m sure we don’t really do that enough [to diagnosis PCOS].
PA,
And part of it if we don’t ask and they don’t want to bring up the periods or their
family,
vague or we just think it’s just your period being abnormal because you’re a
S
teenager then it probably doesn’t get addressed quite as often as it should because
obviously, some of them have PCOS and we probably don’t know. (ID71)
I think we normalize an irregular menstrual period or we normalize a little bit of
overweight when they’re still young; eleven, twelve, thirteen but then by the time
they’re sixteen and it’s more of a significant issue it’s already fostered itself for a
while so making it a part of that regular conversation that we have with kids a little
earlier. (ID25)
So, I would say, I know sometimes in the teenage population it’s hard anyway since a
lot of them will have abnormal periods, or irregular, I shouldn’t say abnormal but
irregular periods. (ID71)

PA,
peds, R

PA,
family,
S

Code: Confusion about diagnostic guidelines (Adolescent-specific guidelines are not clear or
known to the provider.)
I do think every physician will probably tell you like a different lab workup that they MD,
do initially and would definitely be like I have to look that up. Every time, I get
peds, U
confused; I’m not sure which one. (ID69)
I think it’s kind of difficult, and this could just be myself that I haven’t really found
the best resources, adolescents versus adults I think it’s kind of hard to find
distinguishing factors to do that. (ID29)
Okay so the thing with the twelve to fifteen age range is a lot of times girls are
getting their periods for the first time and it’s pretty typical to have irregular periods
like after the first two years from menarche so I would say probably twelve to fifteen
PCOS, it’s just too hard to diagnoses at that time, at that age. (ID01)

PA,
family,
R
PA,
family,
S

I’m not super comfortable with those labs tests. I’ve ordered them for some families
and been able to walk my way through that with them as needed but from a comfort
level perspective if I really think it’s going to be a significant diagnosis or
something’s that going to require more than just maybe a birth control pill then I
may refer that out. (ID25)

PA,
peds, R
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But I don’t think a lot of parents, adolescents or even providers have much of a
perspective on how to actually look for it and how to actually direct the patient in the
right way; which specialty to refer to, what exactly the workup is that kind of thing.
(ID32)
I think it seems the diagnosis and management there’s so many options, there’s so
many different guidelines and input. Yeah I think it’s an interesting topic that I think
can be approached many ways. There probably is a best practice but it seems to me
there’s a couple (ID40)
I think in general there’s not enough comfort with this diagnosis. And I think a lot of
people probably, especially because we have the adolescent doctors who come to our
clinic, I think a lot of people probably refer to the adolescent docs. (ID69)
I do think every physician will probably tell you like a different lab workup that they
do initially and would definitely be like I have to look that up. Every time, I get
confused; I’m not sure which one. (ID69)
I feel like I’ve been to lots of talks and with PCOS there’s just so many different
diagnostic criteria and so sometimes patients don’t necessarily meet all of them.
(ID47)

NP,
family,
S
NP,
peds, U
MD,
peds, U

MD,
peds, S

And I think too recently I’ve heard talk, and you kind of mentioned this in labeling or
giving the diagnosis of PCOS, one of my colleagues had gone to the AAP conference
and they were saying that, I don’t know if the criteria or things had been changed,
but typically they’re not necessarily giving girls the diagnosis or they’re no longer
doing that before the age of eighteen. So it was some talk she went to and then she
came back and said “yeah there’s now new data that they’re not wanting to label
PCOS before the age of eighteen. (ID47)
And, maybe better, I would like it if we could do a lot of the workup in the primary
PA,
care setting. I feel that my supervising physician doesn’t feel so comfortable with
peds, S
once the labs come back and maybe one thing is abnormal I don’t think that in
general she or we would be doing much of the workup from there I think we would
just refer but I don’t know if that’s necessary. (ID54)
Code: Concern with missing other endocrine disorders (Providers are concerned with missing
other endocrine or gynecologic diagnosis that presents similar to PCOS)
“I think anything with endocrinology feels a little bit like oh we’re already getting
MD,
into something a little scary or a little like nebulous and a little confusing I think that peds, U
part of it is not wanting to miss other things that can mimic PCOS. …. just not having
that kind comfort and so feeling like they should see a specialist whether it’s
adolescent or endocrinology first. I think that feels like a barrier.” (ID69)
Now you know part of the management for PCOS because they’re at high risk of
MD,
insulin resistance and things like that is putting them on Metformin and that’s
peds, S
something that a lot of times these patients may already be on at our clinic so that’s
something I’m comfortable managing but often I would have them just see
gynecology just to make sure there are not other reasons that they’re having irregular
menstrual, amenorrhea in some cases. (ID47)
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Code: Harms of labelling (Providers are concerned with potential harm to adolescent by
receiving a diagnosis of PCOS)
So, I kind of have mixed feelings about it. I think from an overall health aspect it’s
PA,
really important but I also think that the diagnosis comes with a psychological
family,
component that I worry that my adolescent patients don’t handle as well as if they
R
were older so I think that’s always a tough conversation. (ID29)
I think sometimes in adolescence especially the disadvantage would be kind of a
PA,
stigmatism of having PCOS and especially with the hirsutism being a part of it. But I family,
don’t know I guess they may tend to feel like there’s something wrong with them.
S
(ID01)
…from a mental health standpoint of placing this in their mind that there can be
PA,
something wrong when it may not be an actual diagnosis but more of a benefit than a fam, U
disadvantage. (ID31)
Depending on how old the patient is, learning that they have a chronic disease so
PA,
early in life, can I think affect their mental health. (ID07)
family,
R
I think the diagnosis comes with a little bit of depression so that just becomes a lot
PA,
for that age group to accept. (29)
family,
R
Code: Point of Care Resources (Providers utilize point of care resources as a guide for
diagnostic evaluation of PCOS)
So I usually would look up the criteria just to determine where I am in the process
PA,
and what I may need to add to any panels. (ID36)
family,
U
I think I would like to see other guidelines are out there, other than just using
PA,
UpToDate, which I think is pretty up to date, but it just to make sure that I am on the family,
right track. (ID07)
R
So that is the main reason that UpToDate is our go to is because it’s a collection of
PA,
many different associations, evidenced based, to be able to practice accurately. So,
family,
where else I would go other than the associations that are collected with UpToDate
U
that would be it for me. (ID31)
So I really I go to UpToDate which has the guidelines from I think it’s the adolescent MD,
health, no maybe it’s the endocrinology guidelines. (ID69)
peds, U
Honestly I probably usually check for updates in things like Epocrates and stuff to
PA,
see if it’s changed recently or whatever when it comes up. (ID71)
family,
S
I kind of have my own things, favorites that I may have used in the past if I have to
PA,
look it up. I would look it up on UpToDate as well though to see what the actual
family,
recommendation is versus what I was thinking, just kind of compare the two, yeah.
U
(ID36)
Clinical guidelines – obtain information from/reference UptoDate. (ID15)
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PA,
family,
S

So typically I’ll get, and usually I have to, because I don’t do this I would say it’s not
something that I’ve seen every single day usually I do have to look at UpToDate.
(ID47)
I usually will go on to UpToDate. Depending, so that’s my first line after that I would
go on UpToDate and use like whatever algorithms they have. (ID54)
Category: Access to Specialty Care (Definition: Availability of specialist for
consultation and multidisciplinary care (nutrition and behavioral health services)).
Code: Specialty provider shortages
Endocrinology, we don’t have pediatric endocrinology here in town. They PA,
have to go down to Richmond to VCU. (ID19)
family, S
And then we also live quite a distance from specialty care so most of our PA, peds,
pediatric specialty care can be, or some of it can be up to an hour’s drive. R
And then in those instances we try to keep those families in house. So we
do have some other providers in our offices that are a little more
comfortable and provide more GYN services it’s just sometimes we’ll lean
on them internally to get some help for those families. (ID25)
The distance, the specialty care if we were to feel like we needed that
piece would be a challenge because it’s far for a lot of our families.
(ID75)

PA,
family, R

There are only 2 endocrine physicians in town. Takes 9-12 months for a
new patient appointment. (ID15)
We don’t have Peds endo in the county so it’s within the health system
locally but they would have to drive for that out of county so that’s why we
usually get stuck with just GYN and we only have two GYN providers,
one’s a group and one’s an individual. And we’ve had some significant
turnover with OBGYN groups. (ID16)

PA,
family, S
PA,
family, S

Yeah so that’s been difficult because like I said this is a rural community
where I work at so we don’t have as many specialists. And so when we do
refer out often that requires some travel and not all of our patients have
transportation readily available to them so that definitely requires us to
get social work involved or a case worker to help with that so I do say
there’s definitely a delay in those kind of visits. (ID29)
In my area, some of the GYN don’t like to manage PCOS they would
rather that a primary care or an endocrinologist manage that. So, in the
absence of having cystic ovaries they don’t really manage, they refer back
to the primary. I’ve had a couple of people who said their gynecologist
refused to give them Metformin or anything else then they’d come back to
us and we’ve done it.
(ID19)

PA,
family, R
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PA,
family
med, S

MD,
peds, S
PA,
peds, S

I have had experience with a gynecologist wouldn’t really address
anything and just tells them to follow back up with us. (ID71)
Often times patients will come back from a specialist and I won’t have
notes, I’ll have to dig for them. There’s not a lot of counseling going on so
the patients are confused about why they’re taking what they’re taking.
And so I would like to see more collaboration. (ID57)

PA,
family
med, S
NP,
family,
S&R

Code: Limited options for multidisciplinary care (Limited options for nutrition and/or
behavioral health both due to availability for these services and insurance coverage for
these services)
We struggle with nutritionists, just the availability of them in our area.
PA, peds,
(ID25)
R
I don’t know if I ever did a psychologist but definitely a nutritionist and
PA,
dietician. If I could get their insurance to cover it, which was a problem a family, S
lot of the times. (ID01)
as far as like counseling and nutritionists go it’s just patients with their
insurance sometimes have very poor coverage for those services so
depending on financial ability sometimes patients just don’t have, you
know that’s a little bit different than just paying your consultation fee to
see a specialist there’s a higher cost associated with those resources.
(ID19)

PA,
family, S

I think one of the reasons is a lot of us don’t use dieticians as much for
anybody, is that a lot of insurances won’t cover it. (ID71)
Behavioral is tough because in Southern Maryland we just don’t have the
horses down there so that one can be a little difficult. (ID57)

PA,
family, S
NP,
family,
S&R
PA,
family, S

It is 3-6 months for a mental health appointment in the community. I have
never considered a mental health appointment for PCOS. I would like to
use nutrition services, but those are not easy to access. There is only one
nutritionist at the hospital, other than private pay nutrition services.
(ID15)
So there are options for nutritionists, that would be, I generally wouldn’t
go that route unless it’s, like I don’t start with that just with a diagnosis
unless that’s something that’s like if they’re morbidly obese or if they’re
really having concerns. But those are difficult appointments to get in and
to get covered sometimes. (ID29)
I think getting patients onboard with that is difficult just because a lot of
our patients have a hard time getting to appointments anyway and it’s
something that a lot of people just don’t think that they need that that’s
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PA,
family, R

something that they think they can do on their own. So I think that’s, for as
much as when we do use nutritionists for other health issues in general I
would probably say fifty percent of our patients maybe go to those
appointments. (ID29)
with them taking all insurance, taking Medicaid because it’s in the system MD, peds,
I think it’s pretty easy for them to get a referral. And I’ve never had
S
patients say it’s not covered. I think on the flip side it would be maybe
some of the patients that have private insurance that may not have great
coverage that are probably more concerned about the expense of seeing
specialists and in particular if gynecology is wanting them to get an
ultrasound or something those are things that may not be covered. (ID47)
I do not generally refer to nutritionists or dietitians; I would like to, but,
not just for PCOS, I find that a lot of patients aren’t able, you know, their
insurance does not cover it. (ID07)

PA,
family, R

Code: Proximity to specialists (References the location of the practice setting in
relation to specialty providers such as gynecologists and endocrinologists)
..so it’s kind of a cohort where I think a lot of the doctors have affiliations MD, peds,
with [named removed for confidentiality] and [named removed for
S)
confidentiality] so a lot of the physicians will work amongst the two
institutions but it’s located in northern Virginia, which the private
practice I work at is in northern Virginia so it becomes a lot more
convenient in terms of referrals for them to go there versus a lot of times
having to go to main campus. (ID47)
The big hospital systems are here and then we do have some outpatient
PA, peds,
whether it be endocrinology or OBGYN, there’s a lot of private practices
S&U
too. And I feel like most of the practices are larger and so I think that they
[patients] are able to get in easier than perhaps some other places”
(ID50)
…we reach out to the local hospital systems, they both have
endocrinology, so they can kind of take over things once we’ve done that
initial evaluation. Or in some cases they’ll say “hey do you mind starting
an oral contraceptive?” Or “I feel like this patient would benefit from
metformin.” And we might do that and then hand off that from there.
(ID50, PA, peds, R&U)
I feel like I’m lucky because my primary care clinic has a lot of
subspecialists in this area so I feel like I can consult with some of the
attending in my teams for more advanced questions so I’ll often involve
them when I need to. (ID40)
We have several local groups I usually see where they would be interested
in traveling to and then I give them the contact information and they call
and make an appointment and probably they get in within a week or two
or three probably at the most. (ID07)
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NP, peds,
U
PA,
family, R

Category: Provider Interaction (Definition: Availability of specialist for consultation
and multidisciplinary care (nutrition and behavioral health services).
Code: Guidance from experienced providers
Honestly I went to my supervisor and we kind of, she has the set rules of
PA,
what bloodwork was ordered. (ID75)
family, R
Yeah I think I learned a lot in my own, in the practice that I’m in because
we have providers who have been there for thirty years and, you know,
our program tends to stay on top of, you know, latest research and we try
to implement or at least communicate what’s new, and so there’s always
someone that you can bounce a case off of or discuss with. (ID42)
So we do have some other providers in our offices that are a little more
comfortable and provide more GYN services it’s just sometimes we’ll lean
on them internally to get some help for those families. (ID25)
There’s one of the other physicians that I work with, does largely, she is
only in one of our offices that I visit, but she does much more with
women’s health and especially with our pregnant patients. So she had
created a little flow chart of management but I think she uses ACOG for
most of her stuff. (ID29)

NP, peds,
U
PA, peds,
R
PA,
family, R

NP, peds,
U

I feel like I can consult with some of the attending in my teams for more
advanced questions so I’ll often involve them when I need to. (ID40)
Code: Peer Collaboration
I’ve been here a little over two years and when I started, the other PA and
I did not really know a lot about PCOS, but working together we kind of
did a little of our own research and kind of bounced ideas off of each
other and put together, I think we got a little bit better at it. (ID07)
I mean I think all of the providers in our offices are having conversations
about concerns or other presenting pieces that might lead them to
diagnosis of PCOS. (ID25)
So, going to different trainings. We tend to, we all can’t go to Society of
Adolescent Health Medicine annual conference but we all take turns and
people bring back the information. (ID42)
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PA,
family, R

PA, peds,
R

NP, peds,
U

And so I haven’t sat down to look at all of them and review them and do
the research I’m just learning clinically from different people that I talk
to. (ID40)

NP, peds,
U

It’s usually colleague input and then also some joint shared decision
making with the family and different comorbidities and working with
what’s bothering them and what they think could work with their lifestyle,
usually. (ID40)
And it’s something I’ve learned a lot about in this clinic and I’m still
continuing to learn about and so I appreciate all these different inputs
from people but it’s just a lot of info out there in general. (ID40)
Code: Collaboration with Specialists (Collaborative relationship with specialists that
allow for direct guidance versus reliance on patient referrals alone.)
So that lab panel is what our practice decided on but it was in
PA,
consultation with our local endocrinologists. (ID50)
pediatrics,
S&U
…because of us having pretty decent relationships with a lot of specialists
we do manage a little bit more of our complex conditions at least to an
extent. We manage a lot of conditions with either consultation by phone
with the specialists or even just consultation with some of the providers
here that have been working in the area since the eighties I believe is the
earliest. (ID50)
But sometimes Endocrine can get busy with diabetics and other endocrine
disorders so they may see them and then refer them back to you so you
can manage….. they may make a recommendation and then we go ahead
and follow that recommendation. (ID42)

NP, peds,
U

Category: Practice structure and policies (Definition: Practice or organizational
policies or services that impact availability of resources or provider’s autonomy in
addressing PCOS in adolescents. Practice settings vary, but it is the structure and
policies unique to each practice that support or restrict provider practice.)
Code: Restrictive practice policies
I think that we could do more on our end with a full lab and diagnostic ability PA,
to help rule out or rule in a potential diagnosis and then refer as needed. But family
right now how our protocol is set up is if it’s a suspected PCOS we would do U
those three labs and then refer. (ID31)
The practice that I mainly work in is urgent care. Percentage wise overall the
company does twenty-eight percent of primary care. And really [we] would
be a first line to detect any potential diagnosis of a hormone imbalance and
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the potential for PCOS. But right now how our protocol is set up is if it’s a
suspected PCOS we would do those three labs and then refer. (ID31)
I will say I wish that we did more to help with some of the management but
it’s tough
on the urgent care side because you don’t want to get into the
primary care role. But the issue that we see is that because urgent care exists
there’s a lot of teens, a lot of that tween age that do not have a primary care,
they don’t have a pediatrician, they don’t have a family medicine doctor. And
so I feel like that’s a group that’s missing some good guidance. (ID73)

PA,
family,
R&S

So right now with our being in urgent care what we’re sort of forced to do is
not really do too much at the site testing wise or long-term medication wise
or anything, we end up referring to gynecology. (73)
Honestly I’m just there to do a quick visit and get them moving…. Weʻre sort
of a hybrid practice where we do some primary care and some, mostly urgent
care so sometimes they’re really not really our primary patients. (ID32)
PAs and NPs do not have their own panel of patients. [This is]one of the
reasons that I do not see a lot of adolescents and adolescents with PCOS.
PAs and NPs will get moved around. Ideally I would have I follow up with
patients who I have ordered a diagnostic work up for or started treatment. I
feel that it [PCOS] is under diagnosed, due to limitations as above in both
the practice setting I am in, in addition to limitations placed by
patient/parent. (ID15)

NP,
family,
S
PA,
family,
S

And it’s really hard, I think follow-up is really inconsistent, follow-up and
continuity and so it’s hard for me. I don’t always see a patient I diagnose or I
saw for follow-up again all the time, sometimes but not always and I think I
would like to do that to assess how many interventions are helping.(ID 40)

NP,
peds,
U

Probably one of the things that, again it’s probably my biggest concern is,
who’s following my labs? Who’s following my referrals? (ID 36)

PA,
family,
U

Code: Healthcare Safety net programs
We have a provider in school so if they leave me and go from the middle to
PA,
the high, or the elementary to the middle we can continue those conversations peds,
to keep it important and relevant. I think that with a lot of our chronic
R
conditions including just obesity in itself we have a much better way of
managing it when we use our school based health centers within our own
FQHC for our kids that we provide primary care to just because it is more
individualized, it’s more one-on-one. They have more access to providers
than they would just a regular clinic. (ID25)
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They [a federally qualified health center] have been around a long time and
have this very unique partnership with the health department in that we
manage all of their contraceptive needs and they manage all of our family
practice needs. (ID16)

PA,
family,
S

Yeah at the [named removed for confidentiality] we do have a nutritionist on
staff so the way the appointments flow is that they see myself and a
nutritionist at each visit so that’s been really nice. (ID47)
Code: Patient exposure
And in adolescents the hard part too, I don’t know what venue of medicine or
what venue of research you do on a regular basis but adolescents are pretty
tough because once they get over age twelve, thirteen and we give them that
last tetanus booster so they can get into high school, basically we don’t see
them for well checks. (ID19)

MD,
peds, S

So we see that as early as really even thirteen years old is about when we
start to think late menstruation. So I would say it’s on a differential as low as
thirteen but to come back and confirm diagnosis really has been above
eighteen that we’ve seen so far. (ID31)

PA,
family,
U

I work at a primary care practice that primarily focuses on or sees almost
exclusively adolescent patients twelve to twenty-two. And we also provide
adolescent medicine consults for community providers. So I address PCOS in
two ways by identifying it through surveillance or routine primary care and
addressing acute concerns that are PCOS related and then a subsequent
workup as well as tend to follow-up for already identified PCOS. And then
sometimes, not too often, but sometimes consults or consult follow-up for
community providers. (ID40)

NP,
peds,
U

We do see a lot of adolescents. We don’t have a separate nearby adolescent
center so we do see a good amount of adolescents. (ID69)

MD,
peds,
U

I think at our clinic we see a lot of teens and I think people are more
comfortable dealing with teen adolescent issues but in general I know
pediatricians tend to like, you know, the ones who like teens are doing
adolescent health, and so, in general. There are a number of us who really do
like working with adolescents and dealing with adolescent life issues. (ID69)
I think we’re really focused on contraception with those teens [teen moms]
it’s like a focus so a lot of them are on contraception so evaluating their
menstrual cycles is a little bit difficult. So I don’t think it’s common to be
thinking about or talking about PCOS. (69)
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I think the other practitioners do similar things although the other PA and I
probably see more teenage girls than the doctors because they’re both male
and older so I think a lot of times they would just feel more comfortable
talking about their periods with us anyway. (ID71)

PA,
family,
R

We do have a decent amount of patients who a lot of times they’re overweight PA,
and having that irregular cycles and their mom brings them in because of
family,
that. That’s typically the patients that I run into that’s obvious. (ID73)
R&S
Category: Provider Behavior Evaluation
(Definition: Provider perception their own personal comfort level/confidence in
managing PCOS and patient benefit.)
Code: Provider discomfort with treatment
I’m not sure from a management perspective that a lot of providers are really PA,
comfortable with the management of it. I think we’re comfortable with talking peds,
about it, we’re comfortable with addressing it and pointing out features or
R
things that we notice that may lead us to be suspicious. But I think once it
becomes more of a management of it or we get close to a diagnosis then I
think a lot of us feel more comfortable to refer. I know it a be a lot easier if
we could feel a little more comfortable managing it ourselves.(ID25)
I think it is an area where pediatricians don’t feel that much comfort. I think
MD,
it would be great to feel more empowered to more easily diagnose and treat
peds,
it. (ID69)
U
And I think that’s more of a reluctance to prescribe medications off label in a PA,
younger population if it’s not really implicated. (ID16)
family,
S
So I’d say I don’t know that my counseling [on life style modifications]
MD,
changes a whole lot other than just letting them know your BMI is already
peds, S
elevated, you have PCOS, this is something that we’re watching. But I would
say from a general pediatrician standpoint I don’t think most pediatricians
though are going to be comfortable or be the ones that are managing
Metformin, I think more so general pediatricians are comfortable with the
birth control aspect but not necessarily the Metformin piece. (ID47)
I can’t say that I’ve ever done Metformin in an actual teenager at that age.
PA,
(ID71)
family,
S
I think when it comes to pediatric patients a lot of times it’s easier to just
PA,
wash your hands of it and say this isn’t in my wheelhouse because people
family,
aren’t as comfortable with, okay what should I do in the pediatric
R&S
population? Can I prescribe this in the pediatric population? And I think that
that leads to lack of care. (ID73)
Code: Provider confidence in treatment options
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Oh, and the people actually do really well and the Metformin along with diet
changes just helps people control those cravings better. They have less
fatigue and brain fog and just to start feeling overall better. (ID01)
But for a lot people their concern is this irregular menstrual cycle and so one
thing that’s easy to start with is just like this [contraception] will help make
your menses more regular and so they’re more predictable and so you’re
kind of like, people feel reassured when they’re having a monthly menstrual
cycle. (ID69)
My goal of treatment with metformin is to help regulate symptoms of weight
gain and fatigue. Patients will have more energy when on metformin.
Sometimes it also helps to regulate menses. (ID15)
And then I would say just the response of patients or the concerns that they
have I think is the biggest thing. I try to make sure that I’m addressing their
concerns and not just mine and so I try to listen to not only the teenagers but
their parents and brothers and sisters, relatives that are there for them. I try
and listen to what their concerns were, how they’d like to manage things
differently. (ID50)
Yeah usually it’s mostly I’ve got this pool of options, what’s most important
to the family, what is needed, and medically kind of important for their health
protection and what can they do with their routine and what else are we
addressing like diabetes concern or a pregnancy prevention, acne, hair
growth, whatever. (ID40)
And sometimes we’ll go ahead and start the patient on Metformin if it’s a
situation where the BMI is very elevated and pre-diabetic and its showing
insulin resistance or, you know, manifestations of PCOS, we may just go
ahead and start them on medication. (ID42)
But I think the advantage is that they can start working on treating the, not
just covering up the symptoms, but treating the problem and understanding
why they’re getting, you know, hairs on their chin or you know why they
can’t lose weight when they’re eating what they consider a normal diet,
things like that. (ID01)
I’d say the advantages is to get treatment early, make some behavioral
interventions such as nutritional diet, weight loss, maybe hormone therapy if
they need it earlier rather than waiting and then they have all these other
issues that happen over time, maybe infertility or something like that. If it
happens over time they’re confused about why is this happening to me when
it could really be something addressed earlier. (ID32)
I think with all of those things the sooner you can get them into the right kind
of treatment the downstream effects are pretty great and that’s from a
psychological as well as a physical health perspective because it’s like you’re
saying you’re decreasing body habitus and hirsutism and all those other kind
of things where they’re not just standing out as much I think is pretty
impactful. Do I think we’re doing a great job of it? No, but we can always be
better with it, a lot of things can always be better. (ID16)
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Category: Provider Perception of Patient Factors (Definition: Participants
recognized multiple patient factors that are unique to the adolescent population and
that may serve as barriers or facilitators to addressing PCOS with their scope of
practice.)
Code: Parent/caregiver influence
Subcode: Parent/caregiver hesitation and opposition to treatment
The disadvantage is parent involvement in this age group and the insertion
of their opinion on their child. (ID15)
So I think there’s sometimes a hesitancy to talk about it because there really
isn’t a solution or the family at least doesn’t see there is one. (ID25)
Yeah I would think, yeah, yeah, birth control first parents it’s a really hard
thing because they’re like “I don’t want my daughter to be promiscuous on
birth control. That’s not something we’re ready for at this time.” And then
sometimes for some, we talk about Metformin and they [parents] hyper focus
on “well they don’t have Diabetes, it’s not Diabetes yet. You know, why do
you want to use this? Why do we need this? Why do they have to take this?”
So sometimes there is some barrier with that just by way of what the
preconceived notion of what those medications treat and what kind of patient
they treat sometimes too. (ID19)
There are definitely some patients whose parents will not let them take birth
control at all; no matter what symptoms their teenagers are having they’re
not going to let them go on birth control. (ID71)
Well you know, there, obviously oral contraceptives can bring up a whole
host of problems in terms of whether or not their religious beliefs dictate that
that should not be something that they should be using, so often times that
does come up. There are a lot of patients in the Southern Maryland area that
just simply don’t want to take medications and that is problematic. (ID57)
I think parents just really associate Metformin with saying my child has
diabetes so I find that they tend to be, or parents have personal experience of
being on it. (ID47)
So some of them the parents just aren’t comfortable with it even though I try
to sit down with them and explain this is not just about birth control it’s a lot
of not sexually active women who are doing this, it could be really be helpful
for the hormone control. (ID54)
Subcode: Adolescents with limited control
I would say that sometimes it becomes how, like how concerned is the family.
(ID47)
A lot of kids don’t have full control over the advantage things especially
when it relates to obesity. There’s not a lot of options around us for fitness
and what they’re eating, what their parents buy and so those conversations
are hard. Just try to expand it for them and let them see opportunities where
they can make changes, make good choices on their own. (ID25)
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And often I probably do talk about carbs and I guess engaging the parent too
to make sure they have the choices and the right choice in the house and less
of the other choices because I think that ends up being a lot of the problem
especially if the teenager doesn’t drive and stuff. (ID71)
Subcode: Normalizing chronic conditions
And then just the socio-economical piece of it like a lot of our families are
overweight so they normalize it. A lot of them don’t have access to the
healthier foods and opportunities for physical activity and so that’s a
challenge as well. (ID25)
I do ‘cause I think there’s a misconception about hereditary diseases and so
like for instance diabetes can run in people’s families that we tend to see and
they may not be as alarmed. (ID42)
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Not that their health isn’t important but they may not see, you know, someone
that we consider overweight may not feel like they’re overweight. (ID42)
Code: Addressing Complex Topics
Disadvantages are just the hard topics that we have to go through. The
weight piece is always a struggle. (ID25)
Disadvantages is in how you do it [counsel patient] going back to the fertility
thing and the weight thing, you don’t want to freak them out for lack of a
proper term and or freak out the family. You don’t want it to be something
that they’re going to obsess about, oh I’m not going to be able to have a kid
in ten years or I’m going to be obese in ten years. Try not to give them,
making sure they have a positive outlook, letting them know that there are
some risks or there can be some long-term effects but that it’s not definitely
going to happen. (ID71)
I also think from just the psych part of it understanding what’s going on,
what’s going wrong and maybe why things are the way they are in your body.
It’s really important especially to that tween, teen population. (ID73)
I think that a lot of girls when you talk to them about it, the only thing they
know about it when they Google it really quick is that they’re not going to be
able to get pregnant someday, which is just not true at all because we’ve got
so many great management options for that and many women with PCOS
don’t even have a problem getting pregnant. So I think that that is maybe one
of the biggest downfalls of information that is available to patients. And I
don’t want twelve to eighteen-year old girls worrying about that for in the
future. (ID01)
I’ve also been finding anecdotally in a lot of the teenagers with irregular
periods with or without a diagnosis with PCOS seem to believe that they
cannot get pregnant now, like in the moment. And so this was a number of
patients. I’m not sure how they got that into their head and so I try and do
some counseling related to that and address the education and medication
and physiologic kind of needs of from PCOS. Kind of, so yeah, number one,
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important for addressing these immediate needs is the misconceptions around
pregnancy
(ID40)
So I think prevention’s really important, so I, I usually try to talk with them
about, you know, the course that their disease, you know, how to look for
them currently as adolescents also as young adults in the future (ID07)
if I had to talk about infertility I really would just say in the future if and
when you’re trying to have a baby you might have some difficulty with
conceiving but there are ways to treat that and just so you know you can go
to the gynecologists or a fertility specialists at that time (54)

PA,
family,
R
PA,
peds, S

I would say it may, especially if they’re engaging in high risk sexual activity.
If you’re telling them it’s unlikely you’re going to be able to have a baby
because of PCOS it may be less safe when they are having sex and things
because they’re like I’m not going to get pregnant. (ID47)
So the way I try to explain to my teens is if you can work with some of these
things early on it prevents them of a lifetime of chronic illnesses such as
diabetes and hypertension. (ID42)
Code: Patient health seeking behavior

MD,
peds, S

I think it’s a growing diagnosis whether it be further recognized and people
are following up and becoming more educated on it at this point. So, we’re
seeing more questions regarding it from patients as they think that they have
PCOS. (ID31)
And I’d say probably the biggest complaint that we have is girls who come in
usually with facial hair growth that they’re concerned about. But sometimes
we also just get late teens who girls, who have menstrual irregularities or
amenorrhea and then you have more of a metabolic syndrome kind of picture
but I would probably say hirsutism is probably the biggest presenting
symptom. Hirsutism is probably the biggest thing that prompts the lab work
and so that’s something that I find that girls are very self-conscious about
and very much want to work up and get rid of. (ID29)
Most patients are willing to try it because again if they’re overweight, maybe
they have some other abnormal labs whether it’s cholesterol or something
like that that they are willing to try something to see if it makes a difference
in their, just how they feel energy wise. Or if the weight loss is a goal that
they have sometimes they’re willing to try that just for that possible weight
loss that Metformin can have. And I always tell them that my goal in seeing
them is “if we can make you happy and healthy now you’ll be happy and
healthy later” and so they tend to understand that and are okay with putting
in the work. (ID50)
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Ways to Address (Definition: Provider input regarding actions to address barriers
and support facilitators in addressing PCOS among adolescents in primary care
practice).
Code: Improve Practice Support
Subcode: Change in practice policies
Change in practice culture and policy. It is never going to change. (ID15) PA,
family, S
I think something to show [to practice leaderships] the benefits of it, why
PA,
it’s [addressing PCOS in primary care setting] important just something
family,
that I could bring to the table when we have our provider meetings and
R&S
stuff to say “you know hey we should probably look into managing this a
little bit better when we see it,” that would be helpful. (ID 73)
Subcode: Increase Patient Visit Duration
In my ideal world I would have an hour time to talk to the teen and the
NP, peds,
parent about PCOS and be able to, you know, listen and educate and
U
make sure they understood what they heard. You know. As opposed to you
coming in and it’s a crazy day and you have a good twenty minutes with
them and you’re shouting out, not shouting out but you know “we’re
going to check you hemoglobin A1C today. We are going to look at your;
we might need to start you on something to help regulate your period.
And see you in three months.” That doesn’t feel so good sometimes. So in
an ideal world you would be able to spend more time with a patient
making sure they understand what’s happening. (ID42)
I think the biggest thing I would like to change is having more time to be
able to talk to them [patients and their caregivers] about it because it’s
such an all-encompassing disease that is I think misunderstood by a lot of
people. (ID01)

PA,
family, S

One would probably be more time with the patient, I feel like most people
would say that. (ID75)
Subcode: Engagement of Clinical Staff
So I think educationally, having the, I would like to see more
educational opportunities on a variety of health literacy levels so that’s
both from patient perspective, family perspective but also then staff
training wise. We have individuals who are medical assistants or aides,
they aren’t even technically MA’s that are helping with paperwork and
scheduling appointments so if they could understand a little bit more what
this means in a patient presentation. And that could flag it for us and also
help them ask the right questions. (ID 16)
I would say honestly more time with our patients, either more screening
tools or more just time to ask those questions and delve into those
histories as well as potentially having one of our providers or nurses or
someone be a point person for that. Because I know we have point people
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for depression and suicidality and we have someone who really focuses
on Autism screening and developmental delays. And so if we could have
someone who almost kept us accountable for that I think that would be
helpful. (ID50)
Subcode: Process for Patient Follow-up
My thing is sometimes we don’t have the best follow-up so it’s hard to
say because you don’t really know. Someone could tell you in the office
“yeah this is great. I’ll start it. And then you’re not really following
through with it you don’t really know that they’ve actually started and
they may have had concerns about it and so forth. (ID36)

PA,
family, U

And it’s really hard, I think follow-up is really inconsistent, follow-up and NP, peds,
continuity and so it’s hard for me. I don’t always see a patient I diagnose U
or I saw for follow-up again all the time, sometimes but not always and I
think I would like to do that to assess how many interventions are helping.
Yeah, I think it would be great if we had a better follow-up system, some
targeted education materials. (ID 40)
One, I think that there could be a better way of flagging any patient at
risk. So any time anything like acne or irregular period or obesity comes
up that that would be some way to flag every patient so that no one really
gets missed. (ID54)
Code: Education/training
I sort of would love to just have, have like an educational professional
development session from an adolescent doctor or an endocrinologist of
like this is what I do and make sure that it aligns with what I do or feel
more empowered to be like okay this is what I’m going to do in every case
so it didn’t feel like I was re-looking it up or re-figuring it out each time.
…. kind of reinforcing what specific OCPs they use and when they would
consider additional treatments like Metformin or Spironolactone; like are
those things that are reasonable for us as general pediatricians to be
prescribing? Is that something like if X, Y, Z isn’t going as expected then
we would refer to adolescent and we would be the ones to decide to add
those things. (ID69)
I think some sort of training, yeah I think a training. And my supervising
physician has also mentioned that if she could go through a training, like
at Children’s or something that would make us much more comfortable.
(ID54)
New evidence based guidelines that I might learn about from UptoDate,
in person CME.(ID15)
Code: Point of Care Protocols
I think it would be nice to have just more just almost like an algorithm
that people are following just more regularly in the community I think. I
feel like I’ve been to lots of talks and with PCOS there’s just so many
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different diagnostic criteria and so sometimes patients don’t necessarily
meet all of them. (ID47)
It really is just implementing a more specific flow sheet. So, all of our
electronicmedical records are created in-house so they’re created by a
group of medical providers and I think it would just be more education on
our part to be able to accurately come up with a good flow sheet and say;
patient presents with this, these are the labs that we’ll do and this is what
we suspect. (ID31)
So it would be helpful to have a deeper understanding of how to recognize
it, warning signs of this and a kind of just a further protocol of what we
can do more so in all settings of medicine and not just specialties. (ID31)
New evidence based guidelines that I might learn about from UptoDate,
in person CME. Sometime ACOG guidelines, but those are difficult to
access unless you get them through another source. Cannot go through
ACOG website easily if not a member.” (ID15
Code: Collaboration with Specialists
I guess what I would change [pause] is being a little bit quicker to treat
and at the same time what I would love to do is just feel more confident
and have, and that requires just some more knowledge and guidelines
from the experts. (ID69)
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And we’ve had some significant turnover with OBGYN groups in the area
so I would wonder if having us all be on the same page and maybe they
can even do an in-service for us on how we can sometimes manage some
of the stuff in-house for us. (ID16)
Code: Resources for Provider-Patient/Caregiver Communication
It would be nice to know early on if there’s things we could prepare them
for especially for irregular periods and stuff so we can start giving them
the tools they need. (ID71)

PA,
family, S

Maybe just learning about how to have that conversation with them even
better in the young population. (ID07)
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NP=Nurse Practitioner; MD= Medical Doctor; PA=Physician Assistant; peds=pediatric
practice focus; family=family medicine practice focus; R=rural practice region; S=suburban
practice region; U= urban practice region
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